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 CHAPTER 1 
 GENERAL INTRODUCTION ON COORDINATION POLYMERS  
“One of the continuing scandals in the physical sciences is that it 
remains in general impossible to predict the structure of even the 
simplest crystalline solids from a knowledge of their chemical 
composition”.                            J. Maddox (Nature, 1988, 335, 201)
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Through these twenty years a myriad of successful studies on this complex subject 
have been conducted and so nowdays this statement has become not completely 
true. An ever-increasing number of elegant, beautiful and useful functional 
architectures has been designed and synthesized. Therefore the fast growing interest 
for molecular design has result in the birth of a new branch of chemistry: crystal 
engineering2,3. The “golden rule” in crystal engineering is that molecular structure are 
built on covalent and non covalent intermolecular interactions. Thanks to these we 
are able to control the rational design of two-(2D) and three-dimensional (3D) 
architectures4.  
 
Figure 1. Examples of natural and synthetic self assembly process. 
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Learning from Nature, crystal engeenering studies the way to include specific 
functionalities in well-defined molecular conformations to drive the packing 
geometry. Nature can combine simple molecules, to create very complex aggregates 
with very specific features, such as proteins. This process occurs through the use of, 
mostly on 3D aggregations, weaker non covalent interactions such as H-bonding, 
charge-charge, donor-acceptor, π stacking and Van Deer Waals forces. In crystal 
engineering5 we use our knowledge to match these interactions in a studied algorithm 
to build fascinating supramolecular architectures with useful characteristics. Thanks 
to the extremely large number of possible application much attention has been 
focused on coordination polymers6 (CPs) and in particular on porous coordination 
polymers (PCPs) or porous coordination networks(PCNs)7. The backbone of these 
coordination polymers consist of metal-ligand coordinative bonds forming polymeric 
or oligomeric species which extend “infinitely” into one, two or three dimensions via 
more or less strong non-covalent interactions. The network design but primarily the 
structure-function relationship are determined by the interplay between the ligand 
and the metal centre.  
 
 
Figure 2. Schematic rappresentation of one, two and three-dimensional coordination 
poymers. 
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Transition metal, driven by their preferred coordination geometry can act as acceptor 
units that can self assemble with the donor ligands into predictable structures. The 
metals in fact act as nodes into the scaffold and favours the formation of the 
supramolecular assembly8–10.  
 
Figure 3. Silver metal ions geometry and the corresponding coordination polymers. 
The ligand plays a key role in the control of the architectures. It has to be at least a 
bridging ligand on order to build network11,12. These ligands are called multitopic 
depending on the number of donor atoms. Also the mutual orientation of these donor 
atoms define the ligand geometry and so the coordinative directionality. For example, 
multicarboxylate ligands are largely used to design coordination polymers13–15. They 
can describe bridges or define angle of 120 degree in the structures. The steric control 
and the coordination sites orientations are crucial in the design of a porous materials.  
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Figure 4. Examples of nitrogen and oxygen donors ligands useful for the construction 
of coordination polymers. 
Ingenious modifications of the organic ligands can control the physical and chemical 
properties. For example in PCPs the size, the shape and the geometry of the pore are 
dominated by the length, the shape and the orientation of ligands. The elegant kinetic 
reversibility between complementary building blocks in the coordination polymers 
yield a new way to yield a “correct” product that is thermodynamically more stable 
then the starting components. This is possible thanks to the synergy of metal-ligand 
bond energies (15-50 kcal/mol) and weak interactions (0.5-10 kcal/mol) which 
stabilizes a supramolecular isomer with respect to the others. Another main feature 
of the ligand is the flexibility. Flexible ligand can give rise to flexible architectures 
useful in the design of porous materials. But on the other hand a rigid ligand can 
afford robust coordination polymer highly sought because of the foreseeable wide 
applications. In fact last decade has seen enormous research efforts in the synthesis 
of materials for reversible exchange of guest molecules. The problem with 
host/framework stability in the absence of guest molecules is fundamental to design 
materials for catalysis, gas storage5 and gas separation16–18. The coordination 
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polymers’ applications are not confined in zeolitic behavior but range in 
luminescence19, chirality, non linear optics20, magnetism21, conductivity, controlled 
drug release materials22 and many others.  
 
Figure 5. A chart of possible applications of three-dimensional coordination polymers.  
For these reason in the following chapters we focus our attention on how ligand 
conformation and characteristics can influence the molecular structures and what 
type of interactions are involved in self-assembled porous molecular capsules23. We 
studied how slight ligand modifications (steric and electronic) can yield  different type 
of coordination polymers. We have also investigated how weak interactions can 
influence the porosity in specific coordination polymers. 
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CHAPTER 2 
 
Crystal engineering of multidimensional Copper (I) and 
Silver (I) coordination polymers with flexible ligands. 
 
In this chapter24 we present here a new ligand class based on a bispyrazole scaffold 
functionalized with a flexible (-CH2-S-Ph) thioether function: L
RCH2S. The steric and 
electronic features are varied by changing the substituents on the 3 and 5 positions of 
the pyrazoles (R=H, Me, i-Pr). The X-ray molecular structures of Ag(I) and Cu(I) binary 
complexes with LRCH2S using different types of counterions (BF4
-, PF6
- and CF3SO3
-) 
reveal that the ligands are suitable components for the construction of coordination 
polymers. In these complexes, the ligands N2 chelate on a metal center and bridges on 
a second metal with the thioether group yielding a polymer. On the other hand, when 
using thiphenylphosphine as an acillary ligand, mononuclear ternary complexes 
[M(L)PPh3]
+ (M = Cu(I), Ag(I);  LRCH2S) are formed. Therefore, from preliminary results, 
the methylene group acting as spacer in LHCH2S imparts an inherent flexibility to this 
ligands so the conformation responsible of the N2S chelation is energetically 
accessible. 
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2.1. Introduction 
Coordination polymers have attracted much attention because of their possible use in 
the development of new functional material. In fact the possible applications of these 
various 1- to 3-dimensionality systems can be grouped into diverse fields such as 
catalysis25, gas adsorption26 (gas separation27 and gas storage28,29), molecular 
recognition30, luminescence31,32, magnetism33,34, and drug-delivery35. Crucial to the 
development of coordination architectures is the ability to design multitopic organic 
ligands that can bind the metal center in a predictable way determined by their 
preferred conformation. With this respect the ligands may be defined as rigid or 
flexible according to the high or low energy barrier, respectively, that separates two 
or more ligand conformers36. The choice of the metal atom as node in the 
construction of coordination polymers is also of great importance since its 
stereoelectronic requirements, i.e. coordination numbers and geometry, heavily 
influence the overall shape of the resulting polymer. Ag(I) is a fashionable metal node 
for the construction of coordination polymers and it has been used extensively for 
this purpose. The lack of crystal field effect allows for the occurrence of different 
coordination geometries, but the most common are the linear, trigonal planar, T-
shaped, and tetrahedral geometries. In literature there are many example of Ag(I) 
coordination polymers in which the nature of the donor ligand may lead to the 
formation of different frameworks with tailored structures and functions37–43. In this 
chapter we present a ligand class based on the bis-pyrazole system functionalized 
with a flexible (-CH2-S-Ph) thioether function: L
RCH2S (R=H, Me, iPr), (Figure 6). The 
molecular structures of Ag(I) and Cu(I) complexes with LRCH2S using different types of 
counterions (BF4
-, PF6
- and CF3SO3
-) are reported and they show how the flexibility of 
the thioether group influences the formation of polymeric structures. Ternary 
complexes using triphenylphosphine as ancillary ligand of the type [M(LRCH2S)PPh3] 
(M=Cu(I) and Ag(I)) are also described and they more clearly show the different 
conformational behavior of ligands.  
14 
 
 
 
Figure 6. Synthetized ligands LRCH2S with different substituents on 3 and 5 positions 
of pyrazoles. 
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2.2. Experimental 
2.2.1. Synthesis 
General Procedures: All reagents and solvents were commercially available, except  
for 3,5-dimethylpyrazole, 3,5-diisopropylpyrazole, 2-(phenylthio)acetaldehyde, 
bis(pyrazolyl)ketone, bis(3,5-dimethylpyrazolyl)ketone, bis(3,5-
diisopropylpyrazolyl)ketone, which were prepared as reported elsewhere44–46. 
Tetrahydrofuran (THF) were distilled over Na/benzophenone. The syntheses of the 
ligands were performed in inert gas (N2) using Schlenk techniques. 
1H and 13C NMR 
spectra were recorded on a Bruker Avance 300 spectrometer using standard Bruker 
pulse sequences. Chemical  shifts are reported in parts per million (ppm) referenced 
to residual solvent protons. Infrared spectra were recorded from 4000 to 700 cm-1 on 
a Perkin-Elmer FTIR Nexus spectrometer equipped with a Smart Orbit HATR accessory 
(diamond crystal). Elemental analyses (C, H, and N) were performed with a Carlo Erba 
EA 1108 automated analyzer.  
Synthesis of 1,1'-(2-(phenylthio)ethane-1,1-diyl)bis(1H-pyrazole) (LHCH2S). A mixture 
of bis(pyrazolyl)ketone (1.90 g, 11.71 mmol), (phenylthio)acetaldehyde (2.00 g, 13.14 
mmol) and CoCl2.6H2O (5 mg) was heated at 80°C for an hour with stirring. The 
mixture was then cooled at room temperature and stirred overnight. 
Dichloromethane (30 mL) was added and the mixture was stirred for 30 minutes. The 
organic phase was washed with water (50 mL) and brine (20 mL), dried with 
anhydrous Na2SO4 and filtered. The solution was concentrated under vacuum yielding 
a dark brown oil  (yield 2.86 g, 89%). IR (cm-1): 3117w, 3057w, 1747m, 1388m, 1086m, 
1035m, 737s, 689s, 618m. 1H NMR (300 MHz, CDCl3): δ, 4.01 (d, J =7.5 Hz, 2H, CH2), 
6.27 (t, J =2.1 Hz, 2H, CH Pz), 6.40 ( t, J =7.2 Hz, 1H, CH), 7.37 (m, 5H, CH Ph), 7.56 (dd, 
J1 =2.1Hz, J2 =9.6Hz 4H, CH Pz). Anal. Calc. for C14H14N4S (270.35): C, 62.19; H, 5.22; N, 
20.72. Found: C, 61.96; H, 5.07; N, 20.51.  
Synthesis of  1,1'-(2-(phenylthio)ethane-1,1-diyl)bis(3,5-dimethyl-1H-pyrazole) 
(LMeCH2S).  The procedure used to prepare L
HCH2S was applied by using a mixture of 
bis(3,5-dimethylpyrazolyl)ketone (2.18 g, 9.88 mmol), 2-(phenylthio)acetaldehyde 
(1.50 g, 9.85 mmol) and CoCl2.6H2O (5 mg). The solvent was removed under vacuum 
and a dark green oil was obtained (yield 2.00 g, 62%). IR (cm-1): 2920m, 2865m, 
1742m, 1559s, 1438m, 1416s, 1378m, 1312m, 1268w, 1024s, 780m, 739s, 690m. 1H 
NMR (300 MHz, CDCl3): δ,  2.16 (s br, 6H, CH3), 2.18 (s br, 6H, CH3), 4.09  (d, J =7.2 Hz, 
2H, CH2), 5.75 (s, 2H, CH Ph), 6.25 (t, J = 7.2 Hz, 1H, CHcentral), 7.27 (m, 5H, CH Ph). Anal. 
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Calc. for C18H22N4S (326.46): C, 66.22; H, 6.79; N, 17.16. Found: C, 66.09; H, 6.21; N, 
17.01%.  
Synthesis of 1,1'-(2-(phenylthio)ethane-1,1-diyl)bis(3,5-diisopropyl-1H-pyrazole) (Li-
PrCH2S).  The procedure used to prepare L
HCH2S was applied by using a mixture of 
bis(3,5-diisopropylpyrazolyl)ketone (0.77 g, 2.34 mmol), 2-(phenylthio)acetaldehyde 
(0.36 g, 2.34 mmol) and CoCl2.6H2O (5 mg). The solvent was removed under vacuum 
and the crude was purified by silica column chromatography (hexane: ethyl acetate 
95:5, r.f. 0.22) and a dark green oil was obtained (yield 0.30 g, 29%). IR (cm-1): 2972m, 
2932m, 2868w, 1665w, 1546m, 1473m, 1459w, 1331w, 1315m, 1260w, 1178w, 
1064m, 1016m, 931w, 808s, 750m, 701m, 652w, 557w. 1H NMR (300 MHz, CDCl3), : δ,  
0.86 ( d, J = 6.9 Hz, 12 H, CH3 i-Pr), 1.26 (d, 12 H, CH3 i-Pr), 2.91 (m, J= 6.9 Hz, CH i-Pr), 
3.21 (m, 2H, CH i-Pr), 4.09 (d, J = 7.2 Hz, 2H, CH2) 5.84 (s, 2H, CH Pz), 6.59 ( t, J = 7.2 
Hz, 1H, CHcentral), 7.16-7.24 (m, 3H, CH Ph), 7.36 (d, 2H, CH Ph). Anal. Calc. for 
C26H38N4S (438.67): C, 71.19; H, 8.73; N, 12.77. Found: C, 70.99; H, 8.66; N, 12.39%. 
Synthesis of [Ag(LHCH2S)]n(BF4)n (1). L
HCH2S (260 mg, 0.95 mmol) and AgBF4 (186 mg, 
0.95 mmol) were mixed in acetone (6 mL), and the colorless solution was stirred for 1 
h. The solvent was then removed under vacuum yielding a pale pink solid (180 mg, 
yield 43%). The compound was recrystallized by stratifying diethyl ether over an 
acetone solution of the complex, yielding colorless crystals. IR (cm-1): 3117 w, 3008w, 
1683m, 1445m, 1400m, 1364w, 1290m, 1227m, 1017s, 971m, 906m, 774m, 745s, 
687m, 617m, 485w.1H NMR (300 MHz, (CD3)2CO): 4.45 (d, J = 7.5 Hz, 2H, CH2), 6.52 (t, 
J = 2.1 Hz, 2H, CH(Pz)), 7.25 (t, J = 7.5 Hz, 1H, CHcentral), 7.34-7.48 (m, 5H, CH(Ph)), 7.81 
(d, J = 1.8 Hz 2H, CH(Pz)), 8.25 (d, J = 2.4 Hz 2H, CH(Pz)). Anal. Calc. for C14H14AgBF4N4S 
(464.00): C, 36.21; H, 3.04; N, 12.07. Found: C, 36.45; H, 3.29; N, 12.46%. 
Synthesis of [Cu(LHCH2S)]n(BF4)n (2). In a Schlenk flask under an inert atmosphere (N2), 
a solution of [Cu(MeCN)4]BF4 (240 mg, 0.76 mmol) in 7 mL of dry MeCN was added to 
a solution of LHCH2S (206 mg, 0.76 mmol) in 8 mL of dry MeCN. The colorless solution 
was stirred for 30 min. The solvent was then concentrated under vacuum, and a white 
solid was precipitated after addition of diethyl ether. The mixture was filtered under 
nitrogen to afford a yellow solid (334 mg, yield 97%). The compound was 
recrystallized by stratifying hexane over a dichloromethane solution of the complex, 
which yielded colorless crystals. IR (cm-1): 3130w, 1441w, 1403m, 1289m, 1022s, 
900m, 747s, 690m, 614m, 520m. 1H NMR (300 MHz, CDCl3): δ 3.80 (s br, 2H, CH2), 
6.22 (s br, 2H, CH(Pz)), 7.15-7.35 (m br, 6H, CH(Ph) and CHcentral), 7.52 (s br, 2H, 
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CH(Pz)), 8.00 (s br, 2H, CH(Pz)). Anal. Calc. for C14H14CuBF4N4S (420.02): C, 40.00; H, 
3.36; N, 13.33. Found: C, 39.76; H, 3.65; N, 13.05%.  
Synthesis of [Ag(LMeCH2S)]n(BF4)n (3). L
MeCH2S (180 mg, 0.55 mmol) and AgBF4 (107 mg, 
0.55 mmol) were mixed in acetone (10 mL). The mixture was stirred for 15 min 
yielding a white precipitate. The solid was filtered and vacuum dried. (110 mg, 38%). 
The compound was recrystallized by stratifying diethyl ether over a methanol solution 
of the complex, yielding colorless crystals. IR (cm-1): 2925w, 1558m, 1466m, 1442m, 
1419m, 1393m, 1319m, 1271m, 1232m, 1024s, 920s, 876m, 801m, 753s, 704m, 690w, 
667w, 654w. 1H NMR (300 MHz, (CD3)2CO): δ 2.45 (s, 6H, CH3), 2.85 (s, 6H, CH3), 4.37 
(d, J = 7.2 Hz, 2H, CH2), 6.10 (s, 2H, CH(Pz)), 6.60 (t, J = 7.2 Hz, 1H, CH), 7.40 (m, 5H, 
CH(Ph)). Anal. Calc. for C18H22AgBF4N4S (520.06): C, 41.53; H, 4.26; N, 10.77. Found: C, 
41.96; H, 4.53; N, 10.55%. 
Synthesis of [Cu(LMeCH2S)]n(BF4)n (4). In a Schlenk flask under an inert atmosphere (N2), 
a solution of [Cu(MeCN)4]BF4 (204 mg, 0.65 mmol) in 7 mL of dry MeCN was added to 
a solution of LMeCH2S (212 mg, 0.65 mmol) in 7 mL of dry MeCN. The red solution was 
stirred for 30 min. The solvent was then concentrated under vacuum and a white 
solid was precipitated after addition of diethyl ether. The mixture was filtered under 
nitrogen to afford a white solid (279 mg, yield 93%). The compound was recrystallized 
by stratifying hexane over a dichloromethane solution of the complex, which yielded 
colorless crystals. IR (cm-1): 3326w, 3002w, 2920w, 1736w, 1556m, 1419m, 1386m, 
1315m, 1265m, 1024s, 739m, 690m, 520m. 1H NMR (300 MHz, CDCl3): δ 1.83 (s br, 
6H, CH3), 2.22 (s br, 6H, CH3), 3.86 (d, J = 5.3 Hz, 2H, CH2), 5.81 (s br, 2H, CH(Pz)), 6.54 
(t, J = 6.7 Hz, 1H, CH), 7.08 (m br, 5H, CH(Ph)). Broad peaks are most likely a 
consequence of the fluxional behaviour of the complex. Anal. Calc. for C18H22BCuF4N4S 
(476.09): C, 45.37; H, 4.66; N, 11.77. Found: C, 45.20; H, 4.22; N, 11.52%.  
Synthesis of [Ag(LMeCH2S)]n(PF6)n (5). L
MeCH2S (323 mg, 0.98 mmol) and AgBF4 (249 mg, 
0.98 mmol) were mixed in acetone (10 mL). The mixture was stirred for 15 min 
yielding a white precipitate. The solid was filtered and vacuum dried. (405 mg, 70%). 
The compound was recrystallized by stratifying diethyl ether over a methanol solution 
of the complex, yielding colorless crystals. IR (cm-1): 3402w, 2926w, 1736w, 1560m, 
1467m, 1420m, 1442m, 1392m, 1319m, 1239m, 1123w, 1037m, 983w, 830s, 750s, 
690s, 654m, 555s, 527m.1H NMR (300 MHz, (CD3)2CO): δ 2.45(s, 6H, CH3), 2.94 (s, 6H, 
CH3), 4.37 (d, J = 7.2 Hz, 2H, CH2), 6.10 (s, 2H, CH(Pz)), 6.60 (t, J = 7.2 Hz, 1H, CH), 7.40 
(m, 5H, CH(Ph)). Anal. Calc. for C18H22AgF6N4PS (578.03): C, 37.37; H, 3.84; N, 9.69. 
Found: C, 37.56; H, 4.02; N, 9.95%. 
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Synthesis of [Ag(LiPrCH2S)]n(PF6)n (6). L
iPrCH2S (78 mg, 0.17 mmol) and AgPF6 (46 mg, 
0.17 mmol) were mixed in acetone (10 mL), and stirred for 20 min. The solution was 
then concentrated and a white solid precipitated after addition of diethyl ether. The 
solid was filtered, vacuum dried, and recovered. (105 mg, yield 86%). The compound 
was recrystallized by stratifying diethyl ether over an acetone solution of the complex, 
yielding colorless crystals. IR (cm-1): 2969m, 2925w, 2865w, 1714w, 1550m, 1462m, 
1434m, 1380m, 1287m, 1259w, 1215w, 1177m, 1111w, 1045w, 1012w, 925w, 821s, 
749m, 687m, 651m, 552s, 486m.1H NMR (300 MHz, CD2Cl2): δ 1.23 (m, 18H, CH3), 1.30 
(d, J = 7.2 Hz, 6H, CH3) 2,46 (m br, 2H, CHiPr), 2.82 (m, J = 7.2 Hz, 2H, CHiPr), 4.09 (s br, 
2H, CH2), 6.11 (s, 2H, CH(Pz)), 6.28 (t br, 1H, CHcentral), 7.42 (s br, 5H, CH(Ph)). Broad 
peaks are most likely a consequence of the fluxional behaviour of the complex. Anal. 
Calc. for C26H38AgF6N4PS (690.15): C, 45.21; H, 5.55; N, 8.12. Found: C, 44.92; H, 5.93; 
N, 8.44%. 
Synthesis of [Ag(LMeCH2S)]n(CF3SO3)n (7). L
MeCH2S (315 mg, 0.96 mmol) and AgCF3SO3 
(247 mg, 0.96 mmol) were mixed in acetone (10 mL), and a white precipitate formed 
immediately. The mixture was stirred for 15 min. The solid was filtered and vacuum 
dried. (150 mg, yield 26%). The compound was recrystallized by stratifying diethyl 
ether over an ethanol solution of the complex, which yielded colorless crystals. IR (cm-
1): 3063w, 2953w, 2920w, 1557m, 1462m, 1444m, 1421m, 1391m, 1325w, 1283s, 
1239s, 1224s, 1146s, 1027s, 978m, 920m, 871w, 795s, 755w, 691w.1H NMR (300 
MHz, (CD3)2CO): δ 2.42 (s, 6H, CH3), 2.88 (s, 6H, CH3), 4.36 (d, J = 7.2 Hz 2H, CH2), 6.08 
(s, 2H, CH(Pz)), 6.58 (t, J = 7.2 Hz, 1H, CHcentral), 7.40 (m, 5H, CH(Ph)). Anal. Calc. for 
C19H22AgF3N4O3S2 (582.01): C, 39.17; H, 3.81; N, 9.62. Found: C, 39.41; H, 3.99; N, 
9.32%.  
Synthesis of [Ag(LiPrCH2S)]n(CF3SO3)n (8). L
iPrCH2S (77 mg, 0.17 mmol) and AgCF3SO3 (43 
mg, 0.17mmol) were mixed in acetone (10 mL), and stirred for 20 min. The solution 
was then concentrated and a white solid precipitated after addition of diethyl ether. 
The solid was filtered, vacuum dried, and recovered. (120 mg, yield 97%). The 
compound was recrystallized by stratifying hexane over a dichloromethane solution 
of the complex, yielding colorless crystals. IR (cm-1): 2969m, 2925w, 2870w, 1544m, 
1465m, 1385m, 1287s, 1232s, 1155s, 1056m, 1023s, 925m, 886w, 843w, 804w, 684m, 
634s, 563m, 508m.1H NMR (300 MHz, (CD2Cl2): δ 1.25 (m br, 24H, CH3), 2.83 (m br, 
2H, CHiPr), 3.06 (m br, 2H, CHiPr), 4.13 (m br, 2H, CH2), 6.11 (s, 2H, CH(Pz)), 6.28 (m br, 
1H, CH), 7.42 (s br, 5H, CH(Ph)). Broad peaks are most likely a consequence of the 
fluxional behaviour of the complex. Anal. Calc. for C27H38AgF3N4O3S2 (694.14): C, 
46.68; H, 5.52; N, 8.07. Found: C, 46.85; H, 5.25; N, 8.36%. 
19 
 
Synthesis of [Ag(LHCH2S)PPh3]BF4 (9). A solution of AgBF4 (57 mg, 0.29 mmol) in 8 mL 
of acetone was added to a solution of LHCH2S (80 mg, 0.29 mmol) and 
triphenylphosphine (68 mg, 0.26 mmol) in 10 mL of acetone. The colorless solution 
was stirred for 15 min. The solvent was then removed under vacuum, the solid was 
triturated with hexane, and a white product was recovered by filtration (140 mg, yield 
73%). Attempts to recrystallize the complex in different solvent mixtures gave 
hexagonal crystals and a gluey material. IR (cm-1): 3123w, 3047w, 1518w, 1474m, 
1430m, 1397m, 1293m, 1047s, 893m, 745s, 690s, 614m, 504s. 1H NMR (300 MHz, 
CD2Cl2): δ 4.08 (t, J = 5.1Hz, 2H, CH2) 6.46 (t, J = 2.4 Hz, 2H, CH(Pz)), 6.99 (d, J = 8Hz, 
2H, CH(Ph)), 7.13-7.28 (m, 3H, CHcentral and CH(Ph)), 7.44-7.66 (m, 18H, CH(Ph) and 
CH(Pz)), 8.23 (d, J = 2.4 Hz , 2H, CH(Pz)). Anal. Calc. for C32H29AgBF4N4PS (726.09): C, 
52.89; H, 4.03; N, 7.71. Found: C, 52.56; H, 4.17; N, 7.96%.  
Synthesis of [Cu(LHCH2S)PPh3]BF4 (10). In a Schlenk flask, and under an inert 
atmosphere (N2), a solution of [Cu(MeCN)4]BF4 (242 mg, 0.77 mmol) in 15 mL of dry 
MeCN was added to a solution of LHCH2S (210 mg, 0.77 mmol) and 
triphenylphosphine (202 mg, 0.77 mmol) in 10 mL of dry MeCN. The colorless solution 
was stirred for 1 hour. The solvent was then concentrated under vacuum and a white 
solid was precipitated after addition of diethyl ether. The mixture was filtered under 
nitrogen affording a white solid (82 mg, yield 85%). The compound was recrystallized 
by stratifying diethyl ether over an acetone solution of the complex, yielding colorless 
crystals. IR (cm-1): 3182w, 3052w, 1556m, 1430m, 1232w, 1094m, 1948s, 996m, 
765m, 745s, 696s, 530m, 510m, 493m. 1H NMR (300 MHz, (CD3)2CO): δ 4.18 (d, J = 3.6 
Hz, 2H, CH2), 6.55 (t, J = 2.4 Hz, 2H, CH(Pz)), 6.63 (d, J = 8.1 Hz, 2H, CH(Ph)), 7.17 (t, J = 
8.1 Hz, 2H, CH(Ph)), 7.24 (m, 1H, CH(Ph)), 7.38-7.58 (m, 15H, CH(Ph)), 7.87 (t, J = 3.6 
Hz, 1H, CHcentral), 8.35 (d, J= 2.4 Hz, 2H, CH(Pz)). Anal. Calc. for C32H29CuBF4N4PS 
(682.12): C, 56.30; H, 4.28; N, 8.21. Found: C, 56.61; H, 4.55; N, 8.36%. 
Synthesis of [Ag(LMeCH2S)PPh3]BF4 (11). A solution of AgBF4 (49 mg, 0.25 mmol) in 8 mL 
of acetone was added to a solution of LMeCH2S (85 mg, 0.25 mmol) and 
triphenylphosphine (59 mg, 0.22 mmol) in 10 mL of acetone. The colorless solution 
was stirred for 15 min. The solvent was then removed under vacuum, the solid was 
triturated with hexane, and a white product was recovered by filtration (135 mg, yield 
77%). The compound was recrystallized by stratifying hexane over a THF solution of 
the complex, which yielded prismatic colorless crystals and hexagonal crystals. IR (cm-
1): 3123w, 3052w, 2970w, 1578w, 1545w, 1518w, 1479m, 1430m, 1397m, 1287m, 
1047s, 920m, 899m, 740s, 690s, 614m, 499s. 1H NMR (300 MHz, CD3CN): δ 2.02 (s, 6H, 
CH3), 2.36 (s, 6H, CH3), 4.02 (d, J = 7.0 Hz, 2H, CH2), 5.99 (s, 2H, CH(Pz)), 6.36 (t, J = 7.1 
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Hz, 1H, CHcentral), 7.03 (d, J = 7.3 Hz, 2H, CH(Ph)), 7.13 (t, J = 7.2 Hz, 2H, CH(Ph)), 7.22 
(m, 1H, CH(Ph)) 7.50 (m, 15H, CH(Ph)). Anal. Calc. for C36H37AgBF4N4PS (782.16): C, 
55.23; H, 4.77; N, 7.16. Found: C, 55.54; H, 5.02; N, 7.31%.  
Synthesis of [Cu(LMeCH2S)PPh3]BF4 (12). In a Schlenk flask, and under an inert 
atmosphere (N2), a solution of [Cu(MeCN)4]BF4 (257 mg, 0.82 mmol) in 10 mL of dry 
MeCN was added to a red solution of LMeCH2S (270 mg, 0.82 mmol) and 
triphenylphosphine (215 mg, 0,82 mmol) in 10 mL of dry MeCN. The pale orange 
solution was stirred for 30 min. The solvent was then concentrated under vacuum and 
a white solid was precipitated after addition of diethyl ether. The mixture was filtered 
under nitrogen to afford a pale yellow solid (200 mg, yield 40%). The compound was 
recrystallized by stratifying hexane over a THF solution of the complex, which yielded 
colorless crystals. IR (cm-1): 3079w, 3057w, 2997w, 2964w, 2915w, 1572w, 1556m, 
1473m, 1345m, 1380m, 1320m, 1271m, 1064s, 909m, 805m, 738s, 684s. 1H NMR (300 
MHz, CDCl3): δ 1.70 (s, 6H, CH3), 2.62 (s, 6H, CH3), 4.05 (s br, 2H, CH2), 5.95 (s, 2H, 
CH(Pz)), 6.50 (d, J = 7.8 Hz, 2H, CH(Ph)), 7.11 (t, J = 7.5 Hz, 2H, CH(Ph)) 7.19-7.47 (m, 
17H, CHcentral and CH(Ph)). Anal. Calc. for C36H37BCuF4N4PS (738.18): C, 58.52; H, 5.05; 
N, 7.59. Found: C, 58.82; H, 5.21; N, 7.89%.  
Synthesis of [Ag(LiPrCH2S)PPh3]BF4 (13). A solution of AgBF4 (28 mg, 0.14 mmol) in 8 mL 
of acetone was added to a solution of LiPrCH2S (65 mg, 0.14 mmol) and 
triphenylphosphine (37 mg, 0.14 mmol) in 10 mL of acetone. The colorless solution 
was stirred for 15 min. The solvent was then removed under vacuum, the solid was 
triturated with hexane, and a white product was recovered by filtration (75 mg, yield 
57%). The compound was recrystallized by stratifying hexane over a dichloromethane 
solution of the complex, which yielded prismatic colorless crystals and hexagonal 
crystals. IR (cm-1): 3129w, 3052w, 2964w, 1584w, 1551w, 1518w, 1474m, 1436m, 
1397m, 1293m, 1047s, 893w, 740s, 690s, 619m, 499s. 1H NMR (300 MHz, CD3CN): δ 
1.02 (m, 12H, CH3), 1.17 (d, J = 6.8 Hz, 6H, CH3), 1.25 (d, J = 6.8 Hz, 6H, CH3), 2.79 (m, J 
= 6.8 Hz, 2H, CHiPr), 3.10 (m, J = 6.8 Hz, 2H, CHiPr), 4.06 (d, J = 6.6 Hz, 2H, CH), 6.17 (s, 
2H, CH(Pz)), 6.55 (t, J = 6.8 Hz, 1H, CH), 7.11 (m, 2H, CH(Ph)), 7.23 (m, 2H, CH(Ph)), 
7.31-7.72 (m, 16H, CH(Ph)). Anal. Calc. for C44H53AgBF4N4PS (894.28): C, 59.04; H, 5.97; 
N, 6.26. Found: C, 59.27; H, 6.03; N, 6.41%.  
Synthesis of [Cu(LiPrCH2S)PPh3]BF4 (14). In a Schlenk flask, and under an inert 
atmosphere (N2), a solution of [Cu(MeCN)4]BF4 (60 mg, 0.19 mmol) in 8 mL of dry 
MeCN was added to a solution of LiPrCH2S (85 mg, 0.19 mmol) and triphenylphosphine 
(50 mg, 0.19 mmol) in 10 mL of dry MeCN. The colorless solution was stirred for 15 
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min. The solvent was then removed under vacuum, the solid was triturated with 
hexane, and a pale pink product was recovered by filtration (135 mg, yield 86%). The 
compound was recrystallized by stratifying hexane over a THF solution of the 
complex, which yielded colorless crystals. IR (cm-1): 2966m, 2931w, 2860w, 1545m, 
1468m, 1438m, 1384m, 1310m, 1051s, 917m, 742s, 693s, 527s, 444m. 1H NMR (300 
MHz, (CD3)2CO): δ 0.82 (m, 12H, CHiPr), 1.40 (d, J = 6.9 Hz, 6H, CHiPr), 1.45 (d, J = 6.6 Hz, 
6H, CHiPr), 1.55 (m, 4H, CH2(THF)), 2.41 (m, J = 6.9 Hz, 2H, CHiPr), 3.35 (m, J = 6.9 Hz, 
2H, CHiPr), 3.39 (m, 4H, CH2(THF)), 3.88 (d, J = 3.3 Hz, 2H, CH2), 6.23 (s, 2H, CH(Pz)), 
6.30 (d, J = 7.5 Hz, 2H, CH(Ph)), 7.04 (t, J = 7.5 Hz, 2H, CH(Ph)), 7.10-7.23 (m, 17H, 
CH(Ph) and CHcentral). Anal. Calc. for C44H53BCuF4N4PS⋅(C4H8O) (922.36): C, 62.45; H, 
6.67; N, 6.07. Found: C, 62.04; H, 6.44; N, 5.90%.  
 
2.2.2. X-ray crystallography 
Single crystal data were collected with a Bruker Smart 1000 and on a Bruker Smart 
APEXII area detector diffractometers (Mo Kα; λ = 0.71073 Å). Cell parameters were 
refined from the observed setting angles and detector positions of selected strong 
reflections. Intensities were integrated from several series of exposure frames that 
covered the sphere of reciprocal space47. A multiscan absorption correction was 
applied to the data using the program SADABS48. The structures were solved by direct 
methods (SIR9747,48 and SIR2004)49 and refined with full-matrix least-squares (SHELXL-
9750), using the Wingx software package51. Graphical material was prepared with the 
Mercury 2.052 program.Crystallographic data are reported in Appendix i-iii. 
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2.3. Results and Discussion 
2.3.1. Synyhesis 
The ligands 1,1’-(2-(phenylthio)ethane-1,1-diyl)bis(1H-pyrazole)) (LHCH2S), 1,1’-(2-
(phenylthio)ethane-1,1-diyl)bis(3,5-dimethyl-1H-pyrazole)) (LMeCH2S), 1,1’-(2-
(phenylthio)ethane-1,1-diyl)bis(3,5-diisopropyl-1H-pyrazole)) (Li-PrCH2S), were 
prepared as described in the Figure 7.   
 
Figure 7. Synthetic path for ligands.  
The synthetic route to obtain C-centered functionalized bispyrazole ligands is based 
on solid state reaction between bis(pyrazolyl)ketones and aldehyde to functionalized 
the bispyrazole scaffold. The N2S donor set of the ligand described in this chapter is 
generated by treating substituted bis(pyrazolyl)ketones with  
(phenylthio)acetaldehyde using CoCl2 hydrate as catalyst and heating at 110°C 
overnight. The ligands present a methylene group linking the bis-pyrazole scaffold and 
the thioether moiety (LRCH2S). Moreover, the steric hindrance on the pyrazole ring 
was increased by substituting the hydrogen atoms in the 3 and 5 positions with 
methyl or isopropyl groups. To investigate the different coordinative behaviour of the 
ligands we have employed Ag(I) and Cu(I) cations. The complexes were prepared by 
treating equimolar amounts (Figure 8) of ligands and [Cu(MeCN)4]BF4 or Ag(I) salts 
(AgBF4, AgPF6 and AgCF3SO3). Different counter anions were employed for the 
preparation of the Ag(I) complexes in order to study their possible influence in the 
resulting supramolecular assembly53. The [M(L)PPh3]
+ ternary complexes were 
prepared by mixing equimolar amounts of metal salts, ligand and PPh3. These 
23 
 
syntheses were performed at room temperature and in the air by using acetone or 
acetonitrile as solvents.  
 
Figure 8.  Complexes synthesis.  
 
2.3.2. Solid state structures 
The complexes 1, 2,3, 4, 5  and 7, are prepared using the LHCH2S or L
MeCH2S ligands, 
and they can be described together as they present very similar crystal structures, 
Figures 9-13. The metal adopts a distorted trigonal planar geometry, with the ligand 
that N,N chelates on a metal center and bridges with the thioether sulfur atom on a 
symmetry related metal ion. By inspecting the coordination bond distances, it is 
evident that in the copper complexes 2, and 4, the Cu-N separation varies in the 
relatively narrow range of 1.958(2)-2.053(2) Ǻ, and the Cu-S bond distance is of 2.17 Ǻ 
for both compounds. 
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Figure 9. Crystal packing of 1. The BF4
- anions and the hydrogen atoms are omitted for 
clarity. Symmetry code ’ = 1-x; -y; 1-z. 
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Figure 10. Crystal packing of 2. The BF4
- anions and the hydrogen atoms are omitted 
for clarity. 
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On the other hand, the silver complexes 1, 3, 5,7 present a greater variability with 
respect to the Ag-N bond distances as they are found in the 2.203(2)-2.404(2) Ǻ 
range. As for the copper complexes, the Ag-S distance is found in a more definite 
range as it is close to the value of 2.41 Ǻ for all complexes, Tables 1-2.  
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Figure 11. Crystal packing of 3. The BF4
- anions and the hydrogen atoms are omitted 
for clarity. 
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Figure 12. Crystal packing of 4. The BF4
- anions and the hydrogen atoms are omitted 
for clarity. 
 
29 
 
 
 
 
Figure 13. Crystal packing of 5. The PF6
- anions and the hydrogen atoms are omitted 
for clarity 
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Table 1. Selected bond lengths (Å) and angles (°) for 1, 3, 5, 6, and 8 
 1   
Ag-N(21) 2.203(2) N(21)-Ag-N(22) 86.43(7) 
Ag-N(22) 2.404(2) N(21)-Ag-S(13)’ 162.25(6) 
Ag-S(13)’ 2.4069(7) N(22)-Ag-S(13)’ 104.43(5) 
 3   
Ag-N(21) 2.255(3) N(21)-Ag-N(22) 84.0(1) 
Ag-N(22) 2.260(4) N(21)-Ag-S(13)’ 132.1(1) 
Ag-S(13)’ 2.400(1) N(22)-Ag-S(13)’ 142.9(1) 
 5   
Ag-N(21) 2.255(3) N(21)-Ag-N(22) 83.1(1) 
Ag-N(22) 2.301(3) N(21)-Ag-S(13)’ 153.50(8) 
Ag-S(13)’ 2.415(1) N(22)-Ag-S(13)’ 123.07(8) 
 6   
Ag(1)-N(21) 2.272(3) N(21)-Ag(1)-N(22) 81.8(1) 
Ag(2)-N(22) 2.289(4) N(21)-Ag(1)-S(16)’’ 136.19(8) 
Ag(1)-S(16)’’ 2.419(1) N(22)-Ag(1)-S(16)’’ 141.85(9) 
Ag(2)-N(24) 2.268(3) N(24)-Ag(2)-N(25) 84.6(1) 
Ag(2)-N(25) 2.289(3) N(24)-Ag(2)-S(13) 135.17(8) 
Ag(2)-S(13) 2.429(1) N(25)-Ag(2)-S(13) 140.24(9) 
 8   
Ag-N(21) 2.288(3) N(22)-Ag-N(21) 86.2(1) 
Ag-N(22) 2.229(3) N(22)-Ag-S(13)’’’ 130.25(9) 
Ag-S(13)’’’ 2.433(1) N(21)-Ag-S(13)’’’ 137.90(9) 
Ag-O(24) 2.556(3) N(22)-Ag-O(24) 98.1(1) 
  N(21)-Ag-O(24) 105.8(1) 
  O(24)-Ag-S(13)’’’ 90.71(7) 
Symmetry codes: ’ = x; 1/2-y; 1/2+z, ’’ = x+1/2; y+1/2; z, ’’’ = -x+1/2,y+1/2,-z+1/2. 
31 
 
Table 2. Selected bond lengths (Å) and angles (°) for 2, 4, and 7. 
 2   
Cu-N(21) 1.958(2) N(21)-Cu-N(22) 94.99(8) 
Cu-N(22) 2.053(2) N(21)-Cu-S(13)’ 153.77(6) 
Cu-S(13)’ 2.1741(7) N(22)-Cu-S(13)’ 110.19(6) 
 4   
Cu-N(21) 1.990(2) N(21)-Cu-N(22) 95.50(7) 
Cu-N(22) 1.999(2) N(21)-Cu-S(13)’ 127.33(5) 
Cu-S(13)’ 2.1779(6) N(22)-Cu-S(13)’ 135.22(6) 
 7   
Ag-N(21) 2.283(3) N(21)-Ag-N(22) 85.0(1) 
Ag-N(22) 2.282(3) N(21)-Ag-S(13)’’ 131.64(8) 
Ag-S(13)’ 2.416(1) N(22)-Ag-S(13)’’ 142.50(8) 
’ = x; 1/2-y; 1/2+z, ’’ = x; 1/2-y; -1/2+z. 
 
The propensity of the ligand to bridge between two metal centers with the N,N and S 
donor systems leads to the formation of zig-zag like chains that run parallel to the c 
crystallographic axis, Figures 9-13. To a different degree of strength, the chains 
interacts with each other, or are close to each other, by means of a partial stack of 
two symmetry related pyrazole rings, in the range of 3.612(4)-3.921(6) Ǻ. This 
supramolecular interaction between the molecular chains forms a motif that may be 
described as perpendicular intersecting rectangles, which are occupied by the anions 
(BF4
-, CF3SO3
- or PF6
-). Moreover, by viewing the structure along the c crystallographic 
axis, it can be appreciated how these molecular chains are organized in layers that are 
parallel to the bc crystallographic plane. It may therefore be inferred that the 
counterion has little influence on the supramolecular aggregation of these complexes. 
The conformation of the central thioether arm influences the mode of interaction of 
the chains. The complexes 6 and 8 form zig-zag chains that are analogous to those of 
the previously described complexes, Figures 14 and 15. Nevertheless, the presence of 
the iPr groups, in place of the H or Me as substituents on the pyrazole rings, hinders 
the approach of the pyrazole rings of symmetry related molecules. Hence, the chains 
do not form the intersecting rectangles found in the previously described complexes. 
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In 6, the chains are organized in layers parallel to the ab crystallographic plane by 
interacting through the iPr and phenyl moieties, and the chains belonging to different 
planes are perpendicular to each other, see Figure 14. At variance with the molecular 
structures reported so far when using the LRCH2S ligands, 8 exhibits the silver atom in 
a distorted trigonal pyramidal geometry, as a consequence of the coordination of the 
CF3SO3
- anion, d[Ag-O(24)] = 2.556(3) Ǻ, Figure 15. 
33 
 
 
Figure 14. Molecular structure and crystal packing of 6. The PF6
- anions, the hydrogen 
atoms, and the solvent of crystallization are omitted for clarity. Green and brown 
spheres are the spacefill representations of the silver atoms, which depict the 
differently oriented molecular chains. Symmetry code ’ = ½+x; ½+y; z.  
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Figure 15. Molecular structure and crystal packing of 8. The hydrogen atoms and the 
solvent of crystallization are omitted for clarity. Symmetry code ’ = ½-x; ½+y; ½-z. 
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To further investigate the coordinative behavior of ligands, LRCH2S, we have employed 
triphenylphosphine (PPh3) as an ancillary ligand for Cu(I) and Ag(I). Mixtures of 
equimolar amounts  LRCH2S ligands, PPh3, and AgBF4 or [Cu(CH3CN)4]BF4 result in the 
formation of easily recovered [M(L)PPh3]BF4 ternary complexes from the reaction 
mixture. The molecular structures of the Cu(I) complexes are reported in Figures 16 
and 17. The presence of PPh3 hinders the formation of coordination polymers so that 
all of the resulting complexes are mononuclear. 10, 12 and 14 show the metal in a 
distorted tetrahedral geometry, and the ligands employ the N2S donor set. In the 
present case, the thioether moiety is in a different conformation than that exhibited 
in the coordination polymers because the sulfur points to the same metal center of 
the N2 donor system. In all the complexes, the Cu-N and Cu-P bond distances are in 
the 1.999(2)-2.065(3) Ǻ and 2.161(6)-2.1863(7) Ǻ ranges, respectively and  the Cu-S 
distance is in the narrow range of 2.4801(8)-2.4860(6) Ǻ (Table 3 and 4). Thus, the 
increase in the steric hindrance on the pyrazole rings when a hydrogen atom is 
substituted for an iPr group appears to neither affect the overall geometry of these 
complexes nor prevent the coordination of a relatively bulky ligand such as PPh3. The 
molecular structures of 11, and 13  (Figure 18) present the metal in a distorted 
tetrahedral geometry, and the LMeCH2S and L
iPrCH2S ligands behave as N2S tridentate. 
On average, the coordination bond distances of these silver complexes are more than 
0.2 Ǻ longer than those of the copper complexes, which is congruent with the larger 
size of the silver cation. 
 
Figure 16. Molecular drawing of 10. Thermal ellipsoids are drawn at the 30% 
probability level. The hydrogen atoms are omitted for clarity. 
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Figure 17. Molecular drawing of 12 and 14. The hydrogen atoms are omitted for 
clarity. 
                   
Figure 18. Molecular drawing of 11 and 13. The hydrogen atoms are omitted for 
clarity 
In conclusion here we have shown a new class of ligands based on a bispyrazolyl 
scaffold N2 donors able to chelate a silver ion. The scaffold possess a thioether arm 
with a S donor function flexible enough to chelate in the N2S fashon (Figure 19 (B)), 
but also able to bridge between two metal centers with the N2 and S donor systems 
giving rise to coordination polymers (Figure 19 (A)). 
 
 
Figure 19. Possible coordination types of LRCH2S. 
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Table 3. Selected bond lengths (Å) and angles (°) for 10, 12 and 14. 
 10   
Cu-N(21) 2.030(2) N(21)-Cu-N(22) 90.55(6) 
Cu-N(22) 2.037(2) N(21)-Cu-P 130.80(5) 
Cu-S(13) 2.4860(6) N(22)-Cu-P 126.13(4) 
Cu-P 2.1656(5) N(21)-Cu-S(13) 90.63(5) 
  N(22)-Cu-S(13) 88.81(5) 
  P-Cu-S(13) 118.15(2) 
 12   
Cu-N(21) 2.065(2) N(21)-Cu-N(22) 92.23(8) 
Cu-N(22) 2.028(2) N(21)-Cu-P 128.98(6) 
Cu-S(13) 2.4801(8) N(22)-Cu-P 126.52(6) 
Cu-P 2.1863(7) N(21)-Cu-S(13) 86.46(6) 
  N(22)-Cu-S(13) 89.03(6) 
  P-Cu-S(13) 121.25(3) 
 14   
Cu-N(21) 2.052(2) N(21)-Cu-N(22) 90.9(1) 
Cu-N(22) 2.016(2) N(21)-Cu-P 133.80(7) 
Cu-S(13) 2.4814(9) N(22)-Cu-P 129.08(7) 
Cu-P 2.1804(9) N(21)-Cu-S(13) 84.95(7) 
  N(22)-Cu-S(13) 92.13(8) 
  P-Cu-S(13) 111.54(3) 
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Table 4. Selected bond lengths (Å) and angles (°) for  11 and 13. 
 11   
Ag-N(21) 2.277(2) N(21)-Ag-N(22) 84.55(8) 
Ag-N(22) 2.396(2) N(21)-Ag-P 138.69(6) 
Ag-S(13) 2.7345(8) N(22)-Ag-P 129.73(6) 
Ag-P 2.3602(7) N(21)-Ag-S(13) 81.66(6) 
  N(22)-Ag-S(13) 75.67(6) 
  P-Ag-S(13) 124.22(3) 
 13   
Ag-N(21) 2.314(3) N(21)-Ag-N(22) 83.9(1) 
Ag-N(22) 2.497(3) N(21)-Ag-P 129.93(9) 
Ag-S(13) 2.624(1) N(22)-Ag-P 122.79(9) 
Ag-P 2.362(1) N(21)-Ag-S(13) 86.8(1) 
  N(22)-Ag-S(13) 75.25(9) 
  P-Ag-S(13) 137.44(4) 
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CHAPTER 3 
Rigid vs Flexible N2S donor ligands: conformational 
studies on Cu(I) and Ag(I) complexes. 
 
 
Here we show24 a new ligands  similar to ligands presented in the previous chapter 
but with a rigid (-Ph-S-Ph) thioether function: LHPhS. A comparison between Ag(I) and 
Cu(I) binary complexes built with LHPhS and LRCH2S, respectively, is usefull to 
demonstrate how the ligand conformation is responsible to the different 
architectures formed. Several molecular structures of complexes using different types 
of counterions (BF4
-, PF6
-) were obtained.. In both cases the ligands are suitable 
components for the construction of coordination polymers. Also in these complexes, 
the ligands behaves as N2 donor on a metal center and bridges on a second metal 
with the thioether arm. But the steric hindrance due to the phenyl ring used as a 
linker, instead of a flexible CH2, determines a completely different behavior of the 
ligand in presence of ancillary ligands such as thiphenylphosphine. As in chapter 2, 
mononuclear ternary complexes are formed, but the thioether arm is unable to 
coordinate the metal center. Throught DFT calculation we demonstrate how the 
ligand preorganization affects the 3D molecular assembly.  
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3.1.  Introduction 
Supramolecular chemistry is an active and ever growing field of investigation where 
elegant structures are spontaneously generated from smaller building blocks54. The 
components of these assemblies are in many cases represented by an anionic or 
neutral part in the form of an organic ligand, and by a cationic part represented by a 
metal center. The ligands can be specifically synthesized in order to incorporate the 
desired donor atoms in the preferred geometric arrangements. In addition, the 
different coordination polyhedra, characteristic of opportunely selected metal ions, 
contribute to the shape of the resulting coordination polymers55–57. Self assembly 
coordination polymers have attracted attention in recent years especially because of 
their potential application in material science. The search of new hybrid inorganic-
organic materials based on heteroscorpionate ligands is of great interest not only 
because of their wide variety of amazing molecular structures, but also because of 
their versatility in metal coordination due to the easy possibility to vary the donor set 
of the ligand. In the Self-assembly process, thanks to metal-ligand interactions, small 
molecules aggregate in large species. Other factors interactions play a fundamental 
role in self-assembled hybrid structures. These factors take into account: 1) the 
nature of metal center; 2) the type and the geometry of ligand chelation the donor 
set of ligand; 3) the counterion and last but not least  5)the week non-covalent As far 
as the silver an copper complexes are concerned, many other examples can be found 
in the literature reporting 1D polymeric structures obtained by using nitrogen donor 
ligands. In some cases, these 1D structures are generated by ligands that act as a 
bridge between two metal centers thus forming a coordination polymer58,59, whereas 
in other cases the building blocks are represented by metal complexes that interact 
with neighboring ones by means of weaker forces such as hydrogen bonds, π-π 
stacking, or C-H···π interactions60. By a judicious choice of ligands, these molecular 
chains can be chiral, either because they form helical structures61–64, or because a 
chiral ligand has been specifically employed65. The choice of metal center results 
therefore of particular importance: the chemical behavior of silver(I) and copper(I) 
coordinated throught nitrogen pyrazoles of the ligands (for example: 
bis(pyrazolyl)borates and methane) is well described in the literature. Based on 
previous reports, most of this monocharge cation complexes are dimeric structures 
with a ratio M:L 1:2 with the metal center in a distorted tetrahedral geometry without 
ancillary ligands. More fascinating and less studied from a structural point of view, are 
the silver complexes based on ditopic heteroscorpionate ligands. Carrano et all. 
studied how silver(I) complexes based on N2O heteroscorpionate ligand self-
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assembled in coordination polymers through hydrogen bonds. In these cases the third 
arm of the ligand does not take part in to the coordination of the metal center but it is 
crucial to make hydrogen bonds essential for the building of polymers. 
Our approach involved the use of ditopic heteroscorpionate ligand in which a 
thioether arm is decisive in the construction of the coordination polymers. In the 
previous chapter we have shown a new class of N2S ligand in which a bispyrazolyl N2 
scaffold is linked to the thioether arm with a CH2, capable of generating coordination 
polymers with silver(I) and copper(I) molecular. In the present chapter we report  a 
typology of ligand endowed with the same N2 bispyrazolyl methane moiety, which is 
functionalized with different substituents linked to the thioether arm with a less 
flexible linker : a phenyl ring (Figure 20).  
 
 
Figure 20. Synthetised ligands. 
To estimate again the coordination ability of these heteroscorpionate ligands, Ag(I) 
and Cu(I) complexes were prepared by treating LRPhS (R= H, Me) with Ag(I) and Cu(I) 
salts. Here we described  the solid state structure of  1D coordination polymers 
emphasizing the difference between the two ligand classes. The synthesis of ternary 
complexes using triphenylphosphine as ancillary ligand, as in the previous chapter, 
are also described to clarify the different conformational behavior of two different 
ligands LRPhS and LRCH2S .  
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Figure 21  A. Schematic rappresentation of coordination capability of rigid LRPhS; B. 
Schematic rappresentation of the coordination abilities for flexible LRCH2S.  
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3.2 Experimental 
3.2.1. Synthesis 
General Procedures: All reagents and solvents were commercially available, except for 
3,5-dimethylpyrazole, bis(pyrazolyl)ketone and  bis(3,5-dimethylpyrazolyl)ketone 
which were prepared as reported elsewhere44–46. 1H and 13C spectra were recorded on 
a Bruker Avance 300 spectrometer using standard Bruker pulse sequences. Chemical  
shifts are reported in parts per million (ppm) referenced to residual solvent protons. 
Infrared spectra were recorded from 4000 to 700 cm-1 on a Perkin-Elmer FTIR Nexus 
spectrometer equipped with a Smart Orbit HATR accessory (diamond crystal). 
Elemental analyses (C, H, and N) were performed with a Carlo Erba EA 1108 
automated analyzer.   
Synthesis of 1,1'-((2-(phenylthio)phenyl)methylene)bis(1H-pyrazole) (LHPhS). A 
mixture of bis(pyrazolyl)ketone (0.76 g, 4.68 mmol), 2-(phenylthio)benzaldehyde 
(1.02  g, 4.76 mmol) and CoCl2.6H2O (5 mg) was heated at 80°C for an hour with 
stirring. The mixture was then cooled at room temperature and stirred overnight. 
Dichloromethane (30 mL) was added and the mixture was stirred for 30 minutes. The 
organic phase was washed with water (50 mL) and brine (20 mL), dried with 
anhydrous Na2SO4 and filtered. The solution was concentrated under vacuum and a 
yellow powder was precipitated with hexane, which was filtered and vacuum dried. 
The crude was washed with diethyl ether (5 mL) and a white solid was obtained (yield 
0.93 g, 60%).  IR (cm-1): 3134w,3095w, 1687w, 1665w, 1440m, 1389m, 1305m, 
1083m, 1044m, 795m, 746s, 684s, 624s, 609m, 503m. 1H NMR (300 MHz, CDCl3): δ,  
6,32 (t, J 2.4 Hz, 2H, CH Pz), 6.94 (m, 1H, CH Ph) 7.20 (m,8H, CH PhSPh), 7.32 (m, 2H, 
CH Pz) 7.60 (d, J =1.8 Hz, 2H, CH Pz),  8.21  (s, 1H, CH) . Anal.Calc. for C19H16N4S 
(332.42): C, 68.65; H, 4.85; N, 16.85. Found: C, 68.54; H, 4.62; N, 16.55%. 
Synthesis of 1,1'-((2-(phenylthio)phenyl)methylene)bis(3,5-dimethyl-1H-pyrazole) 
(LMePhS).  The procedure used to prepare LHPhS was applied by using a mixture of 
bis(3,5-dimethylpyrazolyl)ketone(1.04 g, 4.71 mmol), 2-(phenylthio)benzaldehyde 
(1.00 g, 4.66 mmol) and CoCl2 6H2O (5 mg). A white solid was obtained (yield 1.30 g, 
71%).  IR (cm-1): 2980w, 2947w, 2920w, 1463m, 1318m, 812m, 797m, 754s, 684m, 
619m. 1H NMR (300 MHz, CDCl3): δ,  2.08  (s, 6H, CH3 Pz), 2.20 (s, 6H, CH3 Pz),  5.85 (s, 
2H, CH Pz), 6.90 (t, J =5.7 Hz, 1H, CH Ph ),  7.27  (m, 9H, CH PhSPh) ,  7.99 (s, H, CH). 
Anal. Calc. for C23H24N4S (388.53): C, 71.10; H, 6.22; N, 14.42. Found: C, 70.93; H, 6.09; 
N, 14.28%.  
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Synthesis of [Ag(LHPhS)]n(BF4)n(15).  L
HPhS (300 mg, 0.90 mmol) and AgBF4 (179 mg, 
0.90 mmol) were mixed in acetone (10 mL), and the colorless solution was stirred for 
30 min. The solvent was then removed under vacuum, and the white solid was 
triturated with hexane. The mixture was then filtered to afford a white solid (360 mg, 
yield 84%). The compound was recrystallized by stratifying diethyl ether over an 
acetone solution of the complex, which yielded colorless crystals. IR (cm-1): 3128 w, 
1693 w, 1589 w, 1512 w, 1441 m, 1397 m, 1287 m, 1024 s, 821 w, 745 s, 690 m, 619 
ms, 608 w, 509 m. 1H NMR (300 MHz, (CD3)2CO): δ, 6.65 ( t, J = 2.1 Hz, 1H, CH(Pz)), 
7.05 (m, 1H, CHorto(Ph)), 7.28-7.52 (m, 8H, CH(Ph)), 7.84 (d, J = 2.1 Hz, 2H, CH(Pz)), 
8.35 (d, J = 2.1 Hz, 2H, CH(Pz)), 8.75 (s, 1H, CHcentral). Anal. Calc. for C19H16AgBF4N4S 
(527.09): C, 43.29; H, 3.06; N, 10.63. Found: C, 42.98; H, 3.32; N, 10.40%. 
Synthesis of [Ag(LHPhS)]2(PF6)2 (16). L
HPhS (134 mg, 0.40 mmol) and AgPF6 (100 mg, 
0.40 mmol) were mixed in acetone (8 mL), and the colorless solution was stirred for 
15 min. The solvent was then concentrated under vacuum and a white solid was 
precipitated after the addition of diethyl ether. The solid was filtered and vacuum 
dried (130 mg, yield 56%). The compound was recrystallized by stratifying hexane 
over a dichloromethane solution of the complex, which yielded colorless crystals. IR 
(cm-1): 1698 w, 1440 m, 1398 m, 1289 m, 1096 m, 828 s, 747 s, 648 m, 627 m, 607 w, 
555 s. 1H NMR (300 MHz, (CD3)2CO): δ, 6.56 (t, J = 2.4Hz, 2H, CH(Pz)), 7.17 (m, 1H, 
CH(Ph)), 7.24-7.52 (m, 8H, CH(Ph)), 7.76 (d, J = 2.4 Hz, 2H, CH(Pz)), 8.35 (d, J = 2.4Hz , 
2H, CH(Pz)), 8.66 (s, 1H, CHcentral). Anal. Calc. for C19H16AgF6N4PS (585.29): C, 38.99; H, 
2.76; N, 9.57. Found: C, 38.76; H, 3.04; N, 10.11%. 
Synthesis of [Cu(LHPhS)]2(BF4)2(MeCN)2 (17). In a Schlenk flask, under an inert 
atmosphere (N2), a solution of [Cu(MeCN)4]BF4 (147 mg, 0.47 mmol) in 8 mL of dry 
MeCN was added to a solution of LHPhS (155 mg, 0.47 mmol) in 10 mL of dry MeCN. 
The colorless solution was stirred for 15 min. The solvent was then concentrated 
under vacuum, and a white solid was precipitated after the addition of diethyl ether. 
The mixture was filtered under nitrogen to afford a white solid (103 mg, yield 88%). 
The compound was recrystallized by stratifying hexane over a dichloromethane 
solution of the complex, which yielded colorless crystals. IR (cm-1): 3125 m, 2969 m, 
2864 w, 1581 m, 1508 m, 1435 m, 1402 m, 1285 m, 1029 s, 743 m, 690 w, 621 w. 1H 
NMR (300 MHz, CD3CN, 235 K): δ 6.46 (t, J = 2.0 Hz, 2H, CH(Pz)), 6.53 (d, J = 8.0 Hz, 1H, 
CHorto(Ph)), 7.23 (d, J = 7.9 Hz, 1H, CH(Ph)), 7.29-7.37 (m, 7H, CH(Ph)), 7.57 (s br, 1H, 
CH(Pz)), 7.74 (d, J = 1.6 Hz, 2H, CH(Pz)), 8.26 (s, 1H, CHcentral). Anal. Calc. for 
C42H38Cu2B2F8N10S2 (1047.65): C, 48.15; H, 3.66; N, 13.37. Found: C, 48.38; H, 3.33; N, 
13.14%. 
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Synthesis of [Ag(LHPhS)PPh3]BF4 (18). A solution of AgBF4 (58 mg, 0.29 mmol) in 8 mL 
of acetone was added to a solution of LHPhS (96 mg, 0.29 mmol) and 
triphenylphosphine (68 mg, 0.26 mmol) in 10 mL of acetone. The colorless solution 
was stirred for 15 min. The solvent was then removed under vacuum, the solid was 
triturated with hexane, and a white product was recovered by filtration (170 mg, yield 
77%). The compound was recrystallized by stratifying hexane over a dichloromethane 
solution of the complex, which yielded prismatic colorless crystals and hexagonal 
crystals. IR (cm-1): 3123w, 3052w, 1512w, 1479m, 1430m, 1403m, 1288m, 1041s, 
827w, 740s, 690s, 625m. 1H NMR (300 MHz, CD3CN): δ 6.36 (t, J = 1.5 Hz, 2H, CH(Pz)), 
6.95 (d, J = 10.8 Hz, 1H, CH(Ph)), 7.20-7.65 (m, 27H, CH(Ph) and CH(Pz)), 8.19 (s, 1H, 
CHcentral). Anal. Calc. for C37H31AgBF4N4PS (788.11): C, 56.34; H, 3.96; N, 7.11. Found: C, 
56.24; H, 4.21; N, 7.41%.  
 
Synthesis of [Cu(LHPhS)PPh3]BF4 (19). In a Schlenk flask, under an inert atmosphere 
(N2), a solution of [Cu(MeCN)4]BF4 (99 mg, 0.32 mmol) in 15 mL of dry MeCN was 
added to a solution of LHPhS (106 mg, 0.32 mmol) and triphenylphosphine (86 mg, 
0.32 mmol) in 10 mL of dry MeCN. The colorless solution was stirred for 1 h. The 
solvent was then concentrated under vacuum, and a white solid was precipitated 
after the addition of diethyl ether. The mixture was filtered under nitrogen to afford a 
white solid (82 mg, yield 85%). The compound was recrystallized by stratifying hexane 
over a dichloromethane solution of the complex, which yielded colorless crystals. IR 
(cm-1): 3117 w, 3041 w, 2975 w, 1726 w, 1435 m, 1047 s, 998 m, 741 s, 691 m, 626 m, 
498 m. 1H NMR (300 MHz, (CD3)2CO): δ 6.53 (d, J = 2.1 Hz, 2H, CH(Pz)), 6.91 (t, J = 6 Hz, 
1H, CH(Ph)), 7.07 (m, 3H, CH(Ph)), 7.11 (m, 14H, CH(Ph)), 7.52 (m, 6H, CH(Ph)), 8.45 
(d, J = 2.1 Hz, 2H, CH(Pz)), 8.79 (s, 1H, CH). Anal. Calc. for C37H31CuBF4N4PS (745.06): C, 
59.65; H, 4.19; N, 7.52. Found: C, 60.32; H, 5.24; N, 7.26%. 
Synthesis of [Ag(LMePhS)PPh3]BF4 (20). A solution of AgBF4 (49 mg, 0.25 mmol) in 8 mL 
of acetone was added to a solution of LMePhS (100 mg, 0.25 mmol) and 
triphenylphosphine (59 mg, 0.22 mmol) in 10 mL of acetone. The colorless solution 
was stirred for 15 min. The solvent was then removed under vacuum, the solid was 
triturated with hexane, and a white product was recovered by filtration (160 mg, yield 
86%). Attempts to recrystallize the complex in different solvent mixtures gave 
hexagonal crystals and a gluey material. IR (cm-1): 3118w, 3052w, 2356w, 2159w, 
1578w, 1556w, 1474m, 1436m, 1403m, 1288m, 1047s, 827w, 740s, 685s, 630m, 499s. 
1H NMR (300 MHz, CD3CN): δ 2.11 (s, 6H, CH3), 2.35 (s, 6H, CH3), 6.03 (s, 2H, CH(Pz)), 
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6.79 (m, 2H, CH(Ph)), 7.11 (m, 1H, CH(Ph)), 7.19 (m, 2H, CH(Ph)), 7.27-7.37 (m, 10H, 
CH(Ph)), 7.44 (m, 6H, CH(Ph)), 7.54 (m, 3H, CH(Ph)), 7.70 (s, 1H, CHcentral). Anal. Calc. 
for C41H39AgBF4N4PS (844.17): C, 58.28; H, 4.66; N, 6.64. Found: C, 58.62; H, 4.42; N, 
6.89%.  
Synthesis of [Cu(LMePhS)PPh3]BF4 (21). In a Schlenk flask, and under an inert 
atmosphere (N2), a solution of [Cu(MeCN)4]BF4 (67 mg, 0.21 mmol) in 15 mL of dry 
MeCN was added to a solution of LHPhS (101 mg, 0.21 mmol) and triphenylphosphine 
(55 mg, 0.21 mmol) in 10 mL of dry MeCN. The colorless solution was stirred for 1 
hour. The solvent was then concentrated under vacuum and a white solid was 
precipitated after addition of diethyl ether. The mixture was filtered under nitrogen 
to afford a white solid (82 mg, yield 85%). The compound was recrystallized by 
stratifying hexane over a dichloromethane solution of the complex, which yielded 
colorless crystals. IR (cm-1): 3182w, 3052w, 1556m, 1430m, 1232w, 1094m, 1048s, 
996m, 765m, 745s, 696s, 530m, 510m, 493m. 1H NMR (300 MHz, CDCl3): δ 1.92 (s, 6H, 
CH3), 2.57 (s, 6H, CH3), 6.05 (s, 2H, CH(Pz)), 6.61 (t, J = 7.5 Hz, 1H, CH(Ph)), 6.80 (d, J = 
7.5 Hz, 1H, CH(Ph)), 6.94 (t, J = 7.8 Hz, 1H, CH(Ph)), 7.20 (m, 21H, CH(Ph)), 7.60 (s, 1H, 
CHcentral). Anal. Calc. for C41H39BCuF4N4PS (800.20): C, 61.48; H, 4.91; N, 7.00. Found: C, 
61.25; H, 5.21; N, 6.65%.  
3.2.2. Single Crystal X-ray Structures 
Single crystal data were collected with a Bruker Smart 1000 and on a Bruker Smart 
APEXII area detector diffractometers (Mo Kα; λ = 0.71073 Å). Cell parameters were 
refined from the observed setting angles and detector positions of selected strong 
reflections. Intensities were integrated from several series of exposure frames that 
covered the sphere of reciprocal space47. A multiscan absorption correction was 
applied to the data using the program SADABS48. The structures were solved by direct 
methods (SIR9747,48 and SIR200466) and refined with full-matrix least-squares (SHELXL-
97)50, using the Wingx software package51. Graphical material was prepared with the 
and Mercury 2.052 program. Crystallographic data are reported in Appendix iii-iv. 
3.2.3. DFT calculations  
Rigid potential-energy surface (PES) scans were performed for the LHCH2S and L
HPhS 
ligands starting from the ligand conformations found in the X-ray structures of 
complexes 15 and 1, respectively. The calculations were performed using the 
gradient-corrected hybrid density functionals B3LYP67,68 and the 6-31+G basis set69. In 
particular, the PES scan was performed for LHCH2S by rotating three molecular 
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fragments: 1) one pyrazole ring (360° rotation about the Ccentral-Npz bond: 15 steps, 
24°), 2) the CH2 linker (360° rotation about the Ccentral-CH2 bond: 15 steps, 24°), and 3) 
the peripheral phenyl ring (180° rotation about the S-Ph bond: 10 steps, 18°). The PES 
scan for LHPhS was performed by the following rotations: 1) one pyrazole ring (360° 
rotation about the Ccentral-Npz bond: 15 steps, 24°), 2) the phenyl ring linker (360° 
rotation about the Ccentral-Ph bond: 15 steps, 24°), and 3) the peripheral phenyl ring 
(180° rotation about the S-Ph bond: 10 steps, 18°). To gain insights on the different 
binding abilities of the two ligand classes (LRCH2S and L
RPhS), we optimized the 
geometries of two coordination isomers for each model complex, [Ag(LHCH2S)PH3]
+ 
and [Ag(LHPhS)PH3]
+. The isomers were differentiated by the presence or absence of 
the thioether coordination to the metal center. The PH3 ancillary ligand was used 
instead of the PPh3 one, which is present in some reported X-ray structures, to save 
computational resources. The optimizations of the geometries were performed with 
the B3LYP density functional, with the 6-31+G(d) basis set for C, H, N, S, and P and 
with the SDD valence basis set and MWB28 effective core potentials for Ag70,71. 
Vibrational frequencies were calculated at the same theoretical level to ensure that 
the stationary points were true minima. All the calculations were performed with the 
Gaussian 03 software72.  
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3.3. Results and Discussion 
 
3.3.1. Synyhesis 
The ligands 1,1'-((2-(phenylthio)phenyl)methylene)bis(1H-pyrazole) (LHPhS) and 1,1'-
((2-(phenylthio)phenyl)methylene)bis(3,5-dimethyl-1H-pyrazole)  (LMePhS) were 
prepared as described in  Figure 22.   
 
Figure 22. Ligands Synthesis. 
The reaction to obtain this synthetic C-centered functionalized ligand class is similar 
to the synthetic route used for the preparation of the ligands presented in the 
previous chapter (Chapter 2). These ligands exhibit a phenyl group linking the bis-
pyrazole scaffold and the thioether moiety (LRPhS). The steric hindrance on the 
pyrazole ring was increased by substituting the hydrogen atoms in the 3 and 5 
positions with methyl groups. To investigate the different coordinative behaviour of 
the ligands we have employed Ag(I) and Cu(I) cations. The complexes were prepared 
by treating equimolar amounts (Figure 23) of the ligand LHPhS and [Cu(MeCN)4]BF4 or 
Ag(I) salts (AgBF4, AgPF6). The complexes synthetized with L
MePhS ligand have given 
rise to porous coordination polymer with different supramolecular assembly as a 
function of the counterions. These results will be presented in the forthcoming 
chapter (Chapter 4). Moreover we have tested the coordinative characteristics of 
these rigid ligands by introducing an ancillary ligand as triphenylposphine.  
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Figure 23. Synthesis of Ag(I) and Cu(I) complexes.   
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3.3.2.   Solid state structures 
The reactions between LHPhS and different cations such as Cu(I) or Ag(I) (AgBF4 and 
AgPF6) yield very different molecular structures: 16 and 17 are dinuclear while 15 is a 
polymeric chain. In fact 15 exhibits a chain-like structure that is formed by the N2 
coordination on a metal center and by the bridging of the thioether group on a 
second metal. Two different types of silver atoms define the asymmetric unit. Both 
metal atoms are in a distorted T-shaped geometry (this is more pronounced for Ag(1) 
than for Ag(2)), which is distorted toward the tetrahedral geometry as a consequence 
of an Ag-C interaction that originates by one pyrazole ring for Ag(2) {d[Ag(2)-C(116)] = 
2.773(6) Ǻ} and by the peripheral phenyl ring for Ag(1) {d[(Ag(1)-C(24)] = 2.921(4) Ǻ} 
(Figure 24). The absence of steric hindrance on the pyrazole rings allows for the 
approach of the Ag(2) atom over one of the pyrazole rings. The central phenyl ring of 
the ligand is oriented as previously found for bis(pyrazolyl) functionalized 
ligands.39,40,61-67 This donor-set disposition favors the formation of metal-organic 
chains, and it is also the preferred conformation adopted by the ligands that exhibit a 
phenyl ring as a spacer between the bis(pyrazolyl) moiety and the thioether group 
(vide infra). Details of the data-collection parameters and other crystallographic 
information are given in Appendix iii, whereas experimental bond lengths and angles 
are provided in Table 5. 
The molecular structure of 16 is dinuclear, with the silver atom in a distorted T 
geometry (Figure 25). The donor atoms are represented by the N2 chelate system of 
one ligand and by the S(13) and N(21) atoms of a symmetry-related ligand. Within the 
N2 chelate group, the Ag-N(22) bond distance (2.238(3) Ǻ) is significantly shorter than 
that of Ag-N(21) (2.428(3) Ǻ). This fact is most likely a consequence of a weak π-
interaction that the silver atom exchanges with the symmetry related N(21)’ atom 
(2.691(3) Ǻ). The evidence that both nitrogen atoms interact with the metal is derived 
from the location of the silver atom above the ideal trigonal plane formed by the 
N(21), N(22), and S(13)’ donor atoms and directed toward the N(21)’ atom (symmetry 
code ’ = 1-x; 1-y; -z). As far as the ligand conformation is concerned, the central 
phenyl ring exhibits a conformation that is very close to that of 15. The C(11) carbon 
atom of one pyrazole ring exchanges C-H⋅⋅⋅π interactions with the central phenyl ring 
of the symmetry-related ligand d[C(11)-C1t] = 3.622(4) Ǻ, C1t: phenyl-ring centroid.  
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Figure 24. Molecular drawing of 15. The BF4
- anions and the hydrogen atoms are 
omitted for clarity. 
 
 
Figure 25. Molecular drawing of 16. The hydrogen atoms are omitted for clarity. C1t, 
phenyl ring centroid, symmetry code ’ = 1-x; 1-y; -z. 
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Figure 26. Molecular drawing of 17, above, and a portion of the crystal packing, 
below. The BF4
- anions are omitted for clarity. C-H⋅⋅⋅pi interactions are represented by 
dashed bonds (below). Symmetry codes ’ = 1-x; y; ½-z, ’’ = 1-x; y-1; ½-z. 
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The dinuclear complex 17 is obtained from the reaction between [Cu(CH3CN)4]BF4 and 
LHPhS. The metal shows a distorted tetrahedral geometry attained by the N2 chelate 
system of one ligand, the thioether group of the second ligand, and an acetonitrile 
molecule (Figure 26). The phenyl ring acting as spacer is rotated approximately 60° 
with respect to the previous structures. The result of this arrangement is the S atom 
pointing toward the C-Hcentral, even though it is located at a non-interacting distance. 
Moreover, the pyrazole rings also adopt a different conformation from that of 15 and 
16 because their nitrogen lone pairs are oriented on the same side of the C-Hcentral. 
Obviously, this ligand conformation is unsuitable for the N2S chelation because the C-
Hcentral is interposed between the N2 and S donor atoms. From a pictorial point of view, 
the overall shape of the molecule resembles that of a cone delimited by alternate 
pyrazoles (those with N(12) and N(22)) and the peripheral phenyl rings. Two pyrazole 
rings on the opposite side of the cone face each other at a distance of 3.9 Ǻ 
(measured from the centroids of the penta-atomic rings) with the minimum distance 
between symmetry-related N(21) and N(11) atoms (3.782(4) Ǻ). The dinuclear units 
form pillars in which the stacked pyrazole rings point inside the cone of another 
molecular unit. These pillars are held together by two types of C-H⋅⋅⋅π interactions 
that occur through 1) the C(11) pyrazole carbon atom and the peripheral phenyl ring, 
d[C(11)-C(103)’’] = 3.629(5) Ǻ, and d[C(11)-C(133)’’] = 3.738(6) Ǻ, and 2) through the 
central and peripheral phenyl rings, d[C(123)’’-C(43)’] = 3.773(6) Ǻ, and d[C(123)’’-
C(53)’] = 3.657(6) Ǻ, symmetry codes ’ = 1-x; y; 1/2-z, ’’ = 1-x; y-1; 1/2-z. Adjacent 
pillars are oriented in an antiparallel fashion, and they are aligned along the b 
crystallographic axis (Figure 26).  
 
Table 5. Selected bond lengths (Å) and angles (°) for 15, 16 and 17. 
 15   
Ag(1)-N(21) 2.241(4) Ag(2)-N(24)’ 2.398(3) 
Ag(1)-N(22) 2.384(4) Ag(2)-N(25)’ 2.316(4) 
Ag(1)-S(16) 2.492(1) Ag(2)-S(13) 2.529(1) 
Ag(1)-C(24) 2.921(4) Ag(2)-C(116) 2.773(6) 
N(21)-Ag(1)-N(22) 87.7(1) N(25)’-Ag(2)-N(24)’ 83.0(1) 
N(21)-Ag(1)-S(16) 171.1(1) N(25)’-Ag(2)-S(13) 130.0(1) 
N(22)-Ag(1)-S(16) 86.7(1) N(24)’-Ag(2)-S(13) 117.36(9) 
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 16   
Ag-N(21) 2.428(3) Ag-S(13)’’ 2.522(1) 
Ag-N(22) 2.238(3) Ag-N(21)’’ 2.691(3) 
N(21)-Ag-N(22) 82.4(1) N(22)-Ag-N(21)’’ 137.8(1) 
N(21)-Ag-S(13)’’ 119.69(7) N(22)-Ag-S(13)’’ 143.23(8) 
N(21)-Ag-N(21)’’ 84.1(1) N(21)’’-Ag-S(13)’’ 75.05(9) 
 17   
Cu-N(14) 1.944(3) N(14)-Cu-N(22) 113.0(1) 
Cu-N(21) 2.025(3) N(21)-Cu-N(22) 93.9(1) 
Cu-N(22) 2.028(3) N(14)-Cu-S(13)’’’ 110.0(1) 
Cu-S(13)’’’ 2.335(1) N(21)-Cu-S(13)’’’ 105.4(1) 
N(14)-Cu-N(21) 122.3(1) N(22)-Cu-S(13)’’’ 111.0(1) 
Symmetry codes: ’ = ½+x; ½-y; z, ’’ = 1-x; 1-y; -z, ’’’ = 1-x; y; ½-z 
The Ag(I) and Cu(I) complexes with the LHPhS ligand show a certain structural diversity 
when they exhibit dinuclear or polynuclear structures. Nevertheless, the invariant 
feature appears to be the inability of LHPhS to chelate in the N2S fashion. This ligand, 
in fact, behaves like an N2 chelate with pyrazole rings and bridges to a different metal 
ion with the sulfur atom. 
To further investigate the coordinative behavior of the two classes of ligands, LRPhS 
and LRCH2S, we have employed triphenylphosphine (PPh3) as an ancillary ligand for 
Cu(I) and Ag(I). Mixtures of equimolar amounts of LRPhS and LRCH2S ligands, PPh3, and 
AgBF4 or [Cu(CH3CN)4]BF4 result in the formation of easily recovered [M(L)PPh3]BF4 
ternary complexes from the reaction mixture. The molecular structures of the Cu(I) 
complexes are reported in Figures 27. The presence of PPh3 hinders the formation of 
coordination polymers so that all of the resulting complexes are mononuclear. The 
most striking difference between the complexes exhibiting the two different classes 
of ligands is the role played by the thioether group. 
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Table 6. Selected bond lengths (Å) and angles (°) for 18  
 18   
Ag-N(21) 2.285(2) N(21)-Ag-N(22) 82.73(8) 
Ag-N(22) 2.291(2) N(21)-Ag-P 139.88(6) 
Ag-P 2.3470(8) N(22)-Ag-P 137.39(6) 
 21   
Cu(1)-N(21) 1.999(2) N(21)-Cu(1)-N(22) 90.76(6) 
Cu(1)-N(22) 2.003(2) N(21)-Cu(1)-P(1) 144.30(5) 
Cu(1)-P(1) 2.166(6) N(22)-Cu(1)-P(1) 124.94(5) 
Cu(2)-N(27) 2.014(2) N(27)-Cu(2)-N(28) 93.84(7) 
Cu(2)-N(28) 1.990(2) N(27)-Cu(2)-P(2) 125.54(5) 
Cu(2)-P(2) 2.161(6) N(28)-Cu(2)-P(2) 140.40(5) 
 
 
 In fact, in complexes 19 and 21, the metal is in a distorted trigonal-planar geometry 
and is bound by the N2 chelate ligand and PPh3. The thioether group adopts the same 
conformation already described for the coordination polymers that were constructed 
with these ligands in the absence of PPh3. In contrast, 10, 12 and 14 show the metal in 
a distorted tetrahedral geometry, and the ligands employ the N2S donor set. In the 
complexes (see Figures 16 and 17) , the thioether moiety is in a different 
conformation than that exhibited in the coordination polymers because the sulfur 
points to the same metal center of the N2 donor system. In all the complexes, the Cu-
N and Cu-P bond distances are in the 1.999(2)-2.065(3) Ǻ and 2.161(6)-2.1863(7) Ǻ 
ranges, respectively. In the 10, 12, and 14 complexes, the Cu-S distance is in the 
narrow range of 2.4801(8)-2.4860(6) Ǻ (Table 6). Thus, the increase in the steric 
hindrance on the pyrazole rings when a hydrogen atom is substituted for an i-Pr 
group appears to neither affect the overall geometry of these complexes nor prevent 
the coordination of a relatively bulky ligand such as PPh3.  
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Figure 27. On the top: molecular drawing of 18 and 19. The hydrogen atoms are 
omitted for clarity. Down:  molecular drawing of 21: the two molecules comprising 
the asymmetric unit are reported. The hydrogen atoms are omitted for clarity. 
Under nitrogen atmosphere, the crystallization of the Cu(I) complexes reported here 
always affords colorless crystals of homogeneous shape. In contrast, during the 
crystallization of the Ag(I) complexes, a considerable number of crystals with 
hexagonal prismatic shapes are always present among the differently shaped 
prismatic crystals of the [Ag(L)PPh3]BF4 ternary complexes. The molecular structure 
derived from the X-ray diffraction analysis of the hexagonal crystals reveals that the 
compound is [Ag(PPh3)4]BF4 (Figure 28), which is isostructural with the previously 
reported complex [Ag(PPh3)4]PF6.
68 Given the difficulties encountered during the 
recrystallization of the Ag(I) complexes, only the molecular structures of 18, 11, and 
13 could be obtained, and they can be easily related to the corresponding Cu(I) 
complexes. In fact, in 18, the metal is in a trigonal-planar geometry achieved by the N2 
chelate ligand and PPh3, with a thioether group that is not bound to the metal center. 
In contrast, the molecular structures of 11, and 13 present the metal in a distorted 
tetrahedral geometry, and the LMeCH2S and L
iPrCH2S ligands behave as N2S tridentate. 
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On average, the coordination bond distances of these silver complexes are more than 
0.2 Ǻ longer than those of the copper complexes, which is congruent with the larger 
size of the silver cation. 
 
Figure 28. Molecular drawing of [Ag(PPh3)4]BF4. Thermal ellipsoids are drawn at the 
30% probability level. The hydrogen atoms are omitted for clarity. Selected bond 
distances (Ǻ): Ag-P(1) = 2.681(1), Ag-P(2) = 2.636(2). 
The molecular structures of these ternary complexes provide further evidence that 
the ligands with the methylene group as a spacer are coordinatively flexible and can 
behave as N2S chelate or N2 chelate and S-bridging. In contrast, the ligands with the 
phenyl ring as a spacer can be considered coordinatively rigid. Accordingly, their 
predominant conformation in the complexes presented thus far comprises the N2 and 
S donor systems that are oriented in nearly opposite directions.  
3.3.3. Conformational studies 
Conformational studies were performed to investigate the energetics relative to the 
mobilities of the pyrazole rings and thioether groups of the ligands. The rigid 
potential-energy surface (PES) scans are performed using the two real systems LHPhS 
and LHCH2S as benchmarks for the investigation of the flexibility of the two ligand 
classes. The calculations are performed by varying three torsion angles; τ1 rotates one 
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of the pyrazole rings, τ 2 rotates the spacer between the thioether and bis-pyrazole 
moieties (Ph or CH2), and τ 3 rotates the peripheral phenyl ring. Because the 
calculations are performed without optimization at every step (rigid PES scan), there 
are unrealistic conformations in which the phenyl, pyrazole or thioether groups 
collide with one another. These conformations are characterized by very high energy 
and will not be discussed further. 
The conformation of LHPhS that exhibits the minimum energy is 1a reported in Figure 
29. This conformation is characterized by the pyrazole ring that orients the nitrogen 
lone pair on approximately the same side of the molecule (τ1 = 295.6°) and by the 
thioether group that points toward the methine proton (τ2 = 49.2°). Due to the 
arrangement of the phenyl spacer group, the peripheral phenyl ring does not interact 
with any other molecular fragment (τ3 = 342.1°). This lack of interaction has 
consequences for the energies involved in the free rotation of this group because only 
14 kJ/mol are required when τ1 = 295.6° and τ2 = 49.2°. The 360° rotation of the 
pyrazole ring (τ1) requires 24 kJ/mol when τ2 = 49.2° and τ3 = 342.1°. In comparison, 
the rotation of the thioether group requires at least 90 kJ/mol (with τ1 = 295.6° and 
τ2 = 49.2°). Furthermore, an inspection of all PES scans reported in Figure 29 reveals 
how the pyrazole rotation is a relatively inexpensive process, whereas the rotation of 
the phenyl ring acting as a spacer usually implies high energy barriers. In particular, 
the regions of the PES scans characterized by minor energy are those that are 
associated with the conformation in which the thioether points toward the central 
methine proton (τ2 range of = 25.2-73.2°). Structure 2a corresponds to the ligand 
conformation that would allow the N2S coordination of this ligand class, and its 
energy is at least 30 kJ/mol greater than that of 1a.  
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Figure 29. Rigid PES scan of the LHPhS and LHCH2S ligands. For both ligand classes, the 
conformations corresponding to the potential N2 and N2S coordination behavior are 
indicated by the  and  symbols, respectively. The conformations adopted by the 
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ligands in the polynuclear [M(L)]n
n+ and mononuclear [M(L)PPh3]BF4 complexes are 
indicated with purple and magenta triangles, respectively. 
 
The LHCH2S ligand should be characterized by a greater flexibility when compared to 
the LRPhS ligand class. This is evident when examining the PES scan of LHCH2S, because 
the regions of low energy are more extensive than those of the LHPhS PES scan. The 
conformation of LHCH2S that exhibits the minimum energy is 1b reported in Figure 29. 
This conformation is characterized by 1) pyrazole rings oriented in an antiparallel 
fashion (τ1 = 57.9°), 2) the methylene bridge and the central methine proton in a 
staggered conformation with the thioether that points toward the methine proton (τ2 
= 321.1°), and 3) the peripheral phenyl ring nearly staked over one of the pyrazole 
rings (τ3 = 288.1°). Based on the analysis of the PES scan, the rotation of the phenyl 
ring is the least energetically demanding (~20 kJ/mol), and the most stable 
conformation presumably attains a slight stabilization by the partial π-stack of the 
pyrazole and phenyl rings. Also, the rotation of the pyrazole ring requires a limited 
expenditure of energy: ~33 kJ/mol for a 360° rotation of τ1 when τ2 = 321.1° and τ3 = 
288.1°. The rotation of the thioether group requires slightly more energy, but it is still 
a relatively inexpensive process: ~52 kJ/mol for a 360° rotation of τ2 when τ1 = 57.9° 
and τ3 = 288.1°. Furthermore, by a close inspection of the various energy profiles of 
LRCH2S provided in Figure 30, it is evident that there are a number of conformations 
that are very close in energy; they can be grouped into two main reference structures: 
one corresponds to the minimum of the PES scan, as previously described (1b in 
Figure 29), whereas the other is still characterized by a staggered conformation of the 
methylene and methine protons but with the sulfur atoms pointing to the opposite 
side of the central methine proton (2b in Figure 29). This latter conformation, apart 
from the rotation of one pyrazole ring, is the one adopted by the ligand in the ternary 
complexes in the presence of PPh3.  
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Figure 30. Energy differences (kJ/mol) between the coordination isomers of the two 
model complexes, [Ag(LHPhS)PH3]
+ and [Ag(LHCH2S)PH3]
+ (B3LYP/6-31+G(d)-SDD). 
Selected coordination bond distances (Ǻ) are reported. 
 
In conclusion, it is evident that the LRPhS ligand class is conformationally more rigid 
and pre-organized than the LRCH2S class. In fact, the general and therefore expected 
behavior of the LRPhS ligands is the N2 chelation on a metal and possibly the bridging 
interaction of the thioether group on a second metal. The presence of the phenyl 
group as a spacer precludes the N2S chelation mode for this ligand class. In contrast, 
the LRCH2S class usually N2 chelates and bridges with the thioether group on a second 
metal, but it can also act as a N2S donor on the same metal ion. The energy 
expenditure to drive the thioether and the bis-pyrazole systems to chelate the same 
metal ion is compensated by the metal–sulfur interaction energy, which is evidently 
not sufficient for the LRPhS system. This compensation is further evidenced by 
inspecting the energy profiles of the conformational isomers of the two model 
complexes, [Ag(LHPhS)PH3]
+ and [Ag(LHCH2S)PH3]
+ (Figure 30). For [Ag(LRCH2S)PH3]
+, 
the energy difference between the two isomers is only 2.6 kJ/mol, which confirms 
that there is not a significant energy gain derived by the coordination of the thioether 
group when a metal ion is present. In contrast, for [Ag(LHPhS)PH3]
+, the isomer with 
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the N2S chelate ligand lies 17.7 kJ/mol above that of the isomer with the N2 bidentate 
ligand. An inspection of the optimized molecular structure of this complex indicates 
that the sulfur coordination implies a certain ligand strain. In particular, the sulfur 
coordination requires a destabilizing approach between the CHcentral and the CHortho 
hydrogen atoms.  
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CHAPTER 4 
Porous coordination polymers: synthesis and 
characterization of novel silver(I) supramolecular 
architectures. 
As mentioned in the previous chapter we will described here coordination polymers 
based on the LMePhS ligands. The complexation of a pre-organized thioether-
functionalized bis(pyrazolyl)methane ligand (LMePhS) with silver precursors produces 
supramolecular structures organized at two hierarchical levels: [AgL]6(X)6 metal-
organic cyclic hexamers and their organization in 3D supramolecular architectures73. 
The cyclic toroidal hexamers of 22-26 Å external diameter are found to be stable 
already in solution before self-assembly into the crystalline state. In the 3D lattice the 
hexameric building block are arranged in different highly symmetric space groups as a 
function of a variety of anions (cubic Fd-3 with PF6
- or BF4
- and rhombohedral R-3 with 
CF3SO3
- or NO3
-) and form cavities with the geometrical shapes of Platonic solids 
(tetrahedron and octahedron) that can be occupied by a variety of solvent molecules. 
Upon evacuation, cubic crystals can produce stable frameworks with permanent 
porosity, which can absorb reversibly several vapors, CO2 and CH4. 
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4.1 Introduction 
Many supramolecular architectures are based on the interaction of opportunely 
selected ligands and metal ions, and their stereoelectronic complementary serves to 
shape notable molecular structure74–80. The stability of the metal-ligand association 
depends on the affinity between the ligand donor set and the metal ions and this is 
expressed by the concept of pre-organization. According to that, the more a specific 
ligand is appropriately constructed with the donor lone pairs properly oriented for 
metal ion-binding, the more stable the assembly will result81. Furthermore, the 
existence of weak non covalent-forces in molecular assemblies determines, in many 
cases, a reversibility of association so that the final product is in thermodynamic 
equilibrium with its components, or its partially assembled intermediates. This has 
lead to the formulation of dynamic combinatorial libraries, where a supramolecular 
structure self-assembles out from a pool of different components when a 
complementary species is added to the mixture82. The application of supramolecular 
assemblies are as diverse as their molecular structures and they include 
catalysis30,83,84, the construction of nano-scaled structures for gas storage18,22,26,85,86, 
the design of molecular sensors87 and molecular machines able to execute a 
mechanical function in presence of an external stimulus88,89. Taking into account the 
shape of a particular supramolecular entity, much attention has been paid in recent 
years to self-assembled capsules that provide a confined isolated cavity42,90–95, inside 
which catalysis83,84  and molecular recognition can be efficiently performed. With 
respect to the latter aspect, the discrimination of enantiomers by means of 
enantioselective encapsulation has also been reported96. In this chapter, self-
assembled hexameric complexes having a toroidal shape were synthesized by using 
an N2S donor ligand, [M(L
MePhS)]6
6+ (M = Cu(I) and Ag(I)) . The N2 donor system is 
derived from the bis(pyrazole)methane moiety and a thioether function attached to 
its central carbon atom provides the S donor atom of the ligand LMeSPh already 
introduced in chapter 3. This ligand adopts a conformation that makes it suitable to 
build hexamers when reacted with monovalent metal ions, such as copper or silver, 
since the N2 and S donor groups point in nearly opposite directions. The crystallization 
of [M(LMePhS)]6
6+ hexamers in presence of different anions (BF4
-, PF6
-, CF3SO3
- and 
NO3) yield supramolecular structures whose shape and nuclearity is a function of the 
counterions. 
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Figure 31. Toroidal hexamers of copper and silver metal ions with different 
counterions. 
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4.2 Experimental 
4.2.1. Experimental  
All reagents and solvents were commercially available. 1H NMR spectra were recorded 
on a Bruker Avance 300 spectrometer using standard Bruker pulse sequences. 
Chemical shifts are reported in ppm referenced to residual solvent protons (CDCl3, 
CD3CN, (CD3)2CO). Infrared spectra were recorded from 4000 to 700 cm
-1 on a Perkin-
Elmer FT-IR Nexus spectrometer equipped with a Thermo-Nicolet microscope. 
Synthesis of 22. A solution of [Cu(MeCN)4]BF4 (97 mg, 0.31 mmol) in 8 mL of dry 
MeCN was added to a solution of LMePhS (101 mg, 0.26 mmol) in 10 mL of dry MeCN 
in a Schlenk flask under nitrogen. The colorless solution was stirred for 15 min. The 
solvent was then concentrated under vacuum and a white solid was precipitated after 
addition of diethyl ether. The mixture was filtered under nitrogen affording a white 
solid (113 mg, yield 88%). The compound was recrystallized by stratifying diethyl 
ether over an acetone solution of the complex, yielding colorless crystals. IR (cm-1): 
3534w, 3055w, 2963w, 2924w, 1638m, 1558s, 1457s, 1418s, 1394s, 1231m, 1015s, 
873m, 762m. 1H NMR (300 MHz, (CD3CN) δ: 2.25 (s, 6H, 2CH3(Pz)), 2.45 (s, 6H, 
2CH3(Pz)), 6.06 (s, 2H, CH(Pz)), 6.61 (m, 1H, CHorto(Ph)), 7.16 (m, 2H, CH(Ph)), 7.27-7.36 
(m, 6H, C(Ph)), 7.57 (s, 1H, Ccentral). 
13C NMR (100 MHz, (CD3CN) δ: 11.67 (CH3(Pz)), 
14.19 (CH3(Pz)), 68.37 (CHcentral), 107.52 (CH(Pz)), 128.27 (C(Ph)), 128.84 (C(Ph)), 
130.12 (C(Ph)), 130.43 (C(Ph)), 131.12 (C(Ph)), 131.21 (C(Ph)), 135.05 (C(Ph)), 135.48 
(C(Ph)), 136.30 (C(Ph)), 137.75 (C(Ph)), 143.82 (C(CH3)), 152.24 (C(CH3)). Anal. Calc. for 
(C23H24N4S)6Cu6(BF4)6 (3233.28): C, 51.26; H, 4.49; N, 10.37. Found: C, 51.05; H, 4.27; 
N, 10.15%. 
Synthesis of 23-BF4. L
MePhS (300 mg, 0.76 mmol) and AgBF4 (150 mg, 0.76 mmol) were 
mixed in acetone (6 mL), and the colorless solution was stirred for 30 min. The 
solution was then concentrated under vacuum and a white solid was precipitated 
after addition of diethyl ether. The solid was filtered and vacuum dried (388 mg, yield 
87%). The compound can be recrystallized by stratifying hexane over a 
dichloromethane solution of the complex yielding colorless crystals. Alternatively, 
crystals can be obtained by stratifying diethyl ether over an acetone solution of the 
complex. IR (cm-1): 2975w, 2909w, 1558m, 1463m, 1440m, 1417m, 1315w, 1276w, 
1232w, 1049s, 1031s, 874m, 763m, 690m, 745m, 697m, 687m. 1H NMR (300 MHz, 
(CD3)2CO) δ: 1.93 (s, br , 6H, 2CH3(Pz)), 2.51 (s, 6H, 2CH3(Pz)), 6.14 (s, 2H, CH(Pz)), 7.19 
(d, J = 1.2 Hz, 1H, CHorto(Ph)), 7.21 (d, J = 2.1 Hz, 2H, CH(Pz)), 7.34-7.44 (m, 5H, 
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CH(Ph)), 7.85 (s, 1H, CH central). 
13C NMR (100 MHz, (CD3CN) δ: 11.51 (CH3(Pz)), 14.14 
(CH3(Pz)), 68.55 (CHcentral), 107.63 (CH(Pz)), 128.41 (CH(Ph)), 129.20 (CH(Ph)), 129.28 
(CH(Ph)), 130.48 (CH(Ph)), 131.16 (CH(Ph)), 131.42 (CH(Ph)), 135.38 (CH(Ph)), 135.70 
(CH(Ph)), 135.79 (CH(Ph)), 137.76 (CH(Ph)), 149.31 (C(CH3)), 152.39 (C(CH3)). Anal. 
Calc. for (C23H24N4S)6Ag6(BF4)6 (3499.21): C, 47.37; H, 4.15; N, 9.61. Found: C, 46.95; H, 
4.12; N, 9.30%. 
Synthesis of 24-PF6. L
MePhS (107 mg, 0.27 mmol) and AgPF6 (73 mg, 0.27 mmol) were 
mixed in acetone (10 mL), and the colorless solution was stirred for 10 min. The 
solvent was then concentrated under vacuum and a white solid was precipitated after 
addition of diethyl ether. The solid was filtered and vacuum dried (152 mg, yield 87%). 
The compound was recrystallized by stratifying diethyl ether over an acetone solution 
of the complex, yielding colorless crystals. IR (cm-1): 3057 w, 2909w, 1557m, 1516s, 
1464m, 1439m, 1380s, 1315s, 1250m, 1033m, 754s, 692m, 668s, 619m. 1H NMR (300 
MHz, (CD3)2CO) δ: 1.95 (s, 6H, 2CH3(Pz)), 2.65 (s, 6H, 2CH3(Pz)), 6.15 (s, 2H, CH(Pz)), 
7.08 (m, 1H, CHorto(Ph)), 7.22 (m, 2H, CH(Ph)), 7.33-7.41 (m, 6H, CH(Ph)), 7.85 (s, 1H, 
CHcentral). 
13C NMR (100 MHz, (CD3CN) δ: 11.54 (CH3(Pz)), 14.10 (CH3(Pz)), 68.53 
(CHcentral), 107.60 (CH(Pz)), 128.39 (CH(Ph)), 129.23 (CH(Ph)), 129.38 (CH(Ph)), 130.47 
(CH(Ph)), 131.12 (CH(Ph)), 131.40 (CH(Ph)), 135.35 (CH(Ph)), 135.66 (CH(Ph)), 135.70 
(CH(Ph)), 137.74 (CH(Ph)), 149.29 (C(CH3)), 152.34 (C(CH3)). Anal. Calc. for 
(C23H24N4S)6Ag6(PF6)6 (3848.17): C, 43.07; H, 3.77; N, 8.74. Found: C, 43.36; H, 4.01; N, 
8.91%. 
Synthesis of 25-CF3SO3. L
MePhS (187 mg, 0.48 mmol) and AgCF3SO3 (122 mg, 0.48 
mmol) were mixed in acetone (5 mL), and the colorless solution was stirred for 20 
min. The solvent was then removed under vacuum and the white solid was washed 
with hexane in an ultrasound bath. The mixture was filtered yielding a white solid 
(220 mg, yield 71%). The compound was recrystallized by stratifying hexane over a 
THF solution of the complex, yielding colorless crystals. IR (cm-1): 3052w, 2920w, 
1559m, 1485m, 1440m, 1418m, 1277m, 1237s, 1221s, 1153m, 1024s, 876m, 745m, 
697m, 634s, 569m, 516w. 1H NMR (300 MHz, (CD3)2CO) δ: 1.94 (s, 6H, 2CH3(Pz)), 2.55 
(s, 6H, 2CH3(Pz)), 6.14 (s, 2H, CH(Pz)),  7.11 (d, J = 9 Hz, 1H, CHorto(Ph)), 7.32 (m, 2H, 
CH(Ph)), 7.36-7.44 (m, 6H, CH(Ph)), 7.49 (s, 1H, CHcentral). 
13C NMR (100 MHz, (CD3CN) 
δ: 11.50 (CH3(Pz)), 14.12 (CH3(Pz)), 68.54 (CHcentral), 107.65 (CH(Pz)), 128.38 (CH(Ph)), 
129.19 (CH(Ph)), 129.28 (CH(Ph)), 130.41 (CH(Ph)), 131.13 (CH(Ph)), 131.39 (CH(Ph)), 
135.33 (CH(Ph)), 135.68 (CH(Ph)), 135.77 (CH(Ph)), 135.82 (CH(Ph)), 137.80 (CH(Ph)), 
149.75(C(CH3)), 152.33 (C(CH3)). Anal. Calc. for (C23H24N4S)6Ag6(CF3SO3)6 (3872.81): C, 
44.66; H, 3.75; N, 8.68. Found: C, 44.39; H, 3.58; N, 8.53%. 
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Synthesis of 26-NO3. L
MePhS (120 mg, 0.30 mmol) and AgNO3 (56 mg, 0.30 mmol) 
were mixed in acetone (5 mL), and the colorless solution was stirred for 10 min. The 
solvent was then removed under vacuum yielding a white solid that was washed with 
hexane (150 mg, yield 89%). The compound was recrystallized by stratifying hexane 
over a dichloromethane solution of the complex, yielding colorless crystals. IR (cm-1): 
2920w, 2851w, 1704w, 1557m, 1414s, 1280s, 1027m, 978w, 874w, 845w, 746s, 690s, 
616w, 529w. 1H NMR (300 MHz, (CD3)2CO) δ: 2.09 (s, br, 6H, 2CH3(Pz)), 2.55 (s, 6H, 
2CH3(Pz)), 6.12 (s, 2H, CH(Pz)), 7.14-7.40 (m, 2H, CH(Pz)), 7.88 (s, 1H, CHcentral). 
13C 
NMR (100 MHz, (CD3CN) δ: 11.49 (CH3(Pz)), 14.11 (CH3(Pz)), 68.61 (CHcentral), 107.61 
(CH(Pz)), 128.39 (CH(Ph)), 129.18 (CH(Ph)), 129.30 (CH(Ph)), 130.45 (CH(Ph)), 131.14 
(CH(Ph)), 131.41 (CH(Ph)), 135.34 (CH(Ph)), 135.71 (CH(Ph)), 135.80 (CH(Ph)), 137.86 
(CH(Ph)), 149.79 (C(CH3)), 152.33 (C(CH3)). Anal. Calc. for (C23H24N4S)6Ag6(NO3)6 
(3350.42): C, 49.47; H, 4.33; N, 12.54. Found: C, 49.22; H, 4.23; N, 12.33%. 
4.2.2. Single Crystal X-ray Structures 
Single crystal data were collected with a Bruker Smart 1000 and on a Bruker Smart 
APEXII area detector diffractometers (Mo Kα; λ = 0.71073 Å). Cell parameters were 
refined from the observed setting angles and detector positions of selected strong 
reflections. Intensities were integrated from several series of exposure frames that 
covered the sphere of reciprocal space48. A multiscan absorption correction was 
applied to the data using the program SADABS47. The structures were solved by direct 
methods SIR9747,66 and SIR200466 and refined with full-matrix least-squares (SHELXL-
9750), using the Wingx51 software package. Graphical material was prepared with the 
Mercury 2.052 program. Crystallographic data are reported in Appendix v. 
4.2.3. Solid State NMR 
The 13C solid-state NMR spectra were run at 75.5 MHz on a Bruker Avance 300 
instrument operating at a static field of 7.04 T equipped with 4 mm double resonance 
MAS probe. The samples were spun at the magic angle at a spinning speed of 12.5 
kHz, and ramped-amplitude cross-polarization (RAMP-CP) transfer of magnetization 
was applied. The 90° pulse for proton was 2.9 μs. 13C cross-polarization (CP) MAS 
experiments were performed using a recycle delay of 10 s and contact times of 2 ms. 
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4.2.4. X-ray Powder Diffraction 
Powder XRD patterns were collected using a Thermo ARL X’tra powder diffractometer 
(CuKα radiation) equipped with a Thermo Electron solid state detector. Data collection 
was performed in Bragg-Brentano configuration by 0.05° steps with counting time 
ranging from 1 to 5 sec. Temperature-dependent experiments were performed by 
using an Anton Paar TTK450 chamber connected to a vacuum apparatus. 
4.2.5. Thermal analysis  
Differential Scanning Calorimetry (DSC) traces were recorded on a Mettler Toledo 
Stare DSC1 analysis system equipped with N2 low temperature apparatus. The 
experiments were run under nitrogen atmosphere in a standard 40µl Al pans. The 
samples were first heated from 25 °C to 125 °C, then cooled to 25 °C and later heated 
to 300 °C at 10 °C/min. The sample weight were about 5 mg. Standard 70µl alumina 
pans were used. 
4.2.6. PGSE (Pulsed Gradient Spin Echo) 1H NMR 
1H PGSE NMR measurements were performed for 23-BF4  and 25-CF3SO3 solutions in 
CD2Cl2 and acetone-d
6 in the 0.1-0.001 M concentration range (based on the AgL+ 
unit, 1/6 hexamer). A standard stimulated echo (STE) sequence on a Bruker Avance 
300 spectrometer was employed (300 K without spinning). The most intense signals 
were taken into account during the data processing. The dependence of the 
resonance intensity (I) on the gradient strength (g) is described by the following 
equation: 
)3/(
0
222 δδγ −∆⋅⋅⋅⋅−
⋅=
gD
eII
 
where I = observed intensity (attenuated signal intensity), I0 = reference intensity 
(unattenuated signal intensity), D = diffusion coefficient, γ = nucleus gyromagnetic 
ratio, g = gradient strength, δ= gradient duration, and  ∆= diffusion delay. The 
parameters δ and  ∆ were kept constant during the experiments, whereas g was 
varied from 2 to 95% in 16 steps. Different values of δ (1-2 ms), ∆ (50-100 ms) and 
number of scans (depending on concentration) were used for different samples. All 
spectra were acquired using 16K points and processed with a line broadening of 1.0 
Hz. PGSE data were treated by applying a procedure reported in the literature,97–99 
taking advantage of an internal standard (tetrakis(trimethylsilyl)silane, TMSS; rH
TMSS 
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(hydrodynamic radius) ≈ rvdW
TMSS (van der Waals radius) = 4.28 Å).100 A nonlinear 
regression on I and g2 data was performed with the SPSS 15.0 software in order to 
obtain the coefficients m = D.γ2.δ2.(∆-δ/3) for both the sample and the 
corresponding internal standard signals (msample and mTMSS, respectively). The 
following expression (based on the Stokes-Einstein equation) was applied and 
numerically resolved to get the hydrodynamic radius of each sample (rH
sample): 
TMSS
sample
sample
H
sample
TMSS
H
TMSS
m
m
rc
rc
=
⋅
⋅
 
The coefficients csample and cTMSS can be estimated from the semiempirical equation:  
234.2)695.01(
6
x
H
solv
x
r
r
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where x = sample or TMSS, and rsolv ≈ van der Waals radius of the solvent (2.49 Ǻ for 
CD2Cl2 and acetone-d
6). Uncertainties were obtained by error propagation on m.  
The van der Waals radii (rvdW) 
19 were computed for the two types of hexamers, 23-BF4 
and 25-CF3SO3, using the X-ray geometry and with the software package DS Viewer 
Pro 5.0 and assuming a spherical molecular shape.   
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4.3 Results and Discussion 
4.3.1. Synthesis 
The ligand ((2-(phenylthio)phenyl)methylene)bis(3,5-dimethyl-1H-pyrazole) (L) was 
prepared as previously reported (chapter 3).   
 
Figure 32. Synthetic path of ligand and complexes 
As we have previously described, the synthesis is a solid state reaction in which the 
aldehyde bearing a thioether group and the bispyrazolylketone react in presence of 
CoCl2 as catalyst. The synthesis of silver complexes are performed  in the air at room 
temperature while the copper complexes are produced under inert atmosphere with 
schlenk techniques.  
4.3.2.  Solid state structures 
By using the LMePhS ligand an invariant hexameric molecular arrangement is achieved 
either with copper or with silver. In  23-BF4 the ligand acts as N2 bidentate on a metal 
and bridges on another silver atom with the thioether group. The pre-organization of 
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the ligand was previously described (see chapter 2 and 3) and it determines the 
coordination properties of this ligand class. More specifically, the presence of the 
central phenyl ring as spacer implies that the bis(pyrazole) and thioether donor 
groups are not able to chelate on the same metal center. 
 
Figure 33. Schematic coordinative way of ligand.  
 In addition, the peripheral phenyl ring is located above one of the pyrazole ring giving 
rise to a stabilizing π-π interaction (3.5 Ǻ). The pyrazole rings of six ligands defines the 
exteriors of the hexamer whereas the phenyl rings are oriented towards the interior, 
thus shaping an hydrophobic pore of 5.1 Ǻ in diameter (calculated by taking into 
account the VdW surface of the H oriented towards the interior of the hole). The 
analysis of the anion influence on the crystal packing is hampered by the 
fragmentation of the site occupation of the BF4
- ion within the unit cell. In fact, per 
each silver cation of the asymmetric unit the BF4
- anion is distributed in three 
positions in the unit cell, 1) a 0.1666 fraction lying on a ternary axis and with a halved 
occupancy, 2) a 0.3333 fraction lying on a ternary axis, and a 3) fraction 0.5 lying on a 
binary axis.  
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Figure 34. Anion interaction between hexamers which define the capsule formation.   
This latter fraction links together two silver atoms of symmetry related hexamers in a 
way that the centroids of four hexamers occupy the vertex of a tetrahedron  thus 
defining an internal cavity having the shape of a tetrahedron. The distance between 
the fluorine and the silver atoms is of 2.794(4) Ǻ pointing to the weak nature of this 
interaction.  
 
Figure 35. Molecular capsule.  
On the other hand, the evidence that plays in favor of an Ag-F weak bond comes by 
the deviation of the ideal trigonal geometry of the silver atom, which in fact lies out of 
the plane defined by the N2S donor system by 0.09 Ǻ and is directed toward the 
fluorine atom. The ball shaped assembly comprised of four hexameric units, defines 
the unit cell lattice and forms two types of cavities  one that is contained in the 
sphere (~900 Ǻ3) and the other that is produced by the close packing of the spheres 
(~1400 Ǻ3). These 3D cavities are filled by highly disordered solvent molecules.  
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Figure 36. Two interpenatreted cavities frameworks in yellow and in red.  
Isostructural crystals could be obtained by crystallizing  23-BF4 in different solvents 
such as THF/hexanes, CH2Cl2/hexanes, and acetone/diethyl-ether. In all cases the 
solvent could not be properly located even though the X-ray data collection were 
performed at 205 K, and it was therefore treated with the PLATON/SQUEEZE 
program101. The solvent guest can be removed by the cavities without loss of 
crystallinity. One well defined crystal was evacuated by applying a high vacuum for 
several hours and then an X-ray data collection was performed. The same crystal was 
wet with dichloromethane and quickly positioned under the nitrogen cryostream at 
205 K, and an X-ray data collection was performed. The same procedure was applied 
to another crystal that was impregnated with 1,3-dibromopropane and the X-ray data 
collection was performed at 190 K. In none of the data collection the solvent could be 
properly located inside the cavities. Also solid NMR on compounds 23-BF4 and 24-PF6 
confirmed the absence of the solvent molecules (Figure 41). 
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Table 7. Selected bond lengths (Å) and angles (°) for 23-BF4, 24-PF6, 25-CF3SO3, 26-
NO3, 22. 
 23-BF4   
Ag-N(21) 2.282(3) N(21)-Ag-S(13)’ 124.25(7) 
Ag-N(22) 2.232(3) N(22)-Ag-S(13)’ 148.59(7) 
Ag-S(13)’ 2.3934(9) N(21)-Ag-F(2) 101.1(1) 
Ag-F(2) 2.794(4) N(22)-Ag-F(2) 88.5(1) 
N(21)-Ag-N(22) 86.60(9) S(13)’-Ag-F(2) 90.67(7) 
 24-PF6   
Ag-N(21) 2.302(7) N(21)-Ag-S(13)’’ 125.2(2) 
Ag-N(22) 2.214(6) N(22)-Ag-S(13)’’ 149.2(2) 
Ag-S(13)’’ 2.391(2) N(21)-Ag-F(2) 89.4(2) 
Ag-F(2) 2.719(5) N(22)-Ag-F(2) 91.4(2) 
N(21)-Ag-N(22) 85.6(2) S(13)’’-Ag-F(2) 91.3(2) 
 25-CF3SO3   
Ag-N(21) 2.356(3) N(21)-Ag-S(13)’’’ 126.5(9) 
Ag-N(22) 2.241(3) N(22)-Ag-S(13)’’’ 140.43(9) 
Ag-S(13)’’’ 2.464(1) N(21)-Ag-O(24) 92.9(1) 
Ag-O(24) 2.651(4) N(22)-Ag-O(24) 126.8(1) 
N(21)-Ag-N(22) 87.6(1) S(13)’’’-Ag-O(24) 76.4(1) 
 26-NO3   
Ag-N(21) 2.365(3) N(21)-Ag-S(13)’’’ 123.32(6) 
Ag-N(22) 2.251(3) N(22)-Ag-S(13)’’’ 131.47(8) 
Ag-S(13)’’’ 2.5046(9) N(21)-Ag-O(14) 98.4(1) 
Ag-O(14) 2.569(3) N(22)-Ag-O(14) 139.3(1) 
Ag-O(24) 2.651(4) S(13)’’’-Ag-O(14) 77.75(7) 
N(21)-Ag-N(22) 87.4(1)   
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 22   
Cu-N(21) 2.007(6) N(21)-Cu-N(22) 94.2(2) 
Cu-N(22) 1.997(6) N(21)-Cu-S(13)’ 123.7(2) 
Cu-S(13)’ 2.164(2) N(22)-Cu-S(13)’ 142.1(2) 
Cu-F(2) 2.750(7)   
Symmetry codes: ’ = 1-z; ½-x; ½-y, ’’ = 1/2-z; x-1/4; y+1/4. ’’’ = x-y; x; 1-z. 
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Figure 37. A picture of 24-PF6 evacuated crystal and then deep in CH2Cl2. From picture 
it is possible to show the air bubbles derived from the empty cavities.  
Nevertheless, the residual electron density in the cavities well correlates with the 
electronic density of the solvent employed. In particular, as estimated by SQUEEZE-
PLATON the dimensions of the cavities and the residual electron density is as follow: 
1999 e-/cell and 20187 Ǻ3/cell (23-BF4-evacuated, cavity volume: 26 % of total cell 
volume), 7500 e-/cell and 20925 Ǻ3/cell (23-BF4-CH2Cl2, cavity volume: 28 % of total 
cell volume), 9625 e-/cell and 21487 Ǻ3/cell (23-BF4-C3H6Br2, cavity volume: 28 % of 
total cell volume). The same molecular structure is obtained with Cu+ in place of Ag+, 
with the major difference represented by the metal-donor atom bond lengths, that in 
the case of the copper complex are on average 0.2 Ǻ shorter than in the silver one. 
This has however a minimum effect on the size of the hydrophobic pore, as it now 
measures 5.0 Ǻ. 24-PF6 and  23-BF4 crystallize in the same space group and have 
nearly the same cell parameters, Tables 7 . The phosphorous atom occupies the same 
sites of the boron, the only difference is in the different localization of the fluorine 
atoms. This most likely happens as a favorable match between the spherical 
symmetry of BF4
- and PF6
- anions and the cavity generated by the close approach of 
the hexamers. Also for 24-PF6 the solvent could not be properly located inside the 
cavities. The residual electron density was estimated by SQUEEZE-PLATON: the 
dimensions of the cavities and the residual electron density are: 6055 e-/cell and 
21476 Ǻ3/cell (cavity volume: 27 % of total cell volume).  
A different crystal packing is obtained with NO3
- and CF3SO3
- anions. Both compounds 
crystallize in the rhombohedral space group R-3. Also for these structures, the 
counterions interact with the metal: in 26-NO3 the nitrate acts as symmetric O,O 
bidentate, whereas in 25-CF3SO3 the triflate is monodentate, which is the usual 
behavior of these two anions when bound to a metal center.  
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Figure 38. Different anions interaction between hexamers in different compounds. 
 
The metal interacts more strongly with the anions than in the complexes containing 
BF4
- or PF6
-, and this also reflected in the Ag-N and Ag-S bond lengths, which are 
significantly longer in 26-NO3 and 25-CF3SO3 with respect to 23-BF4 and 24-PF6. 
Another consequence of the Ag-O interaction, is the more pronounced distortion of 
the metal trigonal planar geometry, since the metal lies out of the plane of the N2S 
donor atoms of 0.3 Ǻ. Another difference is evident in the mutual orientation of the 
pyrazole rings, as in 24-PF6 and 23-BF4 they are symmetrically ligated to the metal, 
whereas in 26-NO3 and 25-CF3SO3 one of the pyrazole ring is slightly rotated so that 
there is a considerable mismatch between the directionality of the nitrogen lone pair 
and the metal center. 
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Figure 39. Hexamers assembly for silver compounds with no-symmetrical 
counteranions such as triflate and nitrate.  
Furthermore, as a possible consequence of this pyrazole ring rotation, the peripheral 
phenyl ring is no longer stacked over the pyrazole ring but it is rotated away from it 
(the dihedral angle between the pyrazole and phenyl ring planes is of 65°). This has 
important consequences on the dimension of the hydrophobic pore of the hexamer, 
as now it has shrunk to 3.4 Ǻ in diameter. The crystal packing of 26-NO3 and 25-CF3SO3 
shows other marked differences with that of 24-PF6, and 23-BF4. In fact, six hexameric 
units define an octahedral cavity which is in communication with symmetry related 
cavities aligned along the C3 crystallographic axis by means of the hydrophobic pore. 
In 26-NO3 and 25-CF3SO3 the volumes of the cavities filled by solvent molecules 
amounts to ~40% and ~36% of the unit cell volume, respectively: 1825 e-/cell and 
6287 Ǻ3/cell (26-NO3), and 1901 e
-/cell and 6113 Ǻ3/cell (25-CF3SO3). But the loss of 
solvent molecules implies the collapse of the entire structures.  
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Figure 40. Solvent molecules inside the cavities, determined according to the single 
crystal x-ray data collection performed at 300K. 
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Figure 41. 13C CP MAS NMR of porous 23-BF4 and 24-PF6 materials. The samples were 
crystallized from acetone/diethylether and then subjected to thermal treatment at 
60°C under vacuum. No signals of the solvents are detected. Spinning speed of 12500 
Hz and contact time of 2 ms were used. 
 
4.3.3. Variable temperature PXRD and thermal analysis 
Variable temperature Powder X-ray diffraction was employed to investigate how the 
crystallinity of the different compounds is affected by temperature. The crystals of 23-
BF4/24-PF6 retain a long range structural order in the 0-160 °C range and this is 
confirmed also by DCS thermal analysis. Figures 42 and 46. In fact the cristallinity is 
preserved also at high temperature and the DSC analysis confirmed the presence of a 
peak of glass transition at 160°C for the compound with the weaker interaction 23-BF4 
and at 200°C,  for the compound with the stronger interaction 24-PF6. On the other 
hand the PXRD spectra for 25-CF3SO3 and 26-NO3 show clearly a rapid loss of 
cristallinity. For 26-NO3 crystals, the removal from the mother liquor determines the 
collapse of the entire structure such that in the spectra there is an amourphous 
profile. The 25-CF3SO3 crystals are more robust but the removal of solvent guest 
molecules (THF) at 100°C  determines the collapse of the supramolecular network.  
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Figure 42. Variable temperature X-ray powder patterns of  23-BF4 in the 20-180 °C 
interval. 
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Figure 43. Variable temperature X-ray powder patterns of 24-PF6  in the 20-200 °C 
interval. 
 
Figure 44. Room temperature X-ray powder pattern of  25-CF3SO3performed on 
freshly grounded crystals (grown from CH2Cl2/Hexanes).  
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Figure 45. Room temperature X-ray powder pattern of  26-NO3 performed on 
freshly grounded crystals (grown from CH2Cl2/Hexanes).  
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Figure 46. Calorimetric analysis of  23-BF4 and  24-PF6 compounds. The heating rate 
of 10 °C/min was used. 
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4.3.4. PGSE (Pulse Gradient Spin Echo) 1H NMR  
Pulsed-gradient spin-echo (PGSE) NMR measurements were carried out to investigate 
how the complexes aggregate in solution. Since the aggregation process and the ion 
pairing depends on the solvent polarities,36 these experiments were performed in 
CD2Cl2 (ε= 9.1) and in acetone-d
6 (ε = 20.7) with three different concentrations (0.1-
0.001 M), Figures 47 and 48. The measured hydrodynamic radii (rH) for  23-BF4 and  
25-CF3SO3 are in the 7.6(3)-6.4(2) Å and 6.2(2)-6.7(3) Å interval, respectively, Table 8. 
These values reflect the larger size of the  23-BF4hexamer when compared to the  26-
NO3 one. The relatively narrow range of the rH values is consistent with the presence 
of isolated hexameric units in solution, at least in the investigated concentration 
interval. It is therefore during the crystallization process that the anions intervene in 
shaping the two different types of crystal lattices, cubic Fd-3 with BF4
-/PF6
- and 
rhombohedral R-3 with NO3
-/CF3SO3
-
.  
 
 
Figure 47. 1H PGSE NMR of spectrum of  23-BF4 recorded in CD2Cl2 showing the 
dependence of the resonance intensity on the intensity of the pulsed-field gradient. 
Conc. = 0.1 M based on 1/6 of the hexameric unit. The decay of the signals is in the 
following order: CH2Cl2≈acetone<TMSS< 23-BF4, according to the increasing 
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dimensions of the molecules. Internal standard: tetrakis(trimethylsilyl)silane. CH2Cl2 
and acetone are present as impurities. The crystals were grown from acetone/diethyl-
ether. 
 
Figure 48. 1H PGSE NMR of spectrum of 25-CF3SO3 recorded in CD2Cl2 showing the 
dependence of the resonance intensity on the intensity of the pulsed-field gradient. 
Conc. = 0.1 M based on 1/6 of the hexameric unit. The decay of the signals is in the 
following order: CH2Cl2<TMSS<23-BF4, according to the increasing dimensions of the 
molecules. Internal standard: tetrakis(trimethylsilyl)silane. The crystals were grown 
from CH2Cl2/Hexanes. 
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Table 8. Experimental Hydrodynamic Radii (rH, Ǻ) for  23-BF4, and  25-CF3SO3 in CD2Cl2 
and acetone-d6 at Different Concentrations at 300 K. 
Solvent Conc. (M) rH 23-BF4 rH 25-CF3SO3 
CD2Cl2 0.001 6.4(0.2) 6.2(0.2) 
CD2Cl2 0.05 6.6(0.2) 6.3(0.3) 
CD2Cl2 0.1 7.6(0.3) 6.7(0.3) 
acetone-d6 0.001 6.9(0.3) 6.7(0.3) 
acetone-d6 0.05 6.7(0.3) 6.6(0.3) 
acetone-d6 0.1 7.0(0.4) 6.7(0.2) 
 
 
Figure 49. Dimensions and van der Waals radii (rvdW) of  23-BF4 (above) 25-CF3SO3 
(below) hexamers as derived from the X-ray crystal structures. 
 
4.3.5. Absorption analysis 
The absorption characteristics of these crystal structures were preliminary tested with 
PXRD analysis: when evacuated crystalline material is placed in a chamber saturated 
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with solvent vapours, the powder patterns indicate that all peaks are shifted at lower 
2θ values, pointing to a 2.7-3.7% increase of the unit cell volume depending on the 
solvent employed. This data may be interpreted as an enlargement of the structure 
taking place in order to accommodate the solvent molecules within the empty 
cavities. This behaviour is observed using dichloromethane, acetone, and methanol, 
and several cycles of vacuum/solvent-vapors can be applied to the compound without 
loss of structural order, Figures 50 and 51. As previous reported, a different behaviour 
is exhibited by the crystals of  25-CF3SO3/26-NO3, since the crystallinity of the sample 
is lost very rapidly, Figures 44 and 45. The crystal-to-amorphous transition is 
accelerated when a high vacuum is applied, suggesting that the stability of the overall 
crystal structure strongly depends on the occupancy of the cavities. Contrarily to 
other materials, the crystallinity of the sample is not restored when exposing the 
amorphous material to solvent vapors. This is most likely the result of different 
supramolecular arrangement and crystal packing. In fact, a considerable contribution 
to the stabilization of the 3D structure of  23-BF4/24-PF6 is determined by the Ag-F 
bonds, whereas the crystal packing of 25-CF3SO3/26-NO3 is determined by weaker 
CH···π/CH···F and CH···S/CH···O interactions, see Figure 38. 
 
Figure 50. Effect of the solvent absorption on the X-ray powder spectra of 23-BF4. 
Freshly ground crystals (grown from acetone/diethyl ether) were subjected to high 
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vacuum and T = 60 °C for 2h. The evacuated crystals were then exposed to acetone 
vapors in a closed chamber. Crystals were evacuated (high vacuum, T=60 °C, 2 h) 
before re-exposing them to acetone vapors. Upon contact with solvents, the unit cell 
volume increases in the 2.7-3.7% range.  
 
 
Figure 51. Effect of the solvent absorption on 23-BF4 crystals. Freshly ground crystals, 
blue. Crystals subjected to high vacuum and T = 100 °C for 2h, red. The evacuated 
crystals were then exposed to saturated solvent vapors (methanol, dicholometane, or 
acetone), green. 
 
The permanent porosity of the 23-BF4/24-PF6 compounds was explored by absorption 
isotherms of gases. 23-BF4 can adsorbe 77 cm
3(STP)/g of CO2 at 195K and 1 atm 
(15.1wt%) while only 22 cm3/g of methane was adsorbed under the same conditions 
of pressure and temperature (Figure 52). The CO2 measured capacity, equal to 3.44 
mmol/g, corresponds to an occupied volume of 9600 Å3 per unit cell (dCO2=1.5 g/cm
3 
was used) which matches the intercapsule empty space of 11300 Å3 per unit cell 
explored by a sphere with a radius of 1.6 Å (the kinetic diameter of CO2 is equal to 3.3 
Å). Thus, this result indicates the virtual complete filling of the intercapsule space 
which is easily accessible to the gas species diffusing-in while CO2 molecules are 
prevented to enter inside the capsules(see Figure 36). Furthermore, the porous 
material adsorbes selectively CO2 (40 cm
3(STP)/g) over CH4 and N2 (12 and 6 
cm3(STP)/g, respectively) at room temperature and up to 10 atm. The isosteric heat of 
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absorption was estimated to be 25 kJ/mol for CO2 and 19.4 kJ/mol for CH4 in 
agreement with the hydrophobic nature of the intercapsule cavity.  A forseeadble 
application of the system is in the gas-separation process where a technological 
relevant gas is purified out of a gas mixture. 
 
Figure 52. a) Adsorption/desorption isotherms of CO2 and CH4 of porous 23-
BF4compound at 195K. b) CO2 adsorption/desorption isotherm of porous 24-
PF6compound at 195K. In the inset enlargement of the low pressure region. c) 
Adsorption/desorption isotherms of CO2, CH4 and N2 of 23-BF4compound at room 
temperature and up to 10 atm. 
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CHAPTER 5 
Novel cavity design using pre-organized tripodal ligands: 
synthesis and solid state characterization.  
 
Different porous materials built on the hexameric unit described in the previous 
chapter were prepared by appropriate modification of the N2S donor ligands
102. We 
functionalized thebispyrazolyl scaffold with different thioether arm in order to obtain 
different cavities. We varied the shape and the size of cavities by introducing 
substituents on the terminal phenyl ring. We show here that not only the methyl 
group on the bispyrazolyl scaffold and the phenyl ring are required for the hexamer 
formation but also the terminal phenyl ring is necessary. Five new ligands were 
synthetized and fully characterized. Silver complexes were prepared by mixing ligands 
and AgPF6 and AgCF3SO3. In most of the cases crystals suitable for X-ray structural 
analysis were obtained. With the symmetrical counterion PF6
- ligands and silver ions 
self assembled in hexamers which form capsules at the supramolecular level. These 
crystals are isostructural to those described in chapter 4, but the functionalization of 
the peripheral aromatic group results in the formation of cavities with different 
volumes.   
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5.1. Introduction 
The use of crystal engeneering to design novel porous coordination polymers 
(PCP’s)7,9,13,22,25 is a rapid developing area of inorganic coordination chemistry. In fact 
these porous materials can merge the properties of both porous material and 
polymers. Above all, the diversity of synthetic routes for these PCP’s facilitates the 
design and construction of numerous framework capable of incorporating multiple 
chemical functionalities. Crystal engeneering enables us to control the dimensions 
and the electronic characteristics of the pores to obtain suitable materials with 
defined characteristics. Porous coordination polymers are good candidates due to 
their synthetic flexibility and structural and functional diversity. In host-guest process, 
the shape, the geometry and size of cavities play a key role: for that reason the 
rational design of the pores became particularly important. As we have described in 
the previous chapters, not only the geometry of metal ions but also the ligand 
conformation and the coordinative features of the counterions determine the 
supramolecular architectures24,73,103. For these reasons, various frameworks are 
capable to incorporate atomic or molecular sized guest inside well-defined cavities. In 
particular the self assembled architectures of PCP can be used as gas storage, gas 
separation, controlled released drugs, catalysts and sensors. In literature there are 
many example of nanoscale design of porous solids. Kitagawa et al. show how the 
interactive communication between molecules in the framework determines bulk 
properties starting with a 2D interdigitated structure to obtain porous materials. 
In this chapter we present how we modified the steric and electronic features of the 
cavities in the porous material obtained and described in the previous chapter 
(Chapter 4). Different structural and porous properties were introduced by changing 
the thioether arm on the bispyrazolyl scaffold of the N2S donor ligand. We have 
utilized two type of anions: symmetrical PF6
- and a non symmetrical CF3SO3
- to have 
different supramolecular interaction. Through X-ray on single crystals we determined 
the molecular structures and the porosity of the complexes. 
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Figure 53. Molecular structure of the ligands modified on the peripheral aromate 
moiety. 
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5.2.  Experimental 
5.2.1. Synthesis  
All reagents and solvents were commercially available, except for bis(3,5-
dimethylpyrazolyl)ketone which were prepared as reported elsewhere44–46. The 
synthesis of aldehydes, except for of 2-(methylthio)benzaldheyde which is 
commercially available, derive from a synthesis reported in literature103. 1H  spectra 
were recorded on a Bruker Avance 300 spectrometer using standard Bruker pulse 
sequences. Chemical  shifts are reported in parts per million (ppm) referenced to 
residual solvent protons. Infrared spectra were recorded from 4000 to 700 cm-1 on a 
Perkin-Elmer FTIR Nexus spectrometer equipped with a Smart Orbit HATR accessory 
(diamond crystal). Elemental analyses (C, H, and N) were performed with a Carlo Erba 
EA 1108 automated analyzer. 
 Synthesis of 2-(naphthalen-1-ylthio)benzaldehyde.To a stirred solution of 
naphthalene-1-thiol (4.27 g, 26.71 mmol) and anhydrous Na2CO3 (3.50 g) in dry DMF 
(8 mL) under nitrogen at 90 °C, 2-chlorobenzaldehyde (2.40 ml, 21.31 mmol) was 
slowly added. The mixture was stirred at 90 °C for 3 hours. After cooling, the reaction 
mixture was poured into water (20 mL) and extracted with diethyl ether (20 mL). The 
extract was washed with water (2x20 mL), dried with anhydrous Na2SO4, and 
concentrated under vacuum. The resulting oil was triturated with hexane in an 
ultrasound bath for 20 min, filtered and dried under vacuum to afford a yellow solid 
(5.03 g, 25.35 mmol, 93%).  IR (cm-1): 3356w, 3056w, 2965w, 2860w, 2756w, 1695m, 
1591m, 1552w, 1491m, 1447m, 1400m, 300w, 1269m, 1117w, 1060w, 1047w, 939w, 
860w, 826m, 808m, 743s, 708m, 630w, 530w, 473s, 430w. 1H NMR (300 MHz, CDCl3): 
δ,  7.13 (d, J= 7.5 Hz, 1H, CH (Ph)), 7.36-7.57 (m, 4H, CH(Ph)), 7.80-7.93 (m ,5H, 
CH(Ph)), 7.99 (s, 1H, CH(Ph)), 10.45 (s, 1H, CHO). Anal.Calc. for C17H12OS (264.34): C, 
77.24; H, 4.58. Found: C, 77.19; H, 4.62%. 
Synthesis of 2-(p-tolylthio)benzaldehyde. The procedure used to prepare 2-
(naphthalen-1-ylthio)benzaldehyde was applied by using a stirred solution of 4-
methylbenzenethiol (2.40 g, 19.32 mmol) and anhydrous Na2CO3 (3.01 g) in dry DMF 
(8 mL) under nitrogen at 90 °C, 2-chlorobenzaldehyde (1.80 ml, 15.98 mmol) and 
affording a pale yellow solid (2.23 g, 61%).  IR (cm-1): 3056w, 3026w, 2917w, 2860w, 
1760w, 1686w, 1667m, 1582w, 1552m, 1486w, 1454m, 1440w, 1401m, 1378w, 
1300w, 1247w, 1195m, 1124m, 1040w, 1013w, 842m, 810m, 752s, 672m, 656m, 
519m, 491w. 1H NMR (300 MHz, CDCl3): δ,  2.41 (s, 3H, CH3), 7.04 (dd, J1= 0.9 Hz, J2= 
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7.8 Hz, 1H, CH(Ph)), 7.22-7.40 (m, 6H, CH(Ph)), 7.87 (dd, J1=1.8 Hz, J2= 9Hz,  1H, 
CH(Ph)),  10.40  (s, 1H, CHO) . Anal.Calc. for C14H12OS (228.31): C, 73.65; H, 5.30. 
Found: C, 73.54; H, 5.34%. 
Synthesis of 2-(4-fluorophenylthio)benzaldehyde. The procedure used to prepare 2-
(naphthalen-1-ylthio)benzaldehyde was applied by using a stirred solution of 4-
fluorobenzenethiol (2.1 ml , 19.32 mmol) and anhydrous Na2CO3 (3.01 g) in dry DMF 
(8 mL) under nitrogen at 90 °C, 2-chlorobenzaldehyde (1.80 ml, 15.98 mmol) and 
affording a pale yellow solid (1.35 g, 36%).  IR (cm-1): 3326w, 3086w, 2856w, 2760w, 
1904w, 1673m, 1486s, 1395m, 1186s, 1047m, 830s, 760s, 656m, 521m. 1H NMR (300 
MHz, CDCl3): δ,  7.00 (dd, J= 8.1 Hz, 2H, CH(Ph)), 7.13 (t, J= 8.7 Hz, 2H, CH)Ph)),  7.29-
7.52 (m, 4H, CH(Ph)), 7.87 (dd, J1=1.5 Hz, J2= 6Hz,  1H, CH(Ph)),  10.36  (s, 1H, CHO) .  
Anal.Calc. for C13H9FOS (232.27): C, 67.22; H, 3.91. Found: C, 67.30; H, 3.89%. 
Synthesis of 2-(4-methoxyphenylthio)benzaldehyde. The procedure used to prepare 2-
(naphthalen-1-ylthio)benzaldehyde was applied by using a stirred solution of 4-
methoxybenzenethiol (2.5 ml , 19.32 mmol) and anhydrous Na2CO3 (3.01 g) in dry 
DMF (8 mL) under nitrogen at 90 °C, 2-chlorobenzaldehyde (1.80 ml, 15.98 mmol) and 
affording a yellow solid (2.56 g, 66%).  IR (cm-1): 2991w, 2939w, 2834w, 2752w, 
1669m, 1587m, 1559w, 1491m, 1459w, 1437w, 1405m, 1289m, 1248s, 1197m, 
1169m, 1128w, 1101w, 1023s, 1006w, 848w, 821m, 799w, 704w, 678m, 660m, 528m, 
499m. 1H NMR (300 MHz, CDCl3): δ,  3.87 (s, 3H, OCH3), 6.91-6.99 (m, 3H, CH(Ph)), 
7.26-7.49 (m, 4H, CH(Ph)), 7.84 (dd, J1=1.5 Hz, J2= 7.5Hz,  1H, CH(Ph)),  10.37  (s, 1H, 
CHO) . Anal.Calc. for C14H12O2S (244.31): C, 68.83; H, 4.95. Found: C, 68.88; H, 5.00%. 
Synthesis of 2-(m-tolylthio)benzaldehyde. The procedure used to prepare 2-
(naphthalen-1-ylthio)benzaldehyde was applied by using a stirred solution of 3-
methylbenzenethiol (2.4 ml , 19.32 mmol) and anhydrous Na2CO3 (3.98 g) in dry DMF 
(8 mL) under nitrogen at 90 °C, 2-chlorobenzaldehyde (1.80 ml, 15.98 mmol) and 
affording a yellow solid (2.63 g, 72%). IR (cm-1): 3056w, 3008w, 2854w, 2760w, 
1695w, 1673m, 1588w, 1553m, 1460m, 1439w, 1397m, 1373w, 1304w, 1261w, 
1199m, 1166w, 1124m, 1067w, 1041m, 996w, 844m, 784m, 761s, 711w, 694m, 
673m, 654m, 553w, 490m, 450w. 1H NMR (300 MHz, CDCl3): δ,  2.37 (s, 3H, CH3), 7.13 
(dd, J1= 1.8 Hz, J2= 7.8 Hz, 1H, CH(Ph)), 7.20-7.43 (m, 6H, CH(Ph)), 7.90 (dd, J1=1.5 Hz, 
J2= 7.5Hz,  1H, CH(Ph)),  10.42  (s, 1H, CHO) .Anal.Calc. for C14H12OS (228.31): C, 73.65; 
H, 5.30. Found: C, 73.54; H, 5.34%. 
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Synthesis of 1,1'-((2-(naphthalen-1-ylthio)phenyl)methylene)bis(3,5-dimethyl-1H-
pyrazole) (LNf). A mixture of bis(pyrazolyl)ketone (0.93 g, 4.21 mmol), 2-(naphthalen-
1-ylthio)benzaldehyde(1.07  g, 4.76 mmol) and CoCl2.6H2O (5 mg) was heated at 80°C 
for an hour with stirring. The mixture was then cooled at room temperature and 
stirred for 2 hours. Dichloromethane (30 mL) was added and the mixture was stirred 
for 20 minutes. The organic phase was washed with water (50 mL) and brine (20 mL), 
dried with anhydrous Na2SO4 and filtered. The solution was concentrated under 
vacuum and a white powder was precipitated with hexane, which was filtered and 
vacuum dried (yield 0.62 g, 34%).  IR (cm-1): 3047w, 2952w, 2921w, 1586w, 1552m, 
1495w, 1452m, 1417m, 1369w, 1343m, 1321w, 1256m, 1121w, 1034w, 973w, 886w, 
813s, 760s, 726m, 700m, 621w. 1H NMR (300 MHz, CDCl3): δ, 2.07 (s, 6H, 2CH3), 2.16 
(s, 6H, 2CH3), 5.79 (s, 2H, CH(Pz)), 6.89-6.92 (m, 1H, CH(Ph)), 7.28-7.35 (m, 4H, 
CH(Ph)), 7.24-7.36 (m, 2H, CH(Ph)), 7.65-7.70 (m, 3H, CH(Ph)), 7.75-7-78 (m, 1H, 
CH(Ph)), 7.85 (s, 1H, CHcentral).  Anal.Calc. for C27H26N4S (438.59): C, 73.94; H, 5.98; N, 
12.77. Found: C, 73.99; H, 6.02; N, 12.78%. 
Synthesis of 1,1'-((2-(p-tolylthio)phenyl)methylene)bis(3,5-dimethyl-1H-pyrazole) 
(LpMe). The procedure is similar to the synthesis of LNf previous reported with slight 
modification: a mixture of bis(pyrazolyl)ketone (1.29 g, 5.85 mmol), 2-(p-
tolylthio)benzaldehyde (1.32  g, 5.78 mmol) and CoCl2.6H2O (5 mg) was heated at 
90°C for 3 hour.  The product is a white powder (yield 0.97 g, 41%).  IR (cm-1): 
3430wbr, 3123vw, 3082vw, 3053vw, 3015vw, 2973w, 2944w, 2918w, 2857w, 1589w, 
1562m, 1463s, 1443s, 1414s, 1364m, 1319s, 1251m, 1205w, 1032m, 1014m, 864m, 
815vs, 789m, 745s, 686m, 621w, 525w. 1H NMR (300 MHz, CDCl3): δ, 2.10 (s, 6H, 
2CH3), 2.22 (s, 6H, 2CH3),  2.34 (s, 3H, CH3),  5.87 (s, 2H, CH(Pz)), 6.82-6.85 (m, 1H, 
CH(Ph)), 7.04-7.23 (m, 7H, CH(Ph)), 7.81 (s, 1H, CHcentral).   Anal.Calc. for C24H26N4S 
(402.56): C, 71.61; H, 6.51; N, 13.92. Found: C, 71.66; H, 6.52; N, 13.90%. 
Synthesis of 1,1'-((2-(4-fluorophenylthio)phenyl)methylene)bis(3,5-dimethyl-1H-
pyrazole) (LF). The procedure is similar to the synthesis of LNf previous reported with 
slight modification: a mixture of bis(pyrazolyl)ketone (1.30 g, 5.90 mmol), 2-(4-
fluorophenylthio)benzaldehyde (1.35  g, 5.81 mmol) and CoCl2.6H2O (5 mg) was 
heated at 90°C for  3 hour.  The product is a white powder (yield 1.17 g, 40%).  IR (cm-
1): 3060w, 2921w, 1556m, 1465m, 1321m, 1275s, 1026w, 817m, 756s, 626w, 512w. 
1H NMR (300 MHz, CDCl3): δ, 2.09 (s, 6H, 2CH3), 2.21 (s, 6H, 2CH3), 5.86 (s, 2H, CH(Pz)), 
6.84-6.87 (m, 1H, CH(Ph)), 6.93-6.99 (m, 2H, CH(Ph)), 7.21-7.26 (m, 5H, CH(Ph)), 7.81 
(s, 1H, CHcentral).  Anal.Calc. for C23H23FN4S (406.52): C, 67.95; H, 5.70; N, 13.78. Found: 
C, 68.00; H, 5.71; N, 13.76%. 
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Synthesis of 1,1'-((2-(4-fluorophenylthio)phenyl)methylene)bis(3,5-dimethyl-1H-
pyrazole) (LOMe).The procedure is similar to the synthesis of LNf previous reported with 
slight modification: a mixture of bis(pyrazolyl)ketone (1.18 g, 5.34 mmol), 2-(4-
methoxyphenylthio)benzaldehyde (1.29  g, 5.28 mmol) and CoCl2.6H2O (5 mg) was 
heated at 100°C for  3 hour.  The product is a white powder (yield 1.08 g, 49%).  IR 
(cm-1) : 3445wbr, 2996w, 2969vw, 2918w, 2832w, 1589s, 1586m, 1561m, 1553m, 
1439s, 1458m, 1415m, 1359m, 1342m, 1309m, 1246vs, 1173m, 1181m, 1104w, 
1026m, 873m, 834m, 792m, 752m, 717m, 687m. 1H NMR (300 MHz, CDCl3): δ, 2.13 (s, 
6H, 2CH3), 2.23 (s, 6H, 2CH3), 3.83 (s, 3H, OCH3),  5.89 (s, 2H, CH(Pz)), 6.77 (dd, J1= 1.5 
Hz, J2= 7.2Hz, 1H, CH(Ph)), 6.84-6.87 (m, 2H, CH(Ph)), 7.08-7.31 (m, 5H, CH(Ph)), 7.81 
(s, 1H, CHcentral).  Anal.Calc. for C24H26N4OS (418.55): C, 68.87; H, 6.26; N, 13.39. Found: 
C, 68.88; H, 6.30; N, 13.43%. 
Synthesis of 1,1'-((2-(m-tolylthio)phenyl)methylene)bis(3,5-dimethyl-1H-pyrazole) 
(LmMe). The procedure is similar to the synthesis of LNf previous reported with slight 
modification: a mixture of bis(pyrazolyl)ketone (1.27 g, 5.76 mmol), 2-(m-
tolylthio)benzaldehyde (1.31  g, 5.74 mmol) and CoCl2.6H2O (5 mg) was heated at 
100°C for  3 hour.  The crude is a yellow oil which was purified throught silica column 
chromatography (hexane:acetate; 70:30; r.f. 0.3), yielding a white powder (yield 0.69 
g, 30%) IR (cm-1): 324wbr, 3134vw, 3047vw, 2943w, 2917w, 1591m, 1556s, 1473s, 
1443s, 1408s, 1343m, 1260m, 1552w, 1117w, 1078w, 1060m, 1026m, 969w, 878m, 
847w, 760vs, 717m, 686s, 626m, 547w, 491w. 1H NMR (300 MHz, CDCl3): δ, 2.09 (s, 
6H, CH3), 2.21 (s, 6H, 2CH3), 2.28 (s, 3H, 2CH3),  5.86 (s, 2H, CH(Pz)), 6.89-6.92 (m, 1H, 
CH(Ph)), 7.01-7.06 (m, 3H, CH(Ph)), 7.12-7.17 (m, 1H, CH(Ph)), 7.26-7.33 (m, 3H, 
CH(Ph)), 7.78 (s, 1H, CHcentral).  Anal.Calc. for C24H26N4S (402.56): C, 71.61; H, 6.51; N, 
13.92. Found: C, 71.58; H, 6.55; N, 13.88%. 
Synthesis of 1,1'-((2-(methylthio)phenyl)methylene)bis(3,5-dimethyl-1H-pyrazole) 
(LSMe). The procedure is similar to the synthesis of LNf previous reported with slight 
modification: a mixture of bis(pyrazolyl)ketone (2.00 g, 9.06 mmol), 2-
(methylthio)benzaldehyde (1.30 ml, 10.00 mmol) and CoCl2.6H2O (5 mg) was heated 
at 80°C for  an hour.  The product is a white powder (yield 1.30 g, 44%).  IR (cm-1): 
3121w, 3091w, 3060w, 2982w, 2913m, 2860w, 1691m, 1678m, 1586m, 1551m, 
1560m, 1463m, 1442m, 1415m, 1361m, 1373m, 1384m, 1322s, 1257m, 1216m, 
1147m, 1124m, 1666m, 1023m, 889m, 895m, 825s, 794m, 755vs, 689s, 625m. 1H 
NMR (300 MHz, CDCl3): δ, 2.12 (s, 6H, 2CH3), 2.22 (s, 6H, 2CH3), 2.38 (s, 3H, SCH3),  
5.88 (s, 2H, CH(Pz)), 6.70 (d, J= 7.5 Hz, 1H, CH(Ph)), 7.12-7.18 (m, 1H, CH(Ph)), 7.34 (d, 
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J= 3.9Hz, 2H, CH(Ph)),  7.66 (s, 1H, CHcentral).  Anal.Calc. for C18H22N4S (326.46): C, 
66.22; H, 6.79; N, 17.16. Found: C, 66.19; H, 6.76; N, 17.15%. 
Synthesis of  [Ag(LNf)]6(PF6)6 (27-PF6)  . L
Nf (200 mg, 0.46 mmol) and AgPF6 (118 mg, 
0.46 mmol) were mixed in acetone (12 mL), and the colorless solution was stirred for 
15 min. The solvent was then removed under vacuum and the crude was triturated 
with hexane in an ultrasound bath, yielding a white solid. The solid was filtered and 
vacuum dried (185 mg, yield 60%). The compound can be recrystallized by stratifying 
diethylether over an acetone solution of the complex yielding colorless crystals. IR 
(cm-1): 3035w, 2984w, 2928w, 1735w, 1566w, 1466w, 1418w, 1385w, 1307w, 1277w, 
1274w, 1035w, 836s, 754m, 689m, 616w, 555m, 469m. 1H NMR (300 MHz, (CD3)2CO): 
δ  1.90 (s, 6H, 2CH3), 2.55 (s, 6H, 2CH3), 6.10 (s, 2H, CH (Pz)), 7.08-7.92 (m, 12H, 
CH(Ph) + CHcentral) Anal. Calc. for (C27H26N4S)6Ag6(PF6)6 (4148.52): C, 46.90; H, 3.79; N, 
8.10. Found: C, 46.92; H, 3.76; N, 8.58%. 
Synthesis of  [Ag(LpMe)]n(PF6)n (28-PF6)  . L
pMe (217 mg, 0.54 mmol) and AgPF6 (136 mg, 
0.54 mmol) were mixed in acetone (10 mL), and the colorless solution was stirred for 
15 min. The solution was then concentrated under vacuum and a white solid was 
precipitated after addition of diethyl ether. The solid was filtered and vacuum dried 
(195 mg, yield 55%). The compound can be recrystallized by stratifying diethylether 
over an acetone solution of the complex yielding colorless crystals.  IR (cm-1): 3673w, 
2921w, 1552w, 1413w, 1313w, 1243w, 1039w, 830s, 695m, 552m. 1H NMR (300 MHz, 
(CD3)2CO) : δ 2.08 (s br, 6H, 2CH3), 2.36 (s, 3H, CH3), 2.58 (s, 6H, 2CH3), 6.17  (s, 2H, 
CH(Pz)), 7.00 (d, J= 7.8 Hz, 1H, CH(PH)),  7.16-7.46 (m, 7H, CH(Ph)), 7.83 (s 1H, 
CHcentral). Anal. Calc. for (C24H26N4S)6Ag6(PF6)6 (3932.34): C, 43.98; H, 4.00; N, 8.55. 
Found: C, 43.96; H, 3.99; N, 8.60%. 
Synthesis of  [Ag(LF)]6(PF6)6 (29-PF6). L
F (150 mg, 0.37 mmol) and AgPF6 (93 mg, 0.37 
mmol) were mixed in acetone (10 mL), and the colorless solution was stirred for 15 
min. The solvent was then removed under vacuum obtaining a yellow oil which was 
triturated with hexane in an ultrasound bath, yielding a white solid. The solid was 
filtered and vacuum dried (185 mg, yield 60%). The solution was then concentrated 
under vacuum and a white solid was precipitated after addition of diethyl ether. The 
solid was filtered and vacuum dried (120 mg, yield 50%). The compound can be 
recrystallized by stratifying diethylether over an acetone solution of the complex 
yielding colorless crystals. IR (cm-1): 2017w, 1560w, 1495w, 1417w, 1234w, 1160w, 
1034w, 830s, 695w, 617w, 552m, 500w. 1H NMR (300 MHz, (CD3)2CO):   1.99 (s, 6H, 
2CH3), 2.60 (s, 6H, 2CH3), 6.17 (s, 2H, CH(Pz)), 7.02-7.49 (m, 8H, CH(Ph)), 7.89 (s, 2H, 
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CHcentral). Anal. Calc. for (C23H23N4SF)6Ag6(PF6)6 (3956.10): C, 41.90; H, 3.52; N, 8.50. 
Found: C, 41.92; H, 3.46; N, 8.56%. 
Synthesis of  [Ag(LOMe)]6(PF6)6 (30-PF6) . L
OMe (164 mg, 0.39 mmol) and AgPF6 (99 mg, 
0.39 mmol) were mixed in acetone (10 mL), and the colorless solution was stirred for 
15 min. The solvent was then removed under vacuum and the crude was triturated 
with hexane in an ultrasound bath, yielding a white solid. The solid was filtered and 
vacuum dried (130 mg, yield 50%).  The compound can be recrystallized by stratifying 
hexane over an dichloromethane solution of the complex yielding colorless crystals. IR 
(cm-1): 2926w, 1700w, 1586m, 1565m, 1500m, 1447m, 1360m, 1291m, 1243m, 
1178m, 1121w, 1026m, 826s, 756m, 695m, 613m, 552s, 530m. 1H NMR (300 MHz, 
(CD3)2CO): δ 1.98 (s, 6H, 2CH3), 2.62 (s, 6H, 2CH3), 3.87 (s, 3H, OCH3), 6.21 (s, 2H, 
CH(Pz)), 6.89-7.42 (m, 8H, CH(Ph)), 7.83 (s, 2H, CHcentral). Anal. Calc. for 
(C24H26N4SO)6Ag6(PF6)6 (4028.34): C, 42.93; H, 3.90; N, 8.34. Found: C, 42.92; H, 3.97; 
N, 8.33%. 
Synthesis of  [Ag(LmMe)]6(PF6)6 (31-PF6) . L
pMe (330 mg, 0.82 mmol) and AgPF6 (206 mg, 
0.82 mmol) were mixed in acetone (10 mL), and the colorless solution was stirred for 
15 min. The solvent was then removed under vacuum and the crude was triturated 
with hexane in an ultrasound bath, yielding a white solid. The solid was filtered and 
vacuum dried (383 mg, yield 71%). The compound can be recrystallized by stratifying 
hexane over an dichloromethane solution of the complex yielding colorless crystals.  
IR (cm-1): 3743w, 2017w, 1560w, 1421w, 1239m, 1152m, 1026s, 756m, 634s, 521m.  
1H NMR (300 MHz, CD3Cl) : δ 1.82 (s br, 3H, CH3), 2.19 (s, 3H, CH3), 2.30 (s, 3H, CH3), 
2.38 (s, 6H, CH3), 6.03 (s br, 2H, CH(Pz)), 6.89-7.42 (m, 8H, CH(Ph)), 7.56 (s 1H, 
CHcentral). Anal. Calc. for (C24H26N4S)6Ag6(PF6)6 (3932.34): C, 43.98; H, 4.00; N, 8.55. 
Found: C, 43.88; H, 4.05; N, 8.50%. 
Synthesis of  [Ag(LSMe)]n(BF4)n (32) . L
SMe (212 mg, 0.65 mmol) and AgBF4 (126 mg, 0.82 
mmol) were mixed in acetone (20 mL), and the colorless solution was stirred for 15 
min. The solution was then concentrated under vacuum and a white precipitated. The 
solid was filtered and vacuum dried (265 mg, yield 78%). IR (cm-1): 3147w, 2921w, 
1560m, 1465m, 1443m, 1417m, 1391w, 1313w, 1278w, 1052vs, 1026vs, 873m, 847w, 
760s, 700m, 621w, 517m. 1H NMR (300 MHz, CD3CN) δ: 2.29 (s, 6H, 2CH3(Pz)), 2.54 (s, 
3H, SCH3), 2.59 (s, 6H, 2CH3(Pz)), 6.25 (s, 2H, CH(Pz)), 6.80 (d, J = 7.8 Hz, 1H, 
CHorto(Ph)), 7.31-7.35 (m, 1H, CH(Ph)), 7.56-7.59 (s, 3H, CH(Ph)+ CH central). Anal. Calc. 
for (C18H22N4S)6Ag6(PF6)6 (3475.74): C, 37.32; H, 3.83; N, 9.67. Found: C, 37.37; H, 3.92; 
N, 9.69%. 
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Synthesis of  [Ag(LNf)]n(CF3SO3)n (27-CF3SO3). L
Nf (84 mg, 0.20 mmol) and AgCF3SO3 (52 
mg, 0.20 mmol) were mixed in acetone (12 mL), and the colorless solution was stirred 
for 15 min. The solvent was then removed under vacuum and the crude was 
triturated with hexane in an ultrasound bath, yielding a white solid. The solid was 
filtered and vacuum dried (60 mg, yield 44%). The compound can be recrystallized by 
stratifying hexane over a dichloromethane solution of the complex yielding colorless 
crystals. IR (cm-1): 2969w, 2926w, 1552m, 1460w, 1421w, 1386w, 1278s, 
1239s,1152m, 1021s, 869m, 817m, 756m, 691m, 634s, 687m. 1H NMR (300 MHz, 
(CD3Cl) : δ 2.22 (s, 3H, CH3 (Pz)), 2.45 (s, 3H, CH3 (Pz)), 5.98 (s, 2H, CH(Pz)), 6.98-7.33 
(m, 8H, CH(Ph)), 7.56 (s 1H, CHcentral). Anal. Calc. for C28H26N4S2O3AgF3 (695.52): C, 
48.35; H, 3.77; N, 8.06. Found: C, 48.42; H, 3.76; N, 8.10%. 
Synthesis of  [Ag(LpMe)]n(CF3SO3)n (28-CF3SO3) . L
pMe (193 mg, 0.48 mmol) and AgCF3SO3 
(122 mg, 0.48 mmol) were mixed in acetone (10 mL), and the colorless solution was 
stirred for 15 min. The solution was then concentrated under vacuum and a white 
solid was precipitated after addition of diethyl ether. The solid was filtered and 
vacuum dried (292 mg, yield 92%). The compound can be recrystallized by stratifying 
hexane over a dichloromethane solution of the complex yielding colorless crystals.  IR 
(cm-1): 2978w, 2921w, 2865w, 1717w, 1560w, 1473w, 1413w, 1278m, 1234s, 1152s, 
1026s, 878m, 808m, 756m, 695m, 639s, 569m, 521m. 1H NMR (300 MHz, (CD3Cl) : δ 
2.20 (s, 3H, CH3 (Pz)), 2.35 (s, 3H, CH3 (Ph)), 2.43 (s, 3H, CH3 (Pz)), 5.97 (s, 2H, CH(Pz)), 
6.90 (d, J= 7.2  Hz, 1H, CH(Ph)), 7.01 -7.24 (m, 7H, CH(Ph)), 7.58 (s 1H, CHcentral). Anal. 
Calc. for C25H26N4S2AgF3O3 (659.49): C, 45.53; H, 3.97; N, 8.50. Found: C, 45.96; H, 
3.99; N, 8.60%. 
Synthesis of  [Ag(LF)]n(CF3SO3)n (29-CF3SO3) . L
F (138 mg, 0.34 mmol) and AgCF3SO3 (87 
mg, 0.34 mmol) were mixed in acetone (10 mL), and the colorless solution was stirred 
for 15 min. The solvent was then removed under vacuum obtaining a yellow oil which 
was triturated with hexane in an ultrasound bath, yielding a white solid. The solid was 
filtered and vacuum dried (89 mg, yield 40%). The compound can be recrystallized by 
stratifying hexane over a dichloromethane solution of the complex yielding colorless 
crystals.  IR (cm-1): 3469wbr, 3234wbr, 3147w, 3091w, 3055w, 2973w, 2917w, 1591m, 
1560m, 1419s, 1460m, 1421m, 1382m, 1282s, 1239vs, 1217vs, 1156m, 1026s, 873w, 
834w, 756m, 695w, 634vs, 573w, 517m. 1H NMR (300 MHz, (CD3Cl) : δ 2.22 (s, 3H, CH3 
(Pz)), 2.45 (s, 3H, CH3 (Pz)), 5.98 (s, 2H, CH(Pz)), 6.98-7.33 (m, 8H, CH(Ph)), 7.56 (s 1H, 
CHcentral). Anal. Calc. for C24H23N4S2AgF3O3 (663.46): C, 43.45; H, 3.49; N, 8.44. Found: 
C, 43.42; H, 3.46; N, 8.49%. 
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Synthesis of  [Ag(LOMe)]n(CF3SO3)n (30-CF3SO3) . L
OMe (178 mg, 0.42 mmol) and AgCF3SO3 
(109 mg, 0.42 mmol) were mixed in acetone (10 mL), and the colorless solution was 
stirred for 15 min. The solvent was then removed under vacuum and the crude was 
triturated with hexane in an ultrasound bath, yielding a white solid. The solid was 
filtered and vacuum dried (160 mg, yield 56%). The compound can be recrystallized by 
stratifying diethylether over an acetone solution of the complex yielding colorless 
crystals.  IR (cm-1): 2839w, 1699w, 1565m, 1491m, 1456m, 1247vs, 1156s, 1021vs, 
839m, 756s, 643vs, 517s. 1H NMR (300 MHz, (CD3Cl) : δ 2.61 (s, 3H, CH3 (Pz)), 2.48 (s, 
3H, CH3 (Pz)),  3.83 (s, 3H, OCH3 (Ph)), 6.01 (s, 2H, CH(Pz)), 6.79 (d, J= 7.8  Hz, 1H, 
CH(Ph)), 6.84-7.50 (m, 7H, CH(Ph)), 7.64 (s 1H, CHcentral). Anal. Calc. for 
C25H26N4S2AgF3O4 (675.49): C, 44.45; H, 3.88; N, 8.29. Found: C, 44.46; H, 3.90; N, 
8.30%. 
Synthesis of  [Ag(LmMe)]n(CF3SO3)n (31-CF3SO3) . L
mMe (353 mg, 0.87 mmol) and 
AgCF3SO3 (224 mg, 0.87 mmol) were mixed in acetone (10 mL), and the colorless 
solution was stirred for 15 min. The solvent was then removed under vacuum and the 
crude was triturated with hexane in an ultrasound bath, yielding a white solid. The 
solid was filtered and vacuum dried (467 mg, yield 81%). The compound can be 
recrystallized by stratifying hexane over a THF solution of the complex yielding 
colorless crystals.   IR (cm-1): 3743w, 2017w, 1560w, 1421w, 1239m, 1152w, 1026m, 
756w, 634s, 521w. 1H NMR (300 MHz, (CD3Cl) : δ 2.17 (s, 3H, CH3 (Pz)), 2.29 (s, 3H, CH3 
(Ph)), 2.42 (s, 3H, CH3 (Pz)), 5.94 (s, 2H, CH(Pz)), 6.83-7.31 (m, 8H, CH(Ph)), 7.61 (s 1H, 
CHcentral). Anal. Calc. for C25H26N4S2AgF3O6 (659.49): C, 43.98; H, 4.00; N, 8.55. Found: 
C, 43.90; H, 3.97; N, 8.51%. 
5.2.2. Single Crystal X-ray Structures 
Single crystal data were collected with a Bruker Smart 1000 and on a Bruker Smart 
APEXII area detector diffractometers (Mo Kα; λ = 0.71073 Å). Cell parameters were 
refined from the observed setting angles and detector positions of selected strong 
reflections. Intensities were integrated from several series of exposure frames that 
covered the sphere of reciprocal space48. A multiscan absorption correction was 
applied to the data using the program SADABS47. The structures were solved by direct 
methods SIR97104 and SIR200466 and refined with full-matrix least-squares (SHELXL-
9750), using the Wingx software package51. Graphical material was prepared with the 
Mercury 2.052 program. Crystallographic data are reported in Appendix vi-vii. 
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5.3. Results and discussion 
 
5.3.1. Synthesis 
 
 
Figure 54. Synthetic route for the preparation of the heteroscorpionate N2S 
ligands.  
 
The ligands were prepared according to a slight modification of synthesis 
previously reported in chapter 3.The ligands synthesis derived from a slight 
modification of the synthetic route reported in the previous chapter (chapter 3). 
The different  steric hindrance on the thioether arm determines a certain 
difficulties on the nucleofilic attack of the aldheydic carbonyl carbon so it is 
necessary to increase the time and the temperature of the solid state reaction. 
Silver(I) complexes were synthetized in the air at room temperature using AgPF6 
and AgCF3SO3 as silver precursors. 
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Figure 55. Complexes synthetized 
 
5.3.2. Molecular structures 
When using the PF6
- anion, hexameric molecular structures [Ag(L)]6(PF6)6 are 
preferentially obtained, Figures 56-57. The only exception is represented by the 
system with the Lp-Me ligand  that form a molecular chain analogous to that found for 
the complexes with the triflate anion (Figure 58) and that will be therefore described 
in the section dedicated to the [Ag(L)]n(CF3SO3)n complexes (see below). Since the 
complexes 27-PF6, 29-PF6, 30-PF6, and 31-PF6 are iso-structural, their general 
structural features will be described together. The difference among the four 
hexameric complexes is determined by the different substituents on the peripheral 
aromatic rings, that however has little influence on the overall structural 
arrangement. In all complexes the ligand acts as N2 bidentate on a metal and bridges 
on another silver atom with the thioether group, and central phenyl ring adopts a 
particularly fixed geometry. This can be appreciated by inspecting the torsion angle τ 
that defines the orientation of the phenyl ring with respect to one of the pyrazole 
groups. In fact,τ varies in the very narrow range of 0.8-1.4°. The peripheral phenyl 
ring is located above one of the pyrazole ring giving rise to a weak π-π interaction. 
The pyrazole rings of six ligands defines the exteriors of the hexamer whereas the 
peripheral aromatic rings are oriented towards the interior. As a function of the 
substituents (naphthyl, methoxy, m-Me, and F) that are present on the aromatic 
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ring, a pore of different size can be obtained. The diameter of this pore is 1.6, 2.6 
and 3.0 Ǻ for the 27-PF6, 29-PF6 and 31-PF6 complexes, respectively. In 30-PF6 the 
methoxy groups occlude completely the intra-ring space, Figure 57. The size of the 
pore was calculated in an approximate way by taking into account the vdW surface 
of the H oriented towards the interior of the hole.  
The PF6
- anion exhibits a fragmented site occupation within the unit cell. In fact, per 
each silver cation of the asymmetric unit the PF6
- anion is distributed in three 
positions in the unit cell, 1) a 0.1666 fraction lying on a ternary axis and on an 
inversion center 2) a 0.3333 fraction lying on a ternary axis, and 3) a 0.5 fraction lying 
on a binary axis. This latter fraction links together two silver atoms of symmetry 
related hexamers in a way that the centroids of four hexamers occupy the vertex of a 
tetrahedron thus defining an internal cavity having the shape of a tetrahedron. The 
distance between the fluorine and the silver atoms varies in the range 2.749(3)-
2.818(9) Ǻ suggesting the weak nature of this interaction. The PF6
- anion that acts as a 
linker between the metals is also held in place by a C-H⋅⋅⋅F interaction with one of the 
methyl groups of the pyrazole ring. The capsular shaped assembly comprised of four 
hexameric units, defines the unit cell lattice and forms two types of cavities: one that 
is contained in the sphere and the other that is produced by the close packing of the 
spheres, Figure 57. The size of the cavities diminishes as the bulkiness of the 
substituent of the aromatic ring increases, and the following order of cavity size is 
observed: 27-PF6 (15338 Ǻ
3/cell) < 30-PF6, (19284 Ǻ
3/cell), 31-PF6, (20792 Ǻ
3/cell) ≈ 
29-PF6 (20520 Ǻ
3/cell). In addition if we express the cavities volumes as a percentage 
of the unit cells volumes we have: 27-PF6  (19.3 %) < 30-PF6, (24.3 %), 31-PF6, (25.6 %) 
≈ 29-PF6 (25.7 %). According to the fact that two types of cavities are present, the 
substituents on the peripheral phenyl ring affect the size of only the intra-capsular 
space, and the increasing bulkiness that is present on going from F, m-Me, OMe, and 
Nf, determines the shrinkage of this cavity type. On the opposite, the cavity size of 
the inter-capsular space is lined with methyl groups of the pyrazole rings and is 
almost invariant in the four structures.  
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Figure 56. Left, molecular drawing of the hexameric unit of [Ag(LSNf)]6(PF6)6, 
[Ag(LSPhOMe)]6(PF6)6, [Ag(L
SPhm-Me)]6(PF6)6, and [Ag(L
SPhF)]6(PF6)6. Hydrogen atoms are 
omitted for clarity. The ’ symbol denotes symmetry related atoms. Right, 
representation of the different sizes of the pores for the hexameric complexes. The 
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peripheral aromatic groups were depicted with van deer Waals atomic radii. Colors: 
Ag, green; S, yellow; N, blue; C, gray; O, red; F, light green, P, orange. 
 
Figure 57. Depiction of the two types of cavities that are present in the hexameric 
complexes. Yellow: inter-capsular space; red: intra-capsular space. The cavities were 
generated by rolling a probe sphere of 1.6 Ǻ diameter over the molecular surface. 
 
When employing the triflate anion, the silver complexes crystallize in the form of 
molecular chains, and the general formula is [Ag(L)]n(CF3SO3)n, Figure 58. As stated 
above, when mixing AgPF6 with the ligand L
p-Me, the molecular structure of the 
complex presents structural features analogous to those obtained with the triflate 
anion. The molecular arrangement in 27-CF3SO3, 28-CF3SO3, 29-CF3SO3, 30-CF3SO3, 
and 31-CF3SO3 are very similar despite the fact that these complexes crystallize in 
different space groups, and therefore their structures will described together. The 
complex 29-CF3SO3 crystallizes as a molecular chain but the structural features are 
slightly different from those of the other complexes, Figure 59. For all of these 
compounds the ligand acts as N2 bidentate on a metal and bridges on another silver 
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atom with the thioether group, with the central phenyl ring in a rigid geometry, 
since the π angle is in narrow range of 0.6-6.7°. At variance with the structures of 
the haexameric complexes, the peripheral phenyl ring exhibits a higher degree of 
conformational flexibility, since it is not always stacked above one of the pyrazole 
rings, as it happened for the hexameric complexes. In fact, the dihedral angle 
between the pyrazole and peripheral aromatic rings (β is in the range of 9.7-42.3° for 
the molecular chains and 10.8-15.4° in the hexameric complexes. When viewing the 
molecular chains of 27-CF3SO3, 28-CF3SO3, 29-CF3SO3, 30-CF3SO3, and 31-CF3SO3 
along their direction of propagation (Figure 59) it can be appreciated how their 
projection has a square section with sides in the 18.9-14.4 Ǻ range. The larger size is 
for 27-CF3SO3 that present the most cumbersome substituent. These molecular 
chains exhibit a helical arrangements with a pitch in the range 20.46-22.96 Ǻ and 
that comprises four AgL units. The exterior of the chains is defined by alternate 
anions and pyrazole rings, whereas in the interior are located the peripheral 
aromatic moieties. This is a structural feature that also characterizes the hexameric 
complexes, even though in the molecular chains there is a the less defined 
orientation of the anions that surrounds the molecular chains. In fact, in the 
hexameric complexes, the PF6
- moiety occupies precise and invariant structural sites 
for all of the complexes, whereas in the chains, the anions are interacting with the 
metals, but are somehow free to rotate around the Ag-O bond. From an aesthetical 
point of view the hexameric species can be imagined as derived by a slight twisting 
reorientation of fraction of the chains comprising six AgL units.  
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Figure 58. Portion of the molecular chains of 27-CF3SO3, 28-CF3SO3, 29-CF3SO3, 30-
CF3SO3,31-CF3SO3 and 28-PF6. The ’ symbol denotes symmetry related atoms. Colors: 
Ag, green; S, yellow; N, blue; C, gray; O, red; F, light green, P, orange. 
 
 
The molecular chain of 29-CF3SO3 is different from the previously described 
structures, in fact the silver atoms are organized in a zig-zag fashion and the polymer 
does not form a helix. In addition, by inspecting its projection along the propagation 
of the molecule, it can be observed that the–PhF group and one of the pyrazole rings 
are oriented on one side whereas the central phenyl ring and the triflate anion are 
located on the other side.  
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Figure 59. Depiction of the molecular chains viewed along the direction of 
propagation of the helix. Colors: Ag, green; S, yellow; N, blue; C, gray; O, red; F, light 
green, P, orange. Thick stick representation highlight anions and the peripheral 
aromatic moieties. 
In chapter 2, 3 and 4 we have evaluated the importance of the steric hindrance of the 
methyl groups on the bispyrazolyl scaffold and also the importance of the phenyl 
linker to obtain hexameric species. Now we can add that the presence of terminal ring 
is also fundamental for the building of the spheres (Figure 60). 
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Figure 60. Schematic rappresentation of ligands: in orange and blu the groups 
required for cavities and in green the ring required for preoranization. 
5.3.3. X-ray powder diffraction. 
To investigate the adsorption properties of the new porous compounds, substantial 
amounts of crystalline materials are required (ca 0,5 g). the growth of a considerable 
amount of these crystalline materials presented some pratical problems for some of 
these systems. At present only a sufficient amount of crystals could be grown for  
27-PF6 and 31- PF6.  X-ray powder diffraction was performed on the samples in order 
to verify the purity of the crystalline materials. In Figure 61 and 62 are reported the 
experimental and simulate X-ray powder pattern. The latter is derived by the single 
crystal x-ray analysis. 
 
 
Figure 61. In blue experimental X-ray powder pattern of 27-PF6; in green the 
simulated pattern from single crystal. 
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Figure 62. In blue experimental X-ray powder pattern of 27-PF6; in green the 
simulated pattern from single crystal. 
 
 
The ability of 27- PF6  and 31- PF6 to absorb volatile material was preliminary 
investigated by recording PXRD spectra under vacuum and in presence of saturated 
solvent vapours. In Figure 63 and 64 it is shown that when the evacuated powder is 
exposed to vapours there is an enlargement of the unit cell in agreement with the 
porous properties of the materials. Adsoption experiments will be performed to prove 
the thesis which concerned the filling of only the intercapsules cavities as previously 
hypothesized in chapter 4. In fact if the same gas volume present in the 23-PF 6 
cavities  will be adsorbed, only the intercapsule volume will be occupied and the 
volume of intracapsule cavity will be irrelevant. Future work will improve, increase 
and functionalize the intermolecular cavities modifying the bispyrazolyl scaffold. 
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Figure 63. Effect of the solvent absorption on 27- PF6  crystals. Freshly ground crystals, 
red. Crystals subjected to high vacuum and T = 100°C for 2 h, green. The evacuated 
crystals were then exposed to saturated solvent vapors (acetone), blue. 
 
 
 
Figure 64. Effect of the solvent absorption on 31- PF6  crystals. Freshly ground crystals, 
red. Crystals subjected to high vacuum and T = 100°C for 2 h, green. The evacuated 
crystals were then exposed to saturated solvent vapors (acetone), blue. 
Table 9. Selected bond lengths (Å) and angles (°) for 27-PF6, 28-PF6, 29-PF6, 30-PF6, 31-
PF6  
 27-PF6   
Ag-N(21) 2.222(3) N(21)-Ag-N(22) 84.90(9) 
Ag-N(22) 2.331(3) N(21)-Ag-S(13)’ 148.10(7) 
Ag-S(13)’ 2.378(8) N(22)-Ag-S(13)’ 126.88(7) 
Ag-F(1) 2.754(3)   
 28-PF6   
Ag-N(21) 2.250(3) N(21)-Ag-N(22) 84.6(1) 
Ag-N(22) 2.321(3) N(21)-Ag-S(13)‡ 142.60(9) 
Ag-S(13)‡ 2.4367(9) N(22)-Ag-S(13)‡ 130.68(8) 
 29-PF6   
Ag-N(21) 2.225(4) N(21)-Ag-N(22) 84.4(2) 
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Ag-N(22) 2.285(5) N(21)-Ag-S(13)# 147.0(1) 
Ag-S(13)# 2.386(2) N(22)-Ag-S(13)# 127.5(1) 
Ag-F(1) 2.801(4)   
 30-PF6   
Ag-N(21) 2.229(8) N(21)-Ag-N(22) 84.7(3) 
Ag-N(22) 2.315(9) N(21)-Ag-S(13)’’ 146.5(2) 
Ag-S(13)’’ 2.377(3) N(22)-Ag-S(13)’’ 128.8(2) 
Ag-F(1) 2.818(9)   
 31-PF6   
Ag-N(21) 2.232(3) N(21)-Ag-N(22) 84.5(1) 
Ag-N(22) 2.322(4) N(21)-Ag-S(13)’’’ 151.59(9) 
Ag-S(13)’’’ 2.400(1) N(22)-Ag-S(13)’’’ 123.85(9) 
Ag-F(1) 2.749(3)   
    
Symmetry codes: ’ = ½-z; ½-x; 1-y, ’’ = z-1/4; 1-x; y-1/4, ’’’ =  ½-y; ½-z; 1-x+1, ‡ = 
3/4-y; x-3/4; ¼+z, # = ½-y; ½-z; 1-x. 
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Table 10. Selected bond lengths (Å) and angles (°) for 27-CF3SO3, 28-CF3SO3 , 29-CF3SO3 
, 30-CF3SO3 , 31-CF3SO3.  
 27-CF3SO3   
Ag(1)-N(21) 2.338(4) Ag(2)-N(24) 2.277(5) 
Ag(1)-N(22) 2.231(5) Ag(2)-N(25) 2.285(5) 
Ag(1)-S(16)’ 2.430(2) Ag(2)-S(13) 2.432(2) 
Ag(1)-O(19)§ 2.58(2) Ag(2)-O(17) 2.518(4) 
Ag(1)-O(210)§ 2.53(2) N(24)-Ag(2)-N(25) 84.2(2) 
N(21)-Ag(1)-N(22) 86.4(2) N(24)-Ag(2)-S(13) 129.5(1) 
N(21)-Ag(1)-S(16)’ 119.6(1) N(25)-Ag(2)-S(13) 144.5(1) 
N(22)-Ag(1)-S(16)’ 147.1(1)   
 28-CF3SO3   
Ag(1)-N(21) 2.263(5) Ag(2)-N(24) 2.296(4) 
Ag(1)-N(22) 2.312(4) Ag(2)-N(25) 2.299(5) 
Ag(1)-S(16)‡ 2.435(1) Ag(2)-S(13) 2.465(1) 
Ag(1)-O(17) 2.523(4) Ag(2)-O(18) 2.573(5) 
N(21)-Ag(1)-N(22) 84.8(2) N(24)-Ag(2)-N(25) 85.7(2) 
N(21)-Ag(1)-S(16)‡ 136.9(1) N(24)-Ag(2)-S(13) 129.7(1) 
N(22)-Ag(1)-S(16)‡ 135.0(1) N(25)-Ag(2)-S(13) 136.7(1) 
 29-CF3SO3   
Ag-N(21) 2.345(3) Ag-S(13)# 2.526(1) 
Ag-N(22) 2.283(3) Ag-O(14) 2.398(4) 
N(21)-Ag-N(22) 83.8(1) N(22)-Ag-O(14)  133.1(1) 
N(21)-Ag-S(13)# 120.86(8) N(21)-Ag-O(14) 98.5(2) 
N(22)-Ag-S(13)# 128.06(8) O(14)-Ag-S(13)# 90.9(1) 
 30-CF3SO3   
Ag(1)-N(24) 2.273(3) Ag(2)-N(21) 2.302(4) 
Ag(1)-N(25) 2.327(4) Ag(2)-N(22) 2.297(4) 
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Ag(1)-S(13) 2.434(1) Ag(2)-S(16)’’ 2.446(1) 
Ag(1)-O(17) 2.498(3) Ag(2)-O(18) 2.566(5) 
N(24)-Ag(1)-N(25) 84.9(1) N(21)-Ag(2)-N(22) 84.9(1) 
N(24)-Ag(1)-S(13) 135.39(9) N(21)-Ag(2)-S(16)’’ 126.8(1) 
N(25)-Ag(1)-S(13) 138.45(9) N(22)-Ag(2)-S(16)’’ 144.2(1) 
 31-CF3SO3   
Ag(1)-N(21) 2.283(5) Ag(2)-N(24) 2.290(4) 
Ag(1)-N(22) 2.318(6) Ag(2)-N(25) 2.303(4) 
Ag(1)-S(16)’’’ 2.500(2) Ag(2)-S(13) 2.454(1) 
Ag(1)-O(17) 2.701(4) Ag(2)-O(18) 2.423(2) 
N(21)-Ag(1)-N(22) 84.1(2) N(24)-Ag(2)-N(25) 85.2(2) 
N(21)-Ag(1)-S(16)’’’ 144.3(2) N(24)-Ag(2)-S(13) 139.0(1) 
N(22)-Ag(1)-S(16)’’’ 126.8(1) N(25)-Ag(2)-S(13) 132.1(1) 
§ O(19) and O(210) are two disordered fragments of the same atom. Symmetry codes: 
’ = ½+x; -y; ½-z, ’’ = 1-x; ½+y; 1-z, ’’’ = -x+½; y-½; -z+3/2; ‡ = -x; y-½; -z-½. # = 3/2-x; ½+y; 
z. 
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      CHAPTER 6 
 
Pre-organized N2S2 donor ligand drives Metal-Organic 
chain formation.  
 
Three new N2S2 donor ligands 1,1’-((2-(2-
(phenylthio)phenylthio)phenyl)methylene)bis(3,5-R-1H-pyrazole), R = H 
(LHPhSPhSPh), R = Me (LMePhSPhSPh), R = i-Pr (LiPrPhSPhSPh)103 were prepared and 
characterized. These bifunctional ligands incorporate two distinct chelate donor 
systems, by virtue of the presence of bispyrazole and bisthioether functions. The 
preferred conformation of these ligands is such that the N2 and S2 donor moieties are 
usually oriented in opposite directions, thus favouring the formation of molecular 
chains when reacted with AgBF4. The X-ray structures of Ag(I) complexes show that 
depending on the steric hindrance present on the pyrazole rings, these ligands behave 
as κ4-SSNN-µ bridging tetradentate (when R = H), κ3-SNN-µ bridging tridentate (when 
R = Me, i-Pr). Interestingly, [Ag(LHPhSPhSPh)]BF4 crystallizes in the chiral space group 
P41, with the molecular chain that is folded around the 41 screw axis.  
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6.1  Introduction 
The stability of supramolecular architectures depends on the affinity between the 
ligand donor set and the metal ions, and more specifically it is crucially dependent on 
the capacity that the binding sites of the ligand are suitable for satisfying the 
stereochemical requirement of the metal center. There is in fact a net thermodynamic 
advantage during the generation of the supramolecular structure when the ligands 
display a pre-organized donor set in which the metal ion can easily settle81,105. In this 
chapter, three different N2S2 donor ligands were synthesised, L
HPhSPhSPh, 
LMePhSPhSPh, and LiPrPhSPhSPh. They ideally represent  a modification of the ligands 
described in chapter 4 and 5 since an additional thioether group was attached to the 
bispyrazole scaffold.The N2 donor system derives by a bis(pyrazole)methane moiety, 
and attached to its central carbon a atom is located a bisthioether function that 
provide the S2 donor system. These ditopic ligands adopt a conformation that makes 
them suitable to build molecular chains when reacted with metal ions since the N2 
and S2 donor groups point in nearly opposite directions as found for L
MeSPh class. 
Furthermore, the three ligands differ by the steric hindrance positioned on the 
pyrazole ring in the form of H, Me or i-Pr groups, and this has structural consequences 
on the overall polynuclear structure. To investigate the suitability of these ligands in 
the construction of molecular chains, Ag(I) complexes were prepared by reacting 
AgBF4 with L
HPhSPhSPh, LMePhSPhSPh or LiPrPhSPhSPh. The molecular structures of the 
ligand LiPrPhSPhSPh and of the complexes [Ag(LHPhSPhSPh)]BF4 (33) , 
[Ag(LMePhSPhSPh)(Me2CO)]BF4·Me2CO (34), and [Ag(L
iPrPhSPhSPh)(Me2CO)]BF4 (35)  
are described. Interestingly the complex 33 crystallizes in the chiral space group P41 
due to the formation of a homochiral molecular chain having the shape of a right-
handed helix. As far as the silver complexes are concerned, many other examples can 
be found in the literature reporting 1D polymeric structures obtained by using 
nitrogen donor ligands. In some cases these 1D structures are generated by ligands 
that act as a bridge between two metal centers thus forming a coordination 
polymer58,59, whereas in other cases the building blocks are represented by metal 
complexes that are interacting with neighbor ones by means of weaker forces such as 
hydrogen bonds, π-π stack, or C-H···π interactions60. By a judicious choice of ligands, 
these molecular chains can be chiral either because they form helical structures 61–64 
or because a chiral ligand has been specifically employed65.  
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Figure 65.  Molecular structures of the ligands described in this chapter. 
123 
 
6.2. Experimental 
6.2.1.  Synthesis 
Bis(pyrazolyl)ketones44–46 were prepared as reported in the literature. 2-
(phenylthio)benzenethiol75 and 2-(2-(phenylthio)phenylthio)benzaldehyde103 were 
prepared by slight modifications of reported procedures All reagents and solvents 
were commercially available. Solvents were dried and distilled before use. 1H NMR 
spectra were recorded on a Bruker Avance 300 spectrometer using standard Bruker 
pulse sequences. Chemical shifts are reported in ppm referenced to residual solvent 
protons (CDCl3,CD2Cl2, CD3CN, (CD3)2CO). Infrared spectra were recorded from 4000 to 
700 cm-1 on a Perkin-Elmer FT-IR Nexus spectrometer equipped with a Thermo-
Nicolet microscope. Elemental analyses (C, H, N) were performed with a Carlo Erba EA 
1108 automated analyzer. 
Synthesis of 2-(phenylthio)benzenethiol. A solution of thiophenol (4 ml, 39.0 mmol) in 
cyclohexane (10 ml) was added to a solution of n-BuLi (1.6 M in hexane, 54 ml, 86.4 
mmol) and N,N,N’,N’-tetramethylethylenediamine (TMEDA, 13 ml, 86.7 mmol) in 
cyclohexane (60 ml) at 0 °C under nitrogen. The reaction was stirred for 30 min at 0 °C 
and for 6 h at room temperature. A solution of diphenyl disulfide (9.5 g, 43.6 mmol) in 
cyclohexane (90 ml) was added at 0 °C. After being stirred for 30 min at 0 °C, the 
mixture was stirred overnight at room temperature and quenched with 15% HCl(aq) 
(175 ml). The organic and water layers were separated and the latter was extracted 
with diethyl ether (3x 50 ml). The organic phases were mixed and dried with 
anhydrous Na2SO4. Solvents were removed under vacuum. The solid was 
recrystallized from a CH2Cl2:EtOH mixture, yielding a colorless crystalline solid (4 g, 
18.4 mmol, 47%). 1H NMR (300 MHz, CDCl3): δ, 4.29 (s, 1H, SH), 7.1-7.6 (m, 9H, CH). 
Anal. calcd for C12H10S2 (218.02): C, 66.01; H, 4.62. Found: C, 66.10; H, 4.44. 
Synthesis of 2-(2-(phenylthio)phenylthio)benzaldehyde. To a stirred solution of 2-
(phenylthio)benzenethiol (2 g, 9.2 mmol) and anhydrous Na2CO3 (1.3 g) in dry DMF (5 
ml) under nitrogen at 90 °C, 2-chlorobenzaldehyde (0.9 ml, 7.99 mmol) was slowly 
added. The mixture was stirred at 90 °C overnight. After cooling, the reaction mixture 
was poured into water (50 ml) and extracted with diethyl ether (50 ml). The extract 
was washed with water (2x50 ml), dried with anhydrous Na2SO4, and concentrated 
under vacuum. The resulting oil was triturated with hexane in an ultrasound bath for 
20 min, filtered and dried under vacuum to afford a pale white solid (1.85 g, 5.7 
mmol, 72%). 1H NMR (300 MHz, CDCl3): δ, 7.11-7.51(m, 12H, CH Ph), 7.94 (d, J = 7.5 
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Hz, 1H, CH Ph), 10.39 (s, 1H, CHO). Anal. calcd for C19H14OS2 (322.05): C, 70.77; H, 
4.38. Found: C, 70.53; H, 4.51. 
Synthesis of 1,1'-((2-(2-(phenylthio)phenylthio)phenyl)methylene)bis(1H-pyrazole) 
(LHPhSPhSPh). 2-(2-(phenylthio)phenylthio)benzaldehyde (875 mg, 2.71 mmol) and 
CoCl2·6H2O (5 mg, 0.021 mmol) were added to bis(1H-pyrazol-1-yl)ketone (565 mg, 
3.48 mmol) in a Schlenk flask under nitrogen. The mixture was heated at 130 °C and 
vigorously stirred. After 1 h, the green mixture was cooled to room temperature. 
Diethyl ether (50 ml) and water (50 ml) were then added, the organic phase was 
separated and washed with brine (2 x 50 ml), dried with anhydrous Na2SO4 and 
filtered. The volatiles were removed under vacuum yielding a pale oil. The compound 
was recrystallized in hot methanol (5 ml) and leaving the solution to rest at 0°. 
Colorless micro-crystals were isolated and vacuum dried (LMe, 907 mg, 2.06 mmol, 
76%). 1H NMR (300 MHz, CDCl3): δ, 6.26 (t, J = 2.0 Hz, 2H, CH pz), 6.86 (dd, J = 7.5 Hz, J 
= 1.6 Hz, 1H CH Ph), 6.99-7.40 (m, 14H, CH Ph, CH pz), 7.62 (d, J = 1.7 Hz, CH pz), 8.20 
(s, 1H, CH bridge). Anal. calcd for C25H20N4S2 (440.59): C, 68.15; H, 4.58; N, 12.72. 
Found: C, 67.86; H, 4.21; N, 12.41. 
 
Synthesis of 1,1'-((2-(2-(phenylthio)phenylthio)phenyl)methylene)bis(3,5-dimethyl-1H-
pyrazole) (LMePhSPhSPh). 2-(2-(phenylthio)phenylthio)benzaldehyde (900 mg, 2.79 
mmol) and CoCl2·6H2O (5 mg, 0.021 mmol) were added to bis(3,5-dimethyl-1H-
pyrazol-1-yl)ketone (670 mg, 3.07 mmol) in a Schlenk flask under nitrogen. The 
mixture was heated at 90 °C and vigorously stirred. After 2 h, the dark blue mixture 
was cooled to room temperature. CHCl3 (50 ml) and water (50 ml) were then added. 
The organic layer was separated and washed with water (2 x 50 ml), dried with 
anhydrous Na2SO4 and concentrated under vacuum yielding a pale oil, which was 
purified by column cromatography (Silica gel, gradient of elution from hexane/ethyl 
acetate 18:1 to pure ethyl acetate). The oil was then triturated with hexane in an 
ultrasound bath, filtered and dried under vacuum, affording a white powder (LMe, 790 
mg, 1.59 mmol, 57%). 1H NMR (300 MHz, CDCl3): δ, 2.11 (s, 6H, CH3), 2.20 (s, 6H, CH3), 
5.82 (s, 2H, CH pz), 6.99-7.14 (m, 5H, CH Ph), 7.31 (m, 8H, CH Ph), 7.86 (s, 1H, CH 
bridge). Anal. calcd for C29H28N4S2 (496.69): C, 70.13; H, 5.68; N, 11.28. Found: C, 
69.96; H, 5.79; N, 11.36. 
Synthesis of 1,1'-((2-(2-(phenylthio)phenylthio)phenyl)methylene)bis(3,5-diisopropyl-
1H-pyrazole) (LiPrPhSPhSPh). 2-(2-(phenylthio)phenylthio)benzaldehyde (770 mg, 2.39 
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mmol) and CoCl2·6H2O (4 mg, 0.017 mmol) were added to bis(3,5-diisopropyl-1H-
pyrazol-1-yl)ketone (910 mg, 2.75 mmol) in a Schlenk flask under nitrogen. The 
mixture was heated at 150 °C and vigorously stirred. After 4 h, the dark green mixture 
was cooled to room temperature. CHCl3 (50 ml) and water (50 ml) were then added, 
and the organic layer was separated and washed with water (2 x 50 ml), dried with 
anhydrous Na2SO4 and concentrated under vacuum yielding a dark oil, which was 
purified by column cromatography (Silica gel, hexane:ethyl acetate 9:1). The resulting 
oil was recrystallized from hexane (2-3 ml) at room temperature, yielding a crystalline 
white solid (LiPr, 640 mg, 1.05 mmol, 44%). 1H NMR (300 MHz, CDCl3): δ, 0.92 (d, J = 
6.9 Hz, 6H, CH3), 0.99 (d, J = 6.9 Hz, 6H, CH3), 1.20 (d, J = 6.9 Hz, 12H, CH3), 2.91 (hept, 
J = 6.9 Hz, 2H, CH i-Pr), 3.15 (hept, J = 6.9 Hz, 2H, CH i-Pr), 5.91 (s, 2H, CH pz), 6.95 (m, 
1H, CH Ph), 7.08 (m, 4H, CH Ph), 7.19-7.32 (m, 8H, CH Ph), 8.00 (s, 1H, CH bridge). 
Anal. calcd for C37H44N4S2 (608.90): C, 72.98; H, 7.28; N, 9.20. Found: C, 73.07; H, 7.11; 
N, 9.12. 
Synthesis of [Ag(LHPhSPhSPh)]BF4 (33). L
HPhSPhSPh (100 mg, 0.227 mmol) and AgBF4 
(44 mg, 0.227 mmol) were mixed in acetone (20 ml), and the colorless solution was 
stirred for 1 h. The solvent was then removed under vacuum and the white solid was 
washed with diethyl ether in an ultrasound bath. The mixture was filtered affording a 
white solid (45 mg, 0.091 mmol, 40%). The compound was recrystallized by stratifying 
pentane over an acetone solution of the complex, yielding colorless crystals. IR (cm-1): 
3133 w, 3051w, 2969w, 1689w, 1621w, 1566w, 1511w, 1434m, 1396m, 1287m, 
1052s, 1021s, 746s, 690m, 626m, 520m. 1H NMR (300 MHz, (CD3)2CO): δ, 6.47 (t, J = 
2.4 Hz, 1H, CH pz), 6.98 (d, J = 8.1 Hz, 1H, CH Ph), 7.21 (m, 4H, CH Ph), 7.46 (m, 8H, CH 
Ph), 7.68 (d, J = 1.8 Hz, 2H, CH pz), 8.10 (d, J = 2.7 Hz, 2H, CH pz), 8.69 (s, 1H, CH). 
Anal. calcd for C25H20AgBF4N4S2 (635.26): C, 47.27; H, 3.17; N, 8.82. Found: C, 47.76; H, 
3.02; N, 8.45. 
Synthesis of [Ag(LMPhSPhSPhe)(Me2CO)]BF4·Me2CO (34). L
MePhSPhSPh (100 mg, 0.201 
mmol) and AgBF4 (40 mg, 0.205 mmol) were mixed in acetone (15 ml), and the 
colourless solution was stirred for 1 h. The solvent was then concentrated under 
vacuum and a white solid was precipitated after addition of pentane. The solid was 
filtered and vacuum dried. (138 mg, 0.187 mmol, 93%). The compound was 
recrystallized by stratifying pentane over an acetone solution of the complex, yielding 
colorless crystals. IR (cm-1): 3062w, 2985w, 2914w, 1708w, 1692m, 1577m, 1442m, 
1419m, 1248w, 1051s, 1030s, 876m, 753s, 689m, 521m. 1H NMR (300 MHz, CD3CN): 
δ, 1.95 (s, 6H, CH3), 2.37 (s, 6H, CH3), 6.03 (s, 2H, CH pz), 6.88 (d , J = 7.2 Hz, 1H, CH 
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Ph), 7.22 (m, 12H, CH Ph), 7.72 (s, H, CHcentral). Anal. calcd for C35H40AgBF4N4O2S2 
(807.52): C, 52.06; H, 4.99; N, 6.94. Found: C, 51.67; H, 4.52; N, 6.68. 
Synthesis of [Ag(LiPrPhSPhSPh)(Me2CO)]BF4 (35). L
iPrPhSPhSPh (123 mg, 0.202 mmol) 
and AgBF4 (40 mg, 0.205 mmol) were mixed in acetone (15 ml), and the colorless 
solution was stirred for 1 h. The solvent was then concentrated under vacuum and a 
white solid was precipitated after addition of pentane. The solid was filtered and 
vacuum dried. (147 mg, 0.164 mmol, 81%). The compound was recrystallized by 
stratifying pentane over an acetone solution of the complex, yielding colorless 
crystals. IR (cm-1): 2963w, 2876w, 1693m, 1544w, 1462m, 1441m, 1380w, 1363w, 
1303w, 1276w, 1226m, 1048s, 821m, 758s, 648m, 528m. 1H NMR (300 MHz, CD3CN): 
δ, 1.11 (m, 24H, 8CH3), 2.65 (s br, 2H, CH i-Pr), 3.24 (m, J = 6.9 Hz, 2H, CH i-Pr), 6.24 (s, 
2H, CH pz), 6.56 (s br, 1H, CH Ph), 7.13 (m, 2H, CH Ph), 7.28 (m, 10H, CH Ph), 7.91 (s, 
1H, CH). Anal. calcd for C40H50AgBF4N4OS2 (861.66): C, 55.76; H, 5.85; N, 6.50. Found: 
C, 55.34; H, 5.39; N, 6.17. 
 
6.2.2.  X-ray crystallography 
A summary of data collection and structure refinement for LiPrPhSPhSPh, 33-35 are 
repoted in Appendix viii. Single crystal data was collected with a Bruker AXS Smart 
1000, Mo Kα: λ = 0.71073 Å. The intensity data were integrated from several series of 
exposures frames (0.3° width) covering the sphere of reciprocal space48. An 
absorption correction was applied using the program SADABS with min. and max. 
trasmission factors of: 0.777-1.000 (LiPrPhSPhSPh), 0.506-1.000 (33), 0.828-1.000 (34), 
0.808-1.000 (35), and 0.834-1.000 (35). The structures were solved by direct methods 
(SIR9766) and refined on F2 with full-matrix least squares (SHELXL-9750), using the 
Wingx software package51. Non hydrogen atoms were refined anisotropically for all 
compounds, and the hydrogen atoms were placed at their calculated positions. The 
BF4
- anion in 34 and 35 was statically disordered in two positions with site occupancy 
factors of 0.56/0.44 (34), and 0.67/0.33 (35). Graphical material was prepared with 
Mercury 2.052  programs. 
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6.3. Results and Discussion 
6.3.1.  Synthesis 
There are two main synthetic routes that lead to C-centered heteroscorpionate 
tripodal ligands based on the bispyrazole scaffold. The first method consists in the 
deprotonation of methylene bridge of bis(pyrazolyl)methane with a strong base. The 
generated carbanion can then be reacted with specific electrophiles. This procedures 
has been developed for the production of various tripodal ligands among which are 
the bis(pyrazolyl)carboxylate/bis(pyrazolyl)thiocarboxylate106, and the hybrid 
bis(pyrazolyl)cyclopentadienyl107 ligands. In the second synthetic route, as we have 
already described in previous chapters, bis(pyrazolyl)ketones are reacted with 
aldehydes or ketones bearing the desired donor groups that are to be attached to the 
bispyrazole platform108,109.  
 
Figure 66. Synthesis of the ligands described in this chapter. 
 
The ligands reported were prepared according to the second procedure, by reacting 
bis(pyrazolyl)ketones with 2-(2-(phenylthio)phenylthio)benzaldehyde, Figure 66. 
These ligands exhibit a N2S2 donor set and they could provide the geometric 
environment for the encapsulation of a metal center in a distorted tetrahedral 
arrangement. To test this hypothesis two models based on the LMePhSPhSPh ligand 
and Cu(I) or Ag(I) were taken as benchmark, and their geometry were optimized72. 
The ligand can accommodate both metals, but by doing so it faces a certain degree of 
distortion of the aromatic ring attached to the bispyrazole moiety. In addition, this 
ligand conformation would bring the CHcentral and the aromatic CHortho in close 
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proximity, and this could possibly constitute an additional destabilizing factor. In 
order to investigate the coordinative behaviour of these ligands, Ag(I) complexes 
were prepared by reacting equimolar amounts of ligands and AgBF4. The complexes 
could be crystallized by stratifying pentane over an acetone solution of each complex.  
 
6.3.2. Molecular structures 
The molecular structure of LiPrPhSPhSPh ligand is reported in Figure 67. The two 
pyrazole rings are in an anti conformation, and this arrangement is probably adopted 
to avoid the electronic repulsion between the nitrogen lone pairs. This is a common 
feature of ligands based on the bis(pyrazolyl)methane scaffold [38]. In addition, a 
weak CH···N interaction between N(21) and the C(72) of an i-Pr group (3.196(5) Å) 
contributes to the stabilization of this pyrazoles arrangement. Another feature worth 
of mentioning is represented by the conformation of the thioether arm with respect 
to the pyrazole rings that can be better described by introducing the torsion angle τ(1) 
(Figure 73), which is -121.9(3)° in the present case. Furthermore, the steric repulsion 
between the C(33)-H and C(13)-H forces away these two groups, and may be an 
additional factor contributing to the resulting ligand arrangement. This has important 
consequences on the structures of the metal complexes prepared with these ligands, 
since the pre-organization of the free ligand favours the preorientation of the N2 and 
S2 donor system in different directions. This is responsible of the polymeric molecular 
structures of the Ag(I) complexes described below. 
 
Figure 67. Stereochemical descriptors (a), and torsion angles varied during the 
conformational studies (b). 
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It is worth of note that the asymmetry of the bisthioether group and the present 
ligand conformation implies that LiPrPhSPhSPh is chiral, though we may speak of a 
conformational chirality, and as stereodescriptor we can use the τ(1) angle defined 
above. With this respect, in the unit cell are present both conformational 
enantiomers, one with τ(1) = -121.9(3)° and the other one with τ(1) = 121.9(3)°, Figure 
68. 
 
 
Figure 68. Stereochemical descriptors (a), and torsion angles varied during the 
conformational studies (b). 
Selected bond lengths and angles for complex 33 are reported in Table 9, whereas the 
molecular structure and crystal packing are depicted in Figures 69-70. The ligand 
behaves as κ4-SSNN-µ bridging tetradentate, being N2 chelated on a metal center and 
linking a second metal with the bisthioether functions that are pointing approximately 
in opposite direction with respect to the N2 donor system. The metal adopts a 
severely distorted tetrahedral geometry and the distortion from the ideal geometry is 
a consequence of the small bite angles of the N2 (85°) and S2 (75°) chelate groups. The 
Ag-N bond distances (2.297(6) and 2.355(7) Ǻ) are considerably smaller than the Ag-S 
ones (2.607(2) and 2.625(2) Ǻ). The ligand adopts the same conformation of the 
thioether arm found for LiPrPhSPhSPh with the torsion angle τ(1)-[C(33)-C(23)-C(13)-
N(11)] of -130.3(7)°. This preferred conformation of the thioether moiety with respect 
to the bispyrazole scaffold leads to the formation of molecular chains that are parallel 
to the c crystallographic axis. Furthermore, since the compound crystallizes in the 
chiral space group P41, only one ligand conformation is present in the structure, with 
the molecular chains that are homochiral. These chains have the shape of a right-
handed helix folded around the c axis, and the helix pitch corresponds to the length of 
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the c axis (∼30.5 Ǻ), whereas the displacement of the silver atoms from the helix 
center is ∼1 Ǻ. It is likely that during the crystallization process, a racemic 
conglomerate110 formed and that both enanthiomorphic space groups were present 
(P41 and P43). However, the inspection of the morphology of the crystals did not 
permit to individuate the enantiomorphic pairs as the complex gave rise to long 
needle-like crystals with poorly defined faces111. Similar examples of racemic 
conglomerate formed when using an achiral pyridine-thioether ligand were reported. 
Also in those cases, the formation of the helical structures depends on the 
conformation adopted by the ligand when bound to the metal62,112. 
 
 
Figure 69. Crystal packing of 33 projected along the c axis. The hydrogen atoms and 
the BF4
- counterion were removed for clarity 
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Figure 70. Crystal packing of 33 projected along the a axis. The hydrogen atoms and 
the BF4
- counterion were removed for clarity.  
Selected bond lengths and angles for complex  34 are reported in Table 9, whereas 
the molecular structure and crystal packing are depicted in Figures 71-72. Differently 
from 33, in the present complex the ligand acts as κ3-SNN-µ bridging tridentate, 
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bound to a metal center with the bis(pyrazole)moiety and bridging another metal 
center with the S(14) sulfur atom. The S(13) atom does not take part to the metal 
coordination. The metal is in a trigonal planar geometry that is distorted toward the 
tetrahedral one according to the presence of the acetone molecule ligated to the 
metal (d[Ag-O(1s)] = 2.550(2) Å]. The metal-nitrogen and metal-sulfur bond distances 
are significantly smaller than the metal-oxygen one, attesting the weak nature of the 
latter interaction. The presence of a certain steric hindrance in the form of methyl 
groups on the pyrazole rings causes the second phenyl ring (II) of the thioether arm to 
adopt a conformation that prevents the coordination of the S(13) atom to the metal 
center, Figure 73. The conformation of ring I is analogous to that of the previous 
structures, and since the space group is a non chiral one, both conformers are present 
with τ(1)-[C(33)-C(23)-C(13)-N(11)] of ±121.6(2)º. The pyrazole ring and II form an 
angle of 82°, whereas in 33, where there are no bulky groups on the pyrazoles, this 
angle is of 51°. The formation of molecular chains is determined by the coordination 
of the S(14) atom to a second metal. These chains present the phenyl residues 
oriented on the opposite side with respect to the coordinated acetone molecules, and 
the pyrazole rings are interposed between these two donor groups. The chains are 
homochiral, built by ligands of the same conformations, and chains of opposite 
chirality are present in the unit cell. 
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Figure 71. Portion of the crystal packing of 34, projected along the b axis. The 
hydrogen atoms were removed for clarity.  
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Figure 72. Portion of the crystal packing of 34 projected along the c axis. The 
hydrogen atoms, the BF4
- counterion, and the solvate acetone molecules were 
removed for clarity.  
 
 The molecular structure of the asymmetric unit of complex 35 is essentially 
analogous to that of 34, Figures 73-74. The metal presents a trigonal planar geometry 
achieved by the bis(pyrazole) moiety and by a bridging sulfur atom (S(14)). Also for 
this complex, a weak Ag-O interaction deriving from an acetone molecule distorts the 
trigonal geometry towards the tetrahedral one. However, the Ag-O1s distance in the 
present complex is ~0.2 Å longer than that found in 34, Table 9. The conformation of 
the I phenyl ring of thioether arm is analogous to that of the prevoius complexes, with 
τ(1)-[C(33)-C(23)-C(13)-N(11)] of -130.0(5)°. The steric hyndrance on the pyrazole 
rings is determined by i-Pr residues and this reproduces an effect similar to the 
methyl groups in 34 to the overall structure. In fact, the S(13) atom is not bound to 
the metal and the II pheyl ring of the thioether arm is nearly perpendicular to the 
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pyrazole plane, Figure 75. Differently from the previously described complexes, the 
molecular chains contain alternating ligands of opposite chirality. The crystal packing 
is also similar to that of 34, even though in the present complex there are no 
additional acetone molecules of crystallization. 
 
Figure 73. Portion of the the crystal packing of 35 projected along the b axis. The 
hydrogen atoms were removed for clarity. 
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Figure 74. Portion of the crystal packing of 35 projected along the c axis. The 
hydrogen atoms and the BF4
- counterion were removed for clarity. The chains are 
composed of alternating ligand conformers.  
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Figure 75. Different pyrazole substituents determines different ligand conformation 
and modes of coordination. 
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Table 9. Selected bond lengths (Å) and angles (°) for 33, 34 and 35. 
 33   
Ag-N(21) 2.355(7) N(21)-Ag-N(22) 84.9(2) 
Ag-N(22) 2.297(6) N(21)-Ag-S(13)’ 125.2(2) 
Ag-S(13)’ 2.607(2) N(21)-Ag-S(14)’ 111.2(2) 
Ag-S(14)’ 2.625(2) N(22)-Ag-S(13)’ 128.4(2) 
  N(22)-Ag-S(14)’ 137.0(2) 
  S(13)’-Ag-S(14)’ 75.52(6) 
 34   
Ag-N(21) 2.307(2) N(21)-Ag-N(22) 86.74(6) 
Ag-N(22) 2.253(2) N(21)-Ag-O1s 107.34(7) 
Ag-S(14)’’ 2.4324(6) N(21)-Ag-S(14)’’ 123.96(5) 
Ag-O1s 2.550(2) N(22)-Ag-O1s 94.55(7) 
  N(22)-Ag-S(14)’’ 142.99(5) 
  O1s-Ag-S(14)’’ 94.82(5) 
 35   
Ag-N(21) 2.252(4) N(21)-Ag-N(22) 86.6(2) 
Ag-N(22) 2.321(4) N(21)-Ag-O1s 96.7(1) 
Ag-S(14)’’’ 2.427(1) N(21)-Ag-S(14)’’’ 124.2(1) 
Ag-O1s 2.737(4) N(22)-Ag-O1s 91.3(2) 
  N(22)-Ag-S(14)’’’ 146.1(1) 
  O1s-Ag-S(14)’’’ 98.1(1) 
’ = y; -x; z-1/4, ’’ = x; y+1; z, ’’’ = -x+1/2,y+1/2,z 
 
6.3.3. Conformational studies. 
Conformational studies were performed in order to investigate the energetics relative 
to the mobility of the pyrazole rings and of the thioether group of the ligands. For this 
purpose, a model complex was used in which the –II-S-III fragment was replaced by a 
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methyl group, Figure 73. The calculations were performed by varying two torsion 
angles, one that rotates the thioether group with respect to the pyrazole rings (τ1), 
and the other one that rotates one of the pyrazole rings (τ2). A picture describing this 
rigid potential energy surface scan is depicted in Figure 76. It can be noted that there 
are very high energy peaks, and these correspond to unrealistic conformations where 
C-H and –S-CH3 groups are in very close proximity. This occurs because at every 
calculation step the molecular geometry was not optimized (rigid scan). For all of the 
other regions the maximum energy difference is approximately 80 kJ/mol, and there 
appear preferential pathways for the conformational mobility. In particular, the 
trajectory that connects the 1-3 conformations is characterized by the rotation of the 
pyrazole ring (τ2), but with the sulphur atom that points towards the CHcentral. The 
conformation 1 is similar to that observed for the structure of LiPrPhSPhSPh, with the 
pyrazole rings in anti disposition, whereas in 3 one of the pyrazoles exchanges an 
interaction with the CHphenyl in ortho position. The normalized energy profile of this 
conformational change is depicted in Figure 13. The saddle point (structure 2) lies 
approximately 30 kJ/mol above the 1 and 3 minima. On the other hand, the trajectory 
that connects the 4 and 5 conformations lies 80 kJ/mol above the one that connects 
the 1-3 conformations. Along this 4-5 path, the molecule rotates the pyrazole ring, 
but a destabilizing factor is represented by the repulsive interaction between the 
sulphur atom and one of the nitrogen atoms. Two other structural modifications can 
be envisaged by inspection of Figure 77, and are those linking 1-4 and 3-5 
conformations. These correspond to the rotation of the thioether group with repect 
to the bis(pyrazole) moiety. The normalized energy profile of the 1-4 trajectory shows 
that the saddle point 4 is ∼80 kJ/mol above the minima, and ∼50 kJ/mol higher than 
the saddle point 2. 
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Figure 76. Rigid potential energy surface scan obtained by varying τ(1) and τ(2) torsion 
angles as defined in Scheme 2b. Molecular structures of relevant conformations are 
also reported 
From this calculations, it is evident that the thioether group is preferentially oriented 
towards the hydrogen atom of CHcentral, hence on the opposite direction with respect 
to the N2 donor atoms, whereas the rotation of the pyrazole ring is a more viable 
scenario as it requires a minor energetic expenditure. Extending these results to the 
LHPhSPhSPh, LMePhSPhSPh and LiPrPhSPhSPh ligands, it can be then proposed that, 
prior to their interaction with a metal center, they are in either one of the 1-3 
conformations. When a metal center approaches the ligands, it becomes chelated by 
the pyrazole rings and the sulphur atom(s) is(are) available for bridging on a second 
metal center on the opposite side. The results here presented are to be taken as a 
qualitative picture of the possible conformations occurring in solution for the real 
ligand systems LHPhSPhSPh, LMePhSPhSPh, and LiPrPhSPhSPh. Besides, these results are 
in agreement with the similar results obtained for the simpler system LRPhS already 
studied in chapter 3.  
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Figure 77. Energy profile of selected trajectories of the potential energy surface. The 
energy values were normalized by taking the  conformation 1 as reference (PES 
minimum). 
 
As far as the silver complexes are concerned, the 1H NMR spectra recorded in CD3CN 
or (CD3)2CO at variable temperature suggest that a dynamic behaviour involves at 
least one of the two pyrazole rings. In fact the substituents of LMePhSPhSPh and 
LiPrPhSPhSPh of one pyrazole group exhibit coalescence at approximately 250 K for 
LMePhSPhSPh and 280 K for LiPrPhSPhSPh , Figure 78.  
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Figure 78. Variable temperature 1H NMR spectra of 34 (a) and 35 (b) recorded in 
CD3CN. The asterisks denote fluxional Me or i-Pr protons. # = impurities (CD2HCN and 
acetone). 
The reason for this behavior is not easily interpretable but it may be related to the 
rotation of pyrazole ring along the Ccentral-N vector. This process determines the 
rupture of the Ag-N bond and consequently a modification of the silver geometry. In 
support of this hypothesis are the molecular structures of 33-35, where it is evident 
that one of the Ag-N bond distances is significantly longer than the other one by 0.05 
Å (33 and 34) and 0.07 Å (35). Furthermore the longest Ag-N distance is associated to 
the pyrazole on the same side of the sulfur atom and for which there is a mismatch 
between the directionality of the nitrogen lone pair and the silver atom.  
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Figure 79. Comparison of the Ag environment and Ag-N bond distances in 33-35.  
At the same time, the N-Ag-S bond angle opposite to fluxional Ag-N bond tends 
towards the linearity (128° in 33, 143° in 34 and 146° in 35) further supporting the 
lability of the Ag-N bond113–115. Assuming this fluxional behaviour, the silver 
coordination varies between the distorted tetrahedral and distorted T-shaped  
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CHAPTER 7 
 
GENERAL INTRODUCTION ON THE ROLE OF COPPER IN MEDICINE 
“The adult body contains between 1.4 and 2.1 mg of copper per 
kilogramme of body weight. Hence a healthy human weighing 60 
kilogrammes contains approximately a tenth of one gramme of 
copper. However, this small amount is essential to the overall 
human well-being.”  
Copper is a trace element essential for every living species. The key role plays by 
copper was found out in the early 30’s  when rats fed with a copper-deficient diet 
developed anemia. Also in humans, copper deficiency  is primarily associated with the 
occurrence of anemia, bone abnormalities and altered immune system116. Copper is 
found in the active site of many proteins and enzymes, from microorganisms to 
human beings. The standard potential associated to its redox reactions Cu(I)/Cu(II) is 
accessible even inside a biological system, where the pH must stay close to 7. This 
gives copper the ability to cycle between its two redox states, +1 and +2, and makes it 
an important redox active metal, like iron, commonly used in the redox centre of 
proteins. Consequently it is generally not used for structural functions, which are 
carried out mainly by zinc, a metal that shows only one available redox state (+2).  The 
principal metalloproteins and metalloenzymes containing copper are cytochrome c 
oxidase, blue copper proteins, superoxide dismutase, catechol oxidase (tyrosinase), 
amine oxidase, ceruloplasmin, metallothionein and albumine. Cyotochrome c oxidase 
is the last enzyme of the mitochondrial electron transfer cascade, where each O2 
molecule is reduced to H2O by means of the oxidation of four cytochrome cs.  
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Figure 80. Catalytic core subunits I and II of cytochrome c oxidase from Rhodobacter 
sphaeroides2. Copper atoms are represented as Wan der Waals spheres. 
Blue copper proteins are a family of electron transfer proteins characterized by an 
intense blue color that are used for cellular respiration and photosynthesis by 
bacteria and plants. 
The Cu/Zn superoxide dismutase (SOD) is the enzyme responsible of lowering the 
toxicity of the superoxide radiacal •O2
- by promoting its disproportion into H2O2 and 
O2. The diffusion limited reaction occurs so quickly that SOD is the most efficient 
enzyme known. The active site of the enzyme consists in one Cu atom, which is the 
catalytic core, and in one Zn atom, which plays a structural role. The mechanism is a 
cycle in which the copper atom interacts with superoxide O2
- both in the oxidized 
form Cu(II) and in the reduced form Cu(I) yielding O2 and H2O2
117.  
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Figure 81. Crystal structure of homo sapiens Cu/Zn SOD118. Copper atoms are colored 
in brown and zinc atoms in grey. 
 
After its absorption in the small intestine, copper is immediately bound to different 
plasmatic proteins (albumine and transcuprein) through which it reaches the liver. 
Albumine is a common transporter of spare copper atoms, since it holds high-affinity 
binding sites for Cu(II), with a total logβ of 11-13, and it is contained in the plasma in 
concentration close to 0.6 mM. Albumin can carry up to 35% of the total copper 
present in the blood. Once inside the liver, copper is used for the synthesis of 
ceruloplasmin, a blue copper oxidase implicated in the oxidation of Fe(II) to Fe(III), 
which keeps copper tightly bound and brings it to other tissues. Ceruloplasmin holds 
about 65% of the plasma copper and it is fundamental for delivering copper to 
tissues. Whereas albumin and transcuprein provide labile bonds with copper and can 
exchange it anytime in the plasma, ceruloplasmin holds it irreversibly until specific 
receptors on the cell surface bind the holo-ceruloplasmin, inducing conformational 
changes that release copper. In order to cross the cellular membrane Cu(II) must be 
reduced to Cu(I), which is achieved through cuprireductase. The specific transport 
protein that delivers copper into the cytoplasm is Ctr1. Here at least three different 
paths for copper exist1: each of them is mediated by a specific transporter, the 
chaperon, that transport the metal to specific copper proteins. Cox17 transports 
copper to the mitochondria, CCs transports copper to SOD and  Atox1 transfers 
copper to the Golgi network, where it can be involved in the synthesis of other 
cuproproteins or expelles from the cell. The latter task is fulfilled by two ATPases: 
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Atp7A, known as MNK for humans, and the other is the Atp7B, WND for humans. 
Atp7B is located only in hepatic cells and delivers copper to apo-ceruloplasmin119.  
 
 
Figure 82. Known copper chaperons for mammalian cells120.  
 
Given the huge importance that copper shows into biological systems, its quantity 
inside organisms is strictly since copper, as iron, can promote formation of ROS 
(Reactive Oxygen Species) such as •O2
-, •OH, •OOH and H2O2, through the cycling 
between Cu(I)/Cu(II). This happens through the Fenton reaction121:  
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These radical species are toxic because they generate an oxidative stress that can 
damage proteins, nucleic acids and lipids. For this reason every aerobic organism is 
supplied with proteins like SOD and ceruloplasmin that can lower the concentration 
of ROS. The homeostasis of copper inside the cell is maintained by modulating its 
expulsion through transporters Atp7A and Atp7B or by higher expression of 
metallothioneins, a family of cystein-rich proteins associated with metal 
detoxification.  
Two genetic diseases are correlated with incorrect copper homeostasis: Wilson 
disease and Menkes syndrome117. The first one comes from excessive quantities of 
the metal, due to disfunction of Atp7B (WND), which cannot export copper efficiently, 
leading to its over accumulation in the liver, brain and eyes, where it becomes 
noticeable in the irises. Consequences can be chronicle hepatitis, cirrhosis and 
neurological disturbs. On the other hand Menkes syndrome is determined by a severe 
deficiency in copper, derived from defects of the Atp7A (MNK), which lead to a poor 
absorption of the metal in the organism. A copper deficienty is correlated with a 
reduced activity of Cu-enzymes, which is fatal for brain development. Main effects are 
mental disorders and neurological degeneration.   
The altered metabolism of cancer cells and the differential response between normal 
and tumor cell to copper load may open the way to the success of copper-based 
anticancer strategies. For this reason, copper complexes are the main source of 
putative copper anticancer drugs and the organic framework of these compounds 
(the ligand, L) is of crucial importance since it can modulate the targeting and the 
properties of the metal toxicity: as an example sulphur and phosphorous donor 
ligands stabilize Cu(I), whereas nitrogen and oxygen donor ligands stabilize 
preferentially Cu(II). Additionally, L greatly influence the lipophilic/hydrophilic nature 
of the resulting complex and it can determine its solubility in extracellular fluids as 
well as the ability to permeate the bilayer lipid membrane. Copper is an essential 
cofactor for tumor growth dynamics, because it is known to be associated to 
angiogenesis. Angiogenesis is the process by which new blood vessels are generated. 
Any kind of tissue requires copper to grow, but this is especially true for tumoral 
tissues, because of their fast rate of expansion. Owing to the accelerated and 
defective metabolism of cancer cells, a state of hypoxia is typical for them. The 
construction of more blood vessels in order to keep up with oxygen demand makes 
cancer cells richer in copper than normal cells This point is a valuable weapon against 
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tumor cells, making them more sensitive to any variation in copper concentration. 
There are mainly three ways of attacking cancer cells with copper complexes that 
have been investigated:  
• formation of ROS species in situ, damaging the DNA; 
• chelation and reduction of the copper content in the cell; 
• inibition of the 20S proteasome activity. 
The first strategy is intended to bring copper complexes inside the cell that can induce 
oxidative damages to DNA, lipids or proteins of the unwanted cell. Due to the fast 
vital cycle of these cells, they can be less resistant to modifications and damages 
rather than normal cells; this weakness is already exploited by other antitumoral 
agents, one among all being cisplatin122 which is able to strongly interact with DNA 
and irreversibly alter its structure and function. 
 
 
Figure 83: Molecular structure of cis-diamminedichloroplatinum(II), known as 
Cisplatin 
 
Cytotoxicity of ROS producing complexes is usually decreased by introduction of 
antioxidants like vitamin C or E, and might be also related to an increased oxidation of 
endogeneous glutathione (GSH), leading to its deficiency in the cell. GSH is a gly-cys-
glu tripeptide that is present in millimolar quantities inside cells and determines the 
maintenance of a reducing cytosol environment123,124. As part of the intracellular 
defence against oxidative stress, the cys residue of GSH is oxidized to disulfide 
forming oxidized-GSH (GSSG) in presence of oxidizing agents. One of the mechanisms 
that scavenges hydrogen peroxide inside cells involves the enzyme glutathione 
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peroxidase125 that catalyze the reaction: 2GSH + H2O2 → GSSG + 2H2O. GSSG can be 
converted back to glutathione by the enzyme glutathione reductase that employs a 
mole of NADPH per mole of GSH produced. In addition, given the high affinity of thiol 
groups for Cu(I) and considering the high GSH concentration into the cytosol, GSH has 
also the role of an intracellular copper chaperon. 
 
 
Figure 84. Glutathione (GSH) and oxidized glutathione (GSSG) 
An interesting Cu(II) complex reported to be cytotoxic by formation of reactive oxygen 
species is 1,10-phenanthroline126 (Figure 85). It is supposed to act as an intercalating 
agent that brings the redox active metal close to the DNA, producing toxic species in 
situ127. In support of this mechanism is the fact that chelating agents that can remove 
copper from the ligand and other divalent metals that can compete with copper to 
bind 1,10-phenanthroline significantly decrease the toxicity of the complex. 
 
Figure 85. Schematic structure of 1,10-phenanthroline. 
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The second strategy is based on the sequestration of the essential element from 
cancer cells using chelating ligands with high affinity for copper. The main target is the 
decrease of the blood vessels formation which then lowers the rate of tumor growth. 
Chelating agents used for treatment of Wilson’s disease such as D-penicillamine (a) or 
tetrathiomolybdate (b), TM, have been successfully used as anticancer agents127. In 
addition, the synthesis of essential copper proteins and their mechanism of action are 
also affected by sequestering agents. The tetrathiomolydbate based ligand ATN-224 
(c) has proven to act as a SOD1 inhibitor in multiple myeloma cell line MM1S, causing 
the accumulation of H2O2 with correlated increase of oxidative stress
128 and 
eventually cellular death. 
 
 
Figure 86. Schematic structures of D-penicillamine, TM and ATN-224. 
 
The last strategy has recently provided a great number of potential antitumor agents, 
that act as inhibitors of the chymotrypsin-like activity of 20S proteasome. The 
proteasome is a multicatalytic protease responsible of the degradation of damaged or 
misfolded proteins. These proteins are first tagged by ubiquitine, which serves as a 
marker for defective proteins, and are then dismantled in (at least) three ways: with 
cleavage after basic residues (“trypsin-like” mechanism), with cleavage after acidic 
residues (“caspase-like”) or with cleavage after hydrofobic residues (“chymotrypsin-
like”). The activity of proteasome is implicated in normal cellular processes and its 
inhibition has proven to be able to induce death by apoptosis in tumoral cells, but not 
in normal cells, which are less sensitive to apoptosis-inducing stimuli21,22. A few 
ligands that have been found to inhibit proteasome leading to apoptosis when 
complexed with copper are d23 (2,4-diiodo-6-((pyridine-2-ylmethylamino)methyl)-
phenol), e24 (quinoline-2-thiosemicarbazone) and f25 (neocuproine = 2,9-dimethyl-
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1,10-phenanthroline). It was also investigated  how the oxidation number of copper 
affects proteasome inhibition; it appears that, even though both Cu(I) and Cu(II) are 
active, Cu(I) is more efficient in inhibiting the protein. Moreover, Cu(I) complex of f is 
more cytotoxic because of higher concentrations of ROS formed; the toxicity caused 
by H2O2 is reduced using radical scavengers, which do not seem though to lower 
proteasome inhibition activity and the successive cell death.  
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Figure 87. Previously reported ligands whose Cu(II) complexes can inhibit 
proteasome. 
Another important aspect that deserves particular attention concerning Cu complexes 
is their stability, that it roughly related to the strength of the Cu-L association129. In 
fact, coordination competitors such as aminoacids and proteins (albumin and 
transcuprein), largely present in the extracellular environment, can dislocate the 
ligand in complexes that are characterized by small stability. In this case the effect of 
a given CuL complex may be associated to an increase of the extracellular copper 
concentration bound to biomolecules, instead of deriving from the CuL entity. On the 
other hand, a complex characterized by a high stability will difficultly release copper in 
biological fluids (intra- and extra-cellular) and its activity will be ascribed to the 
chemical properties of the complex. 
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CHAPTER 8 
Copper complexes with N2 and N2S donor ligands: from 
caspase inhibition to paraptotic cell death in human 
cancer cells 
 
 
In this chapter we present a structure-activity relationship study130 of new classes of 
pyrazole-pyridine copper complexes that establishes a clear correlation between the 
ability to promote copper accumulation and cytotoxicity. Intracellular metal 
accumulation is maximized when ligand lipophilicity allows the complex to rapidly 
cross the membrane. Copper and ligand follow different uptake kinetics and reach 
different intracellular equilibrium concentrations. These results support a model in 
which the ligand acts as an ionophore for the metal ion, cycling between intra- and 
extracellular compartments as dissociated or complexed entities. When treating 
cancer cells with structurally unrelated disulfiram and pyrazole-pyridine copper 
complexes, as well as with inorganic copper, the same morphological and molecular 
changes were reproduced, indicating that copper overload is responsible for the 
cytotoxic effects. Copper-based treatments drive sensitive cancer cells toward 
paraptotic cell death, a process hallmarked by endoplasmic reticulum stress and 
massive vacuolization in the absence of apoptotic features. 
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8.1 Introduction 
Metal complexes have been investigated in recent decades as potential anticancer 
compounds, largely due to the success of cisplatin. This compound, one of the most 
widely employed chemotherapeutic agents, has had a major impact on the treatment 
of several tumor types, especially for testicular and ovarian cancers.131 The efforts of 
synthetic chemistry to provide novel anticancer agents have focused on low-toxicity 
platinum-based and non-platinum-based drugs with alternative mechanisms of 
action. Regarding the latter, ruthenium,132 gold,133 and titanium have been 
investigated as candidates for the production of anticancer compounds. In all of these 
cases, ligands that are able to modulate metal ion reactivity and toxicity may 
contribute to a successful outcome. Copper is a fundamental component of 
metalloproteins because it exerts both catalytic and structural functions, and its 
distribution is strictly regulated at the levels of the cell, organ and body.134–136 In 
particular, copper is crucial to the angiogenic process that sustains tumor and 
metastasis development, and its sequestration underlies an anticancer strategy aimed 
at preventing establishment of the tumor blood supply.137 Alternatively, copper 
complexes have shown anticancer activity, whereby the organic component (the 
ligand) is responsible for directing the metal to different molecular targets.138  
Although the majority of anticancer compounds trigger apoptosis, other types of 
programmed cell death (PCD) occur in response to common treatment regimens.139,140 
Among the various types of PCD, paraptosis, characterized by the occurrence of large 
cytoplasmic vacuoles derived from the endoplasmic reticulum (ER),141 was observed in 
cancer cells treated with different copper complexes.142,143 To understand the 
structural basis of these effects, we prepared and screened a series of pyrazole-
pyridine and bis-pyrazole copper complexes for cytotoxicity. The effects of the most 
active compound were compared with those of inorganic copper and disulfiram, a 
copper-interacting drug with promising anticancer properties.144 The results showed 
that a) the copper complexes induce paraptosis as a function of their ability to cause 
intracellular copper accumulation, b) the metal itself is sufficient to produce 
paraptotic features in cancer cells (provided that high doses are used). 
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8.2. Experimental 
 
8.2.1. Synthesis of ligands (L36-L55) and copper complexes (36-55).  
 
General Procedures. All reagents and solvents were commercially available, except 
for 3,5-dimethylpyrazole, 3,5-diisopropylpyrazole, 3,5-ditertbutylpyrazole, 2-
(phenylthio)benzaldehyde145, 2-(phenylthio)acetaldehyde146, bis(pyrazolyl)ketone, 
bis(3,5-dimethylpyrazolyl)ketone, bis(3,5-diisopropylpyrazolyl)ketone44–46, which were 
prepared as reported elsewhere. The synthesis of the ligands L36 L41, L45147,148, L46, 
and L47149 was performed as previously reported. The synthesis of L50-L54 are 
reported in chapter 2, 3 and 4 respectively. Tetrahydrofuran (THF) were distilled over 
Na/benzophenone. The syntheses of the L36-L55 ligands were performed in inert gas 
(N2) using Schlenk techniques. 1H and 13C NMR spectra were recorded on a Bruker 
Avance 300 spectrometer using standard Bruker pulse sequences. Chemical shifts are 
reported in parts per million (ppm) referenced to residual solvent protons. Infrared 
spectra were recorded from 4000 to 700 cm-1 on a Perkin-Elmer FTIR Nexus 
spectrometer equipped with a Smart Orbit HATR accessory (diamond crystal). 
Elemental analyses (C, H, and N) were performed with a Carlo Erba EA 1108 
automated analyzer. 
 
Synthesis of 2-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-methoxy-3,5-dimethylpyridine 
(L37). 2-Chloromethyl-4-methoxy-3,5-dimethylpyridine hydrochloride (9.20 g, 41.42 
mmol) and 3,5-dimethylpyrazole (3.98 g, 41.42 mmol) were mixed in toluene (100 
ml). After adding NaOH (40% in water, 40 ml) and 30 drops of n-tetrabutylammonium 
hydroxide (40% in water) the mixture was refluxed 4 h with stirring. The organic 
phase was separated from the aqueous one, washed with water (20 ml), dried with 
anhydrous Na2SO4 and filtered. The solvent was removed under vacuum and a white 
powder was collected (yield 9.90 g, 85%). IR (cm-1) : 2999w, 2954w, 2918w, 2225w br, 
2048w br, 2031w br, 1590w, 1551m, 1473m, 1395m, 1382m, 1345m, 1318w, 1290m, 
1264m, 1238m, 1216m, 1186w, 1129w, 1066s, 1027m, 993s, 904m, 867w, 820m, 
771s , 722m, 663w, 637w, 623w, 580w, 516w, 502w, 467w. 1H NMR (300 MHz, CDCl3): 
δ, 2.19 (s, 3H, CH3), 2.21 (s, 3H, CH3), 2.23 (s, 3H, CH3), 2.24 (s, 3H, CH3), 3.75 (s, 3H, 
OCH3), 5.32 (s, 2H, CH2), 5.81 (s, 1H, CH Pz), 8.18 (s, 1H, CH Py). Anal. Calc. for 
C14H19N3O (245.32): C, 68.54; H, 7.81; N, 17.13. Found: C, 68.31; H, 7.76; N, 16.99%.  
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 Synthesis of 2-[(3,5-Diisopropyl-1H-pyrazol-1-yl)methyl]-4-methoxy-3,5-
dimethylpyridine (L38). 2-Chloromethyl-4-methoxy-3,5-dimethylpyridine 
hydrochloride (5.83 g, 26.27 mmol) and 3,5-diisopropylpyrazole (4.00 g, 26.27 mmol) 
were mixed in toluene (100 ml). The procedure is analogous to that reported for L37, 
giving a yellow oil (yield 7.11 g, 89%). IR (cm-1): 2960m, 2869m, 2158w br, 1588m, 
1566m, 1542m, 1470m, 1381m, 1369m, 1362m, 1347m, 1290m, 1255m, 1223m, 
1179m, 1093s, 1031m, 1000s, 978m, 911w, 867w, 808w, 784s , 720w, 683w, 646w, 
618w, 561w, 522w, 450w.1H NMR (300 MHz, CDCl3): δ, 1.10 (d, 6H, CH3 i-Pr), 1.27 (d, 
6H, CH3 i-Pr), 2.22 (s, 3H, CH3 Py), 2.28 (s, 3H, CH3 Py), 2.93 (m, 2H, CH i-Pr), 3.69 (s, 3H, 
OCH3), 5.38 (s, 2H, CH2), 5.85 (s, 1H, CH Pz), 8.15 (s, 1H, CH Py). Anal. Calc. for 
C18H27N3O (301.43): C, 71.72; H, 9.03; N, 14.94. Found: C, 71.55; H, 8.89; N, 14.67%. 
Synthesis of 2-[(3,5-Di-tert-butyl-1H-pyrazol-1-yl)methyl]-4-methoxy-3,5-
dimethylpyridine (L39). 2-Chloromethyl-4-methoxy-3,5-dimethylpyridine 
hydrochloride (2.51 g, 11.30 mmol) and 3,5-ditertbutylpyrazole (2.04 g, 11.32 mmol) 
were mixed in toluene (50 ml). The procedure is analogous to that reported for L37, 
but the crude product was purified by silica column chromatography (hexane/ethyl 
acetate 80:20, r.f. 0.25; yield 2.29 g, 62%). IR (cm-1): 2964m, 2898m, 2865m, 1567m, 
1539m, 1457m, 1391m, 1249m, 1227m, 1180s, 1008s, 957m, 909w, 789s, 717m. 1H 
NMR (300 MHz, CDCl3): δ, 1.23 (s, 9H, CH3 t-Bu), 1.31 (s, 9H, , CH3 t-Bu), 2.09 (s, 3H, 
CH3 Py), 2.25 (s, 3H, , CH3 Py), 3.75 (s, 3H, , OCH3), 5.53 (s, 2H, CH2), 5.90 (s, 1H, CH Pz), 
8.18 (s, 1H, CH Py). Anal. Calc. for C20H31N3O (329.48): C, 72.90; H, 9.48; N, 12.75. 
Found: C, 72.86; H, 9.25; N, 12.35%. 
Synthesis of 2-[(3,5-Diphenyl-1H-pyrazol-1-yl)methyl]-4-methoxy-3,5-dimethylpyridine 
(L40). 2-Chloromethyl-4-methoxy-3,5-dimethylpyridine hydrochloride (3.60 g, 16.21 
mmol) and 3,5-diphenylpyrazole (3.57 g, 16.20 mmol) were mixed in toluene (50 ml). 
The procedure is analogous to that reported for L37, and a white powder was 
obtained (yield 2.70 g, 42%). IR (cm-1): 3043w, 2956w, 2162w br, 2052w br, 1892w br, 
1605w, 1567w, 1546w, 1486m, 1476m, 1463w, 1440m, 1395m, 1369w, 1349w, 
1290m, 1261m, 1237m, 1218w, 1193w, 1147w, 1090m, 1028w, 1000m, 957m, 919w, 
907w, 863w, 823w, 792w, 776m, 766m, 749m, 694s, 670m, 647w, 578m, 547m, 
529w, 517w, 502w, 471w, 432w. 1H NMR (300 MHz, CDCl3): δ, 2.14 (s, 3H, CH3 Py), 
2.17 (s, 3H, CH3 Py), 3.76 (s, 3H, OCH3), 5.45 (s, 2H, CH2), 6.65 (s, 1H, CH Pz), 7.16-
7.83(m, 10H, CH Ph), 8.17 (s, 1H, CH Py). Anal. Calc. for C24H23N3O (369.46): C, 78.02; 
H, 6.27; N, 11.37. Found: C, 77.97; H, 6.05; N, 11.21%. 
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Synthesis of 4-methoxy-3,5dimethyl-2-[2-(methylthio)-1-(1H-pyrazol-1-
yl)ethyl]pyridine (L42). A solution of 2-(pyrazolylmethyl)-4-methoxy-3,5-
dimethylpyridine (0.97 g, 4.46 mmol) in THF (50 ml) was cooled to -78 °C, and then n-
BuLi (3.2 ml, 1.6 M in hexane, 5.12 mmol) was slowly added. After stirring the red 
solution at -78 °C for 45 min, chloromethyl methyl sulfide (0.44 ml, d = 1.17 g/ml, 5.33 
mmol) was added. The solution was allowed to warm to room temperature and 
stirred overnight. The clear yellow solution was then dried under vacuum and the 
residual solid was treated with diethyl ether/water (40 ml/15 ml). The organic phase 
was separated and washed with brine and dried with anhydrous Na2SO4. The solvent 
was removed under vacuum, giving a yellow oil that was purified by silica column 
chromatography (hexane:ethyl acetate 70:30; r.f. 0.2), affording a colourless oil (yield 
0.54 g, 30%) IR (cm-1): 2917w, 1992w br, 1566m, 1509w, 1472m, 1393m, 1290m, 
1261m, 1224m, 1082m, 1026m, 999m, 961m, 917w, 880w, 849w, 822w, 748s, 655w, 
621m, 597w, 532w, 439w, 412w.1H NMR (300 MHz, CDCl3): δ, 2.06 (s, 3H, CH3), 2.31 
(s, 3H, CH3), 2.37 (s, 3H, SCH3), 3.46 (dd, J1 =6.9 Hz, J2 =6.9 Hz, 1H, CH2), 3.54 (dd, J1 
=7.8 Hz, J2 =5.6 Hz , 1H, CH2), 3.70 (s, 3H, OCH3), 5.85 (t, J = 7.5 Hz, 1H, CHcentral), 6.20 
(t, J = 2.1 Hz, 1H, CH Pz), 7.46 (d, J = 1.5 Hz, 1H, CH Pz), 7.51 (d, J = 2.1 Hz, 1H, CH Pz), 
8.27 (s, 1H, CH Py). Anal. Calc. for C14H19N3SO (277.39): C, 60.62; H, 6.90; N, 15.15. 
Found: C, 60.56; H, 6.79; N, 15.01%. 
Synthesis of 2-[1-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)ethyl]-4methoxy-(3,5-
dimethyl)pyridine (L43). The same procedure used to prepare L42 was applied by 
using 2-(3,5-dimethylpyrazolymethyl)-4-methoxy-3,5-dimethylpyridine (2.79 g, 9.89 
mmol), n-BuLi (7.30 ml, 1.6 M in hexane, 11.68 mmol) and chloromethyl methyl 
sulfide (0.96 ml, d = 1.17 g/ml, 11.63 mmol). After purification by silica column 
chromatography (hexane: ethyl acetate 50:50, r.f. 0.48) a colourless oil was obtained 
(yield 1.41 g, 41%) . IR (cm-1): 2922m, 2287w, 2198w, 2185w, 2161w, 2138w, 2051w, 
1980w, 1861w, 1587m, 1565m, 1548m, 1478m, 1457m, 1422m, 1394m, 1372m, 
1331m, 1303m, 1267m, 1254m, 1241m, 1205m, 1147w, 1110w, 1087m, 1038m, 
1018m, 995s, 934m, 899m, 885m, 821s, 785s, 751m, 713w, 698m, 666w, 643w, 
613m, 601m, 592m, 540m, 512m, 502m, 424m. 1H NMR (300 MHz, CDCl3): δ, 2.13 (s, 
3H, CH3), 2.15 (s, 3H, CH3 ), 2.20 (s, 6H, 2CH3), 2.28 (s, 3H, SCH3), 3.45 (dd, J1 = 7.5 Hz, 
J2 = 6.6 Hz, 1H, CH2), 3.65 (dd, J1 = 7.5 Hz J2 = 6.6 Hz, 1H, CH2), 3.76 (s, 3H, OCH3), 5.72 
(t,  1H, CHcentral), 5.78 (s, 1H, CH Pz), 8.33 (s, 1H, CH Py). Anal. Calc. for C16H23N3SO 
(305.44): C, 62.92; H, 5.24; N, 13.75. Found: C, 62.76; H, 5.08; N, 13.36%. 
Synthesis of 2-[1-(3,5-diisopropyl-1H-pyrazol-1-yl)-2-(methylthio)ethyl]-4methoxy-(3,5-
dimethyl)pyridine (L44). The same procedure used to prepare L42 was applied by 
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using 2-(3,5-diisopropylpyrazolylmethyl)-4-methoxy-3,5-dimethylpyridine (8.40 g, 
27.87 mmol), n-BuLi (20 ml, 1.6 M in hexane, 32.00 mmol) and chloromethyl methyl 
sulfide (2.8 ml, d = 1.17 g/ml, 33.92 mmol). After purification by silica column 
chromatography (hexane: ethyl acetate 50:50) a yellow oil was obtained (yield 5.55 g, 
55%). IR (cm-1): 2961m, 2925m, 2867m, 2166w, 2050w, 2036w, 1983w, 1585m, 
1563m, 1542m, 1470m, 1393m, 1380m, 1361m, 1289m, 1262m, 1244m, 1177m, 
1078m, 1025m, 997s, 908m, 880m, 822m, 786m, 759m, 720m, 625m, 598m, 549m, 
501m, 431m. 1H NMR (300 MHz, CDCl3): δ, 0.88 (d, J =6.75 Hz, 3H, CH3 i-Pr), 1.09 (d, J 
=6.75 Hz, 3H, CH3 i-Pr), 1.20 (dd, J1 = 2.5 Hz, J2 = 4.3 Hz, 6H, CH3 i-Pr), 1.99 (s, 3H, CH3 
Py), 2.07 (s, 3H, CH3 Py), 2.24 (s, 3H, SCH3), 2.95 (m, J= 4.9 Hz, 2H, CH i-Pr), 3.35 (dd, J1 
=7.08 Hz, J2= 6.5 Hz, 1H, CH2), 3.66 (m, 1H, CH2overlapped by OCH3), 3.67 (s, 3H, 
OCH3), 5.72 (t, J = 7.26 Hz, 1H, CHcentral), 5.83 (s, 1H, CH Pz), 8.27 (s, 1H, CH Py). Anal. 
Calc. for C20H31N3SO (361.54): C, 66.44; H, 8.64; N, 11.62. Found: C, 66.13; H, 8.49; N, 
11.36%. 
Synthesis of bis(3,5-diisopropyl-1H-pyrazol-1-yl)methane (L48). A mixture of 3,5-
diisopropylpyrazole (0.51 g, 3.35 mmol), NBu4HSO4 (0.05 g, 0.13 mmol), NaOH (50% in 
water, 4 ml) and dichloromethane (10 ml) was refluxed overnight. The organic phase 
was separated from the aqueous one, which was washed with diethyl ether (20 ml). 
The organic phases were mixed together, dried with anhydrous Na2SO4 and filtered. 
The solvent was removed under vacuum and a yellow oil was obtained (yield 0.39 g, 
37%). IR (cm-1): 3227m, 2964m, 2931m, 2871w, 2158w, 1561m, 1457m, 1419w, 
1380m, 1353m, 1315w, 1260m, 1221m, 1156m, 1139m, 1035w, 1008m, 947m, 882w, 
849m, 800s, 772m, 728m, 668m, 624m, 591w, 531w, 456m. 1H NMR (300 MHz, 
CDCl3): δ, 1.12 (d, J = 6.9 Hz, 12 H, CH3 i-Pr), 1,20 (d, J = 6.9 Hz, 12 H, CH3 i-Pr), 2.91 (m, 
J = 6.9 Hz, 2H, CH i-Pr)), 3.42 (m, J = 6.9 Hz, 2H, CH i-Pr)), 5.86 (s, 2H, CH Pz), 6.26 (s, 
2H, CH2). Anal. Calc. for C19H32N4 (316.48): C, 72.11; H, 10.19; N, 17.70. Found: C, 
72.03; H, 10.07; N, 17.38%. 
Synthesis of bis(3,5-di-tert-butyl-1H-pyrazol-1-yl)methane (L49) The same procedure 
used to prepare L48 was applied by using 3,5-ditertbutylpyrazole (2.00 g, 11.11 
mmol), NBu4HSO4 (0.18 g, 0.50 mmol), NaOH (50% in water, 4 ml) and 
dichloromethane (20 ml). A colourless oil was obtained (yield 2.38 g, 58%). IR (cm-1): 
2962m, 2924m, 2866m, 2051w, 1997w, 1542m, 1461m, 1397w, 1361w, 1371s, 
1257m, 1228s, 1205m, 1134w, 1085w, 1067w, 1022w, 999m, 967m, 930w, 842w, 
800s, 773m, 727m, 686m, 624w, 611w, 551w, 501w, 450w. 1H NMR (300 MHz, CDCl3): 
δ, 1.21 (s, 18 H, CH3 t-Bu), 1.25 (s, 18 H, CH3 t-Bu), 5.91 (s, 2H, CH2), 6.52  (s, 2H, CH 
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Pz). Anal. Calc. for C23H40N4 (372.59): C, 74.14; H, 10.82; N, 15.04. Found: C, 73.99; H, 
10.67; N, 14.88%. 
Synthesis of 1,1'-(2-(phenylthio)ethane-1,1-diyl)bis(3,5-diisopropyl-1H-pyrazole)(L55). 
A mixture of bis(3,5-diisopropylpyrazolyl)ketone (0.77 g, 2.34 mmol), 2-
(phenylthio)acetaldehyde (0.36 g, 2.34 mmol)and CoCl2
.6H2O (5 mg) was heated at 
80°C for an hour with stirring. The mixture was then cooled at room temperature and 
stirred overnight. Dichloromethane (30 ml) was added and the mixture was stirred for 
30 minutes. The organic phase was washed with water (50 ml) and brine (20 ml), 
dried with anhydrous Na2SO4 and filtered. The solution was concentrated under 
vacuum and a yellow powder was precipitated with hexane, which was filtered and 
vacuum dried. The solvent was removed under vacuum and the crude was purified by 
silica column chromatography (hexane: ethyl acetate 95:5, r.f. 0.22) and a dark green 
oil was obtained (yield 0.30 g, 29%). IR (cm-1): 2972m, 2932m, 2868w, 1665w, 1546m, 
1473m, 1459w, 1331w, 1315m, 1260w, 1178w, 1064m, 1016m, 931w, 808s, 750m, 
701m, 652w, 557w. 1H NMR (300 MHz, CDCl3), : δ,  0.86 ( d, J = 6.9 Hz, 12 H, CH3 i-Pr), 
1.26 (d, 12 H, CH3 i-Pr), 2.91 (m, J = 6.9 Hz, CH i-Pr), 3.21 (m, 2H, CH i-Pr), 4.09 (d, J = 
7.2 Hz, 2H, CH2) 5.84 (s, 2H, CH Pz), 6.59 ( t, J = 7.2 Hz, 1H, CHcentral), 7.16-7.24 (m, 3H, 
CH Ph), 7.36 (d, 2H, CH Ph). Anal. Calc. for C26H38N4S (438.67): C, 71.19; H, 8.73; N, 
12.77. Found: C, 70.99; H, 8.66; N, 12.39%. 
Synthesis of [CuCl2(L36)]2 (36). A pale green solution of CuCl2 
.2H2O (139 mg, 0.82 
mmol) in 3 ml of methanol was added to a colourless solution of L36 (206 mg, 0.82 
mmol) in 3 ml of methanol. A green precipitate immediately formed, which was 
filtered, washed with methanol and vacuum dried (yield 140 mg, 44%).  IR (cm-1): 
3139w, 3128w, 3095w, 3024w, 2964w, 2962w, 1600w, 1572m, 1517w, 1470m, 
1428m, 1402s, 1277m, 1257s, 1161w, 1087s, 1072s, 993s, 881w, 757s, 646w, 606w. 
Anal. Calc. for C12H15N3OCuCl2 (335.72): C, 42.93; H, 4.50; N, 12.52. Found: C, 42.46; H, 
4.28; N, 12.48%.  
Synthesis of [CuCl2(L37)]2 (37). A pale green solution of CuCl2 
.2H2O (123 mg, 0.70 
mmol) in 3 ml of methanol was added to a colourless solution of L37 (204 mg, 0.71 
mmol) in 3 ml of methanol yielding a dark green solution. The solvent was then 
concentrated under vacuum and a bright green solid was precipitated after addition 
of diethyl ether. The precipitate was filtered and vacuum dried (yield 125 mg, 42%). IR 
(cm-1): 3123w, 3083w, 3016w, 2919w br, 2219w br, 2010w br, 1593m, 1574m, 
1554m, 1470m, 1437m, 1419m, 1397m, 1351m, 1291m, 1258s, 1207w, 1161w, 
1135w, 1091m, 1058m, 1033m, 999m, 939w, 880m, 835m, 815m, 789m, 767m, 
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717m, 645m, 569m, 530w, 476w.  Anal. Calc. for C28H38Cl4Cu2N6O2 (759.54): C, 44.28; 
H, 5.04; N, 11.06. Found: C, 44.06; H, 4.88; N, 10.97%.  
Synthesis of [CuCl2(L38)]2 (38). A pale green solution of CuCl2 
.2H2O (115 mg, 0.67 
mmol) in 3 ml of methanol was added to a colourless solution of L38 (200 mg, 0.66 
mmol) in 3 ml of methanol yielding a dark green solution. The solvent was then 
concentrated under vacuum and a green solid was precipitated after addition of 
diethyl ether. The solid was filtered and vacuum dried (yield 192 mg, 66%). IR (cm-1): 
3424m, 2964m, 2931w, 2860w, 1600w, 1545w, 1474m, 1435w, 1369w, 1282s, 1260s, 
1079s, 1030s, 980s, 876w, 810m, 778m, 728w. . Anal. Calc. for C38H58Cl8Cu2N6O2 
(1041.62): C, 42.82; H, 5.61; N, 8.06. Found: C, 42.68; H, 5.58; N, 7.89%.  
Synthesis of [CuCl2(L39)] (39). A pale green solution of CuCl2 
.2H2O (84 mg, 0.49 mmol) 
in 3 ml of methanol was added to a colourless solution of L39 (161 mg, 0.49 mmol) in 
3 ml of methanol. A green precipitate immediately formed which was filtered, washed 
with methanol and vacuum dried (yield 148 mg, 52%). IR (cm-1): 2966m, 2172w br, 
2036w br, 1589m, 1536m, 1464m, 1428m, 1395m, 1371m, 1290m, 1258s, 1227m, 
1134w, 1081s, 1030m, 986m, 975m, 929w, 883w, 810m, 802m, 771m, 727w, 697w, 
618w, 520w, 460w. . Anal. Calc. for C40H62Cl4Cu2N6O2 (927.86): C, 51.78; H, 6.74; N, 
9.06. Found: C, 51.57; H, 6.39; N, 9.01%.  
Synthesis of [CuCl2(L40)] (40). A pale green solution of CuCl2 
.2H2O (73 mg, 0.43 mmol) 
in 3 ml of methanol was added to a colourless solution of L40 (170 mg, 0.43 mmol) in 
3 ml of methanol giving a dark green solution. The solvent was then concentrated 
under vacuum and a green solid was precipitated after addition of hexane. The solid 
was filtered and vacuum dried (yield 70 mg, 31%). IR (cm-1): 3735w br, 2969w, 1735m, 
1596m, 1576m, 1553m, 1463m, 1397m, 1378m, 1259m, 1217m, 1156m, 1085m, 
1031m, 1014m, 981m, 920m, 879m, 825m, 758m, 697m, 583m, 566m, 526m, 430m, 
419m. . Anal. Calc. for C24H23Cl2CuN3O (503.91): C, 57.20; H, 4.60; N, 12.61. Found: C, 
57.01; H, 4.28; N, 12.30%.  
Synthesis of [CuCl2(L41)] (41). A pale green solution of CuCl2 
.2H2O (50 mg, 0.29 mmol) 
in 3 ml of methanol was added to a yellow solution of L41 (92 mg, 0.27 mmol) in 3 ml 
of methanol yielding a dark brown solution. The solvent was then concentrated under 
vacuum and a green solid precipitated. The precipitate was filtered, washed with 
methanol and vacuum dried (yield 76 mg, 60%). IR (cm-1): 3074w, 3008w, 2918w, 
2167w br, 2020w br, 1598w, 1501w, 1478w, 1433m, 1359m, 1320w, 1294w, 1263m, 
1228m, 1092m, 1070m, 975m, 956w, 904w, 887w, 791m, 765s, 690w, 573w. Anal. 
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Calc. for C19H21Cl2CuN3OS (473.91): C, 48.15; H, 4.46; N, 8.87. Found: C, 48.03; H, 4.22; 
N, 8.55%.  
Synthesis of [CuCl2(L42)]2 (42). A pale green solution of CuCl2 
.2H2O (125 mg, 0.73 
mmol) in 5 ml of methanol was added to a colourless solution of L42 (202 mg, 0.73 
mmol) in 5 ml of methanol yielding a green precipitate, which was filtered, washed 
with methanol and vacuum dried (240 mg, 80%). IR (cm-1): 3100m, 2901w, 2361w, 
2341w, 1595w, 1569w, 1507w, 1477m, 1426m, 1409m, 1376m, 1333w, 1298m, 
1267m, 1203m, 1164m , 1082m, 1070s, 1038m, 1018m, 995s, 920m, 903m, 883m, 
829m, 774s, 755m, 729m, 709m, 681w, 658w, 614m, 532m, 470m. Anal. Calc. for 
C28H38Cl4Cu2N6O2S (791.61): C, 42.48; H, 4.84; N, 10.62. Found: C, 42.25; H, 4.69; N, 
10.35%.  
Synthesis of [CuCl2(L43)]2 (43). A pale green solution of CuCl2 
.2H2O (80 g, 0.47 mmol) 
in 5 ml of methanol was added to a colourless solution of L43 (160 mg, 0.47 mmol) in 
5 ml of methanol yielding a green solution. The solvent was then concentrated under 
vacuum and a green solid was precipitated after addition of diethyl ether, which was 
filtered and vacuum dried (yield 130 mg, 58%). IR (cm-1): 2922m, 2185w, 2161w, 
2051w, 1980w, 1587m, 1565m, 1548m, 1478m, 1457m, 1422m, 1394m, 1372m, 
1331m, 1303m, 1267m, 1084m, 1058m, 1032m, 1015m, 996s, 834m, 814m, 796m, 
752m, 530m. Anal. Calc. for C33H50Cl4Cu2N6O3S2 (911.82): C, 43.47; H, 5.53; N, 9.21. 
Found: C, 43.28; H, 5.36.; N, 9.10%.  
Synthesis of [CuCl2(L44)]2 (44). A pale green solution of CuCl2 
.2H2O (137 mg, 0.80 
mmol) in 5 ml of methanol was added to a yellow solution of L44 (292 mg, 0.81mmol) 
in 5 ml of methanol yielding a bright green solution. A green solid precipitated after 
10 min, which was filtered, washed with methanol and vacuum dried (200 mg, 50%). 
IR (cm-1): 2967m, 2927m, 2868m , 2324w, 2168w, 2051w, 1981w, 1592m, 1546m, 
1473m, 1443m, 1409m, 1379m, 1367m, 1358m, 1344m, 1332m, 1304m, 1260s, 
1182m, 1081m, 1058m, 1039m, 101m, 995s, 928m, 911m, 892m, 834m, 806m, 789m 
, 760m, 723m, 699w, 663w, 607m, 563w, 536m, 438w. Anal. Calc. for 
C40H62Cl4Cu2N6O2S2 (991.99): C, 48.43; H, 6.30; N, 8.47. Found: C, 48.22; H, 6.16; N, 
8.38%.  
Synthesis of [CuCl2(L45)] (45). A pale green solution of CuCl2 
.2H2O (91 mg, 0.53 mmol) 
in 3 ml of methanol was added to a colourless solution of L45 (201 mg, 0.50 mmol) in 
3 ml of methanol yielding a dark green solution. The solvent was then concentrated 
under vacuum and a green solid precipitated. The solid was filtered, washed with 
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methanol and vacuum dried (208 mg, 78%). IR (cm-1): 3083w, 2997w, 2924w, 2026w 
br, 1596w, 1573w, 1499w, 1474m, 1431m, 1366w, 1352m, 1299w, 1265m, 1234m, 
1220m, 1134w, 1116w, 1084m, 1016m, 986m, 952m, 909w, 971w, 828m, 801w, 
786w, 774s, 758m, 745m, 730w, 689w, 664w, 648w, 621w, 463m, 432m.  Anal. Calc. 
for C21H25Cl2CuN3OS2 (534.02): C, 47.23; H, 4.71; N, 7.87. Found: C, 47.14; H, 4.56; N, 
7.51%.  
Synthesis of [Cu(L46)2][CuCl4] (46). A pale green solution of CuCl2 
.2H2O (187 mg, 1.1 
mmol) in 5 ml of methanol was added to a colourless solution of L46 (163 mg, 1.1 
mmol) in 5 ml of methanol yielding a green precipitate, which was filtered, washed 
with methanol and vacuum dried (160 mg, 51%). IR (cm-1): 3350m, 3145w, 3106w, 
2997w, 2953w, 2860w, 2158w, 1638w, 1463w, 1403m, 1279m, 1205w, 1059m, 989m, 
785m, 761s, 729m, 644m, 499m. Anal. Calc. for C14H16Cl4Cu2N8 (565.23): C, 29.75; H, 
2.85; N, 19.82. Found: C, 29.38; H, 2.72; N, 19.44%.  
Synthesis of [CuCl2(L47)] (47). A pale green solution of CuCl2 
.2H2O (137 mg, 0.80 
mmol) in 5 ml of methanol was added to a colourless solution of L47 (163 g, 0.80 
mmol) in 5 ml of methanol yielding a green precipitate, which was filtered, washed 
with methanol and vacuum dried (203 mg, 75%). IR (cm-1): 3473w br, 3145w, 3123w, 
2960w, 2860w, 2043w, 1556m, 1464m, 1418m, 1384m, 1276s, 1150w, 1041m, 
1004w, 830m, 704w, 678m, 660w, 626w, 597w, 491w, 474w, 420w. Anal. Calc. for 
C22H38Cl2CuN8O3 (597.04): C, 44.26; H, 4.41; N, 18.77. Found: C, 44.03; H, 4.28; N, 
18.56%.  
Synthesis of [CuCl2(L48)] (48). A pale green solution of CuCl2 
.2H2O (172 mg, 1.00 
mmol) in 5 ml of methanol was added to a colourless solution of L48 (316 mg, 1.00 
mmol) in 5 ml of methanol yielding a green solution. The solvent was then 
concentrated under vacuum and a green solid was precipitated after addition of 
diethyl ether, which was filtered and vacuum dried (300 mg, 67%). IR (cm-1): 3134w, 
1964m, 2931m, 2871w, 2361w, 1550m, 1460m, 1430m, 1380m, 1336w, 1309w, 
1276s, 1216w, 1183m, 1161w, 1112w, 1068m, 1019m, 980m, 926w, 876w, 816m, 
717m, 646m, 542m. Anal. Calc. for C19H32Cl2CuN4 (450.93): C, 50.61; H, 7.15; N, 12.42. 
Found: C, 50.44; H, 7.03; N, 12.11%.  
Synthesis of [CuCl2(L49)] (49). A pale green solution of CuCl2 
.2H2O (75 mg, 0.44 mmol) 
in 5 ml of methanol was added to a brown solution of L49 (163 mg, 0.44 mmol) in 5 
ml of toluene yielding a dark yellow precipitate, which was filtered, washed with 
toluene and vacuum dried (189 mg, 84%). IR (cm-1): 3444w br, 3127w, 2962w, 2362w, 
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2163w, 2051w, 1982w, 1617w, 1557m, 1463m, 1438m, 1486m, 1366m, 1281s, 1276s, 
1161w, 1041m, 1006w, 830m, 704w, 679m, 660w, 626w, 473m. Anal. Calc. for 
C23H40Cl2CuN4 (507.04): C, 54.48; H, 7.95; N, 11.05. Found: C, 54.37; H, 7.21; N, 7.08%.  
Synthesis of [CuCl2(L50)]2 (50). A pale green solution of CuCl2 
.2H2O (86 mg, 0.50 
mmol) in 5 ml of methanol was added to a colourless solution of L50 (162 mg, 0.49 
mmol) in 5 ml of methanol yielding a green precipitate, which was filtered, washed 
with methanol and vacuum dried (130 mg, 57%). IR (cm-1): 3128w, 3106w, 3057w, 
1511w, 1468m, 1456m, 1443m, 1421m, 1409s, 1290m, 1256m, 1210w, 1134w, 1062s, 
992w, 915w, 849w, 830w, 781s, 744s, 716s, 693s, 621s, 597m, 531m. Anal. Calc. for 
C38H32Cl4Cu2N8S2 (933.74): C, 48.87; H, 3.45; N, 12.00. Found: C, 48.62; H, 3.16; N, 
11.85%.  
Synthesis of [Cu2Cl3(L51)2]Cl (51). A pale green solution of CuCl2 
.2H2O (64 mg, 0.37 
mmol) in 5 ml of methanol was added to a colourless solution of L51 (145 mg, 0.37 
mmol) in 5 ml of methanol yielding a green solution. The solvent was then 
concentrated under vacuum and a green solid was precipitated after addition of 
hexane, which was filtered and vacuum dried (100 mg, 51%). IR (cm-1): 3254w, 3134w, 
3052w, 2986w, 2920w, 1682w, 1560m, 1462m, 1457m, 1438m, 1415m, 1402m, 
1377m, 1312m, 1255m, 1039m, 1024m, 793m, 739s, 690s, 616m, 531w, 421w. Anal. 
Calc. for C46H50.50Cl4Cu2N8O1.25S2 (1068.48): C, 51.71; H, 4.76; N, 10.49. Found: C, 51.36; 
H, 4.55; N, 10.37%.  
Synthesis of [CuCl2(L52)] (52). A pale green solution of CuCl2 
.2H2O (65 mg, 0.38 mmol) 
in 5 ml of methanol was added to a colourless solution of L52 (190 mg, 0.38 mmol) in 
5 ml of methanol yielding a green precipitate, which was filtered, washed with 
methanol and vacuum dried (160 mg, 66%). IR (cm-1): 3050w, 2968m, 2929w, 2868 w, 
1961w, 1735w, 1579w, 1547m, 1467m, 1437m, 1401w, 1381m, 1361m, 1344w, 
1319m, 1305m, 1291m, 1275m, 1246m, 1225m, 1185m, 1111w, 1079m, 1057m, 
1020m, 966w, 929w, 911w, 895w, 881w, 854m, 824m, 807m, 800m, 757m, 737s, 
727m, 716m, 701m, 689m, 670m, 625m, 547w, 487w, 468w, 454w. Anal. Calc. for 
C31H46Cl2CuN4S (641.24): C, 58.06; H, 7.23; N, 8.74. Found: C, 57.96; H, 7.11; N, 8.58%.  
Synthesis of [CuCl2(L53)] (53). A pale green solution of CuCl2 
.2H2O (66 mg, 0.39 mmol) 
in 5 ml of methanol was added to a colourless solution of L53 (105 mg, 0.39 mmol) in 
5 ml of methanol yielding a green precipitate, which was filtered, washed with 
methanol and vacuum dried (114 mg, 72%). IR (cm-1): 3120w, 2969w, 1512w, 1406m, 
1285m, 1662m, 987w, 901w, 750s, 734s, 101w, 689m, 611s, 476w. Anal. Calc. for 
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C14H14Cl2CuN4S (404.80): C, 41.54; H, 3.49; N, 13.84. Found: C, 41.38; H, 3.37; N, 
13.71%.  
Synthesis of [CuCl2(L54)] (54). A pale green solution of CuCl2 
.2H2O (32 mg, 0.19 mmol) 
in 5 ml of methanol was added to a colourless solution of L54 (62 mg, 0.19 mmol) in 5 
ml of methanol yielding a green precipitate, which was filtered, washed with 
methanol and vacuum dried (48 mg, 55%). IR (cm-1): 2997w, 2980w, 2936w, 1558m, 
1462m, 1441w, 1419w, 1383m, 1319w, 1267w, 1232w, 1064m, 922m, 865w, 797w, 
748s, 705m, 690m, 487w. Anal. Calc. for C18H22Cl2CuN4S (460.91): C, 46.90; H, 4.81; N, 
12.15. Found: C, 46.72; H, 4.66; N, 12.03%.  
Synthesis of [CuCl2(L55)] (55). A pale green solution of CuCl2 
.2H2O (90 mg, 0.53 mmol) 
in 5 ml of methanol was added to a solution of L55 (237 mg, 0.53 mmol) in 5 ml of 
methanol yielding a yellow precipitate, which was filtered, washed with methanol  
and vacuum dried (230 mg, 74%).  IR (cm-1): 3676w, 3481w br, 2972m, 2932m, 
2868m, 1616w, 1546m, 1473m, 1459m, 1439m, 1396m, 1383m, 1364m , 1315m, 
1292m, 1278m, 1263m, 1223m, 1184m, 1092w, 1064m, 1016m, 928m, 912w, 882w, 
839m, 808s, 773m, 750m, 743m, 695m, 660m, 557m, 512w, 487m, 432w.  Anal. Calc. 
for C26H38Cl2CuN4S (573.12): C, 54.48; H, 6.68; N, 9.77. Found: C, 54.36; H, 6.41; N, 
9.63%.  
8.2.2. Stability consants determination 
The thermodynamic stability of Cu(II) complexes with the L38, L44, L45, L51, and L54 
ligands was studied in a methanol:water 90:10 (v/v) mixture (T = 25 °C) by 
spectrophotometric titrations in the visible range (400 – 900 nm). Cu(II) stock 
solutions (CCu = ca. 0.0105 M) were prepared by weight from CuCl2
.2H2O. Their titre 
was determined by complexometric titrations with standard EDTA2- solutions using 
fast sulphon black F as indicator. Ligand stock solutions (0.02 M) were prepared by 
weight and used within two days. Attempts to use Hepes buffered ligands solutions 
(pH 7.4) resulted in the precipitation of copper(II) hydroxide during the titrations. 
All Cu(II)/ligand systems were studied by spectrophotometric titrations by collecting 
visible spectra of batch samples containing a fixed metal ion concentration with 
increasing concentrations of ligand up to 1/2.6 (Cu(II)/ligand) ratio. The spectra were 
collected using a Perkin Elmer Lambda 25 spectrophotometer equipped with a Peltier 
device, using matched quartz cells of 1 cm path length. Visible spectrophotometric 
data were treated by means of the SPECFIT32150,151 and Hyperquad 2006152 programs, 
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which allowed determination of both the complexation log β values and the molar 
absorbances of the absorbing species. 
8.2.3. Single Crystal X-ray Structures 
Single crystal data were collected with a Bruker Smart 1000 and on a Bruker Smart 
APEXII area detector diffractometers (Mo Kα; λ = 0.71073 Å). Cell parameters were 
refined from the observed setting angles and detector positions of selected strong 
reflections. Intensities were integrated from several series of exposure frames that 
covered the sphere of reciprocal space48. A multiscan absorption correction was 
applied to the data using the program SADABS. The structures were solved by direct 
methods SIR97104  and SIR200449  and refined with full-matrix least-squares (SHELXL-
97)50, using the Wingx software package51. Graphical material was prepared with  
Mercury 2.0 52 programs. Cristallographic data are reported in Appendix ix-xii. 
 
 8.2.4. Cell lines and culture 
HT1080 and SW872 cell lines derived from human fibrosarcoma and liposarcoma, 
respectively, were obtained from the Istituto Zooprofilattico Sperimentale (Brescia, 
Italy); HeLa cell line, derived from a human cervix carcinoma, was obtained from 
ATCC. Human foreskin fibroblasts (HF) were obtained as previously described153. Cells 
were all grown in Dulbecco’s modified Eagle’s medium (DMEM 4.5g/L glucose ) 
supplemented with 10% fetal bovine serum (FBS), 4 mM glutamine, 100 U/mL 
penicillin, and 100 µg/mL streptomycin. Cells were cultured at 37 °C in an atmosphere 
of 5% CO2 in air, pH 7.4. 
8.2.5. Cell viability assay 
Cells were seeded in a complete growth medium in 96-well plates (Costar Corning, 
NY), at a density of 7.5·103 cells/well, 24 h before treatment. Compounds to be tested 
were freshly dissolved 15mM in DMSO (final DMSO concentration ≤0.2%). The growth 
medium was then substituted with fresh complete medium containing the compound 
at the selected concentration and cells incubated for 48 hours. Cell viability was 
tested replacing the culture medium with a solution of resazurin and reading 
fluorescence at 572 nm with a fluorimeter (Wallac 1420 Victor2 Multilabel Counter, 
Perkin Elmer). Viability and Cytotoxicity were expressed as % value calculated from 
the equations: Viability = [(Vt-B)/(Vu-B)]·100 and Cytotoxicity = (100-Viability), where 
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Vt and Vu are the fluorescence values obtained in treated and untreated cells, 
respectively, and B is the background value. Dose response curves were fitted with 
non linear regression and IC50 values were calculated with GraphPad Prism 5.0™. 
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8.3. Results and Discussion 
8.3.1 Synthesis 
Ligands L36-L41 were prepared by reacting the electrophilic chloroethyl-
dimethylpyridine and pyrazole, in biphasic solvent (toluene/water) via phase transfer 
catalysis (n-Bu4NOH).
148 The preparation of L42-L45 ligands is preformed by treating 
the pyrazole-pyridine parent compounds with n-BuLi and an electrophile bearing a 
thioether function (ClCH2SCH3).
147  
 
Figure 88. Synthesis of pyrazole-pyridine ligands L36-L45 
 
The bis-pyrazole ligands L46-L49 were prepared by refluxing deprotonated pyrazoles 
in dichloromethane, whereas ligands L50-L55 were prepared by treating 
bis(pyrazolyl)ketones with aldehydes bearing the desired sulfur donor groups that 
were to be attached to the bispyrazole scaffold.103,109 
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Figure 89. Synthesis of bispyrazole ligands L46-L55. 
  
170 
 
8.3.2.   Solid state structures 
According to the molecular backbone and the nature of a thioether third arm on the 
carbon center linking the two rings, the ligands could be divided into five classes (a-e, 
Figure 97). Within each class, peripheral residues on the pyrazole ring were modified 
to vary the hydrophobicities or coordinative abilities of ligands. Specifically, 
hydrophobicity was modulated by substituting the H-atom of the parent compound 
with Me and i-Pr as well as t-Bu and Ph when synthetically feasible. To influence 
coordinative ability, a thioether group was introduced on the pyrazole ring of 
compounds 41 and 45. According to the X-ray structures reported in Figures 90-94, 
the invariant feature of the Cu(II) complexes is an N,N-chelation motif, whereas sulfur 
binding strongly depends on the types of thioether fragments introduced. In fact, the 
sulfur atom participates in metal coordination only when it is introduced in a favorable 
steric position (compounds 41 and 45, Figures 90 and 91). When the thioether was 
attached as a flexible (compounds 42-44 and 53-55) or rigid (50-52) central arm, it 
influenced the hydrophobicity of the ligand, but not its coordinative properties. The 
molecular structures can be grouped in two categories: mononuclear and dinuclear. In 
the first case, the metal geometry is flattened tetrahedral (compounds 39, 40, 48, 52, 
54, and 55), whereas for the dinuclear case, the metal geometry is square pyramidal, 
with the apex of the pyramid occupied by a bridging chloride anion (compounds 37, 
38, 42, 43, 44, 50, and 51). Exception are represented by compounds 41 and 45 that 
exhibit a trigonal bypyramidal geometry by virtue of the presence of the N,N,S ligand 
donor set, and by compound 46 that forms chains constituted by the tetrahedral 
[CuCl4]
2- anion and the octahedral [Cu(L46)2]
2+ cation.  
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Figure 90. Molecular structures of 37-41 copper complexes. Hydrogen atoms were 
omitted for clarity. Selected bond distances are reported in Ǻ. C (grey), N (blue), Cl 
(green), O (red), S (yellow), Cu (brown). 
 
Figure 91. Molecular structures of 42-45 copper complexes. Hydrogen atoms were 
omitted for clarity. Selected bond distances are reported in Ǻ. C (grey), N (blue), Cl 
(green), O (red), S (yellow), Cu (brown).  
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Figure 92. Molecular structures of 46 and 48 copper complexes. Hydrogen atoms are 
removed for clarity in 11. Selected bond distances are reported in Ǻ. C (grey), N 
(blue), Cl (green), Cu (brown). 
 
Figure 93. Molecular structures of 50-52 copper complexes. Hydrogen atoms were 
omitted for clarity. Selected bond distances are reported in Ǻ. C (grey), N (blue), Cl 
(green), S (yellow), Cu (brown). 
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Figure 94. Molecular structures of 54 and 55 copper complexes. Hydrogen atoms 
were omitted for clarity. Selected bond distances are reported in Ǻ. C (grey), N (blue), 
Cl (green), S (yellow), Cu (brown). 
  
174 
 
8.3.3. Stability Constants 
The stability of the Cu(II)-ligand complexes was assessed by evaluating the equilibrium 
formation constant  β as derived from the following equation: Cu(II) + L ⇌ Cu(II)L (β = 
[Cu(II)L]/([Cu(II)]·[L])). The log β value was determined for five complexes; it varied 
between 3.34 ±0.15 and 4.69 ±0.08 (Figure 95A). As expected, the highest stability 
was found for compound 45, which employs three donor atoms (N,N,S) for copper 
binding instead of the bidentate N,N coordination seen in all of the other complexes. 
Higher stability was not associated with increased cytotoxicity. Speciation calculations 
(Figure 95B) showed that when the ligand of compound 44 and copper were present 
at 5 µM each, the expected concentration of the complex was less than 50 nM, a 
value that would decrease further if copper-binding competitors were taken into 
account.  
Cell copper content was determined for the eleven active complexes (IC50 < 30 µM) by 
means of ICP-AES. When cells were incubated with the complexes at constant 
concentrations corresponding to the mean IC50 (13.2 µM), a strong correlation 
emerged between cytotoxic activity and cell copper content (non-parametric 
Spearman r=1). Figure 96 describes the relationship between these two parameters 
and indicates that the ability of a complex to promote copper accumulation in the cell 
depends on the ligand structure and is predictive of its cytotoxic activity. 
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Figure 95. Stability of selected Cu(II) complexes. (A) The Log β1 and Log β2 values are 
presented. (B) Expected concentrations of the indicated species, calculated in 
accordance with the reported Log β for 44, at the concentration of 5 µM in the 
absence of other competitors for copper bindin
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8.3.4. Citotoxicity 
The anticancer activities of the complexes were evaluated in human fibrosarcoma 
HT1080 cells by means of a resazurin-based viability assay. The IC50 values, 
extrapolated from the dose response curves reported in Figure 102, allowed us to 
identify the following structure-activity relationships: i) substitution of the H-atom on 
the pyrazole ring is essential to the activity of the complex, ii) the presence of the 
pyridine in place of pyrazole (compare classes a with c) and the presence of the 
central thioether arm (compare classes a with b and c with d and e) both enhance 
activity. The highest activity was observed for classes with flexible thioether groups 
(compare classes b with d and e). Among the twenty compounds, 44 was the most 
active (IC50 = 3.3 µM). The rank of the IC50 values within each class points to the 
fundamental role of ligand hydrophobicity in the biological response of the 
corresponding Cu(II) complex. The relationship between the calculated logP value154 of 
the ligand and the cytotoxic activity of the respective complex suggests that, for each 
class of compounds, there is an optimal logP value (between 4 and 6) at which activity 
is maximal (Figure 96).  
 
Figure 96. Relationship between hydrophobicity and cytotoxic activity of copper 
complexes. Copper complexes 1-20 are clustered in 6 groups according to their 
similarity. For each group a nonlinear regression curve (second order polynomial 
curve) is presented with the exception of the group of inactive complexes (11-14). The 
R2 for the goodness of fit was > 0.85 for the presented curves. S.D are not presented 
for simplicity. Data were analyzed with GraphPad Prism 5.0. 
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Figure 97. Structure and cytotoxic activity of novel copper complexes. Pyrazole-
pyridine based (rows a, b) and bis-pyrazole based (rows c, d, e) copper(II) complexes 
together with the relative dose response curve in HT1080 cells. The chlorine atoms 
were removed for clarity. The different functional groups are indicated at  
 
To correlate cytotoxic activity and complex bioavailability, we assessed ligand uptake 
of the most active compound 44, and of an inactive compound, 42. The cell extracts 
were analyzed by means of Reversed-Phase Liquid Chromatography (RPLC) combined 
with an electrospray ionization linear ion trap (ESI-LIT) mass spectrometry. As shown 
in Figure 98A, the accumulation of 44-ligand was 30-fold higher than that observed for 
the ligand of the inactive (and less lipophilic) compound 42. This evidence strongly 
suggests that passive diffusion accounts for membrane crossing for this class of 
complexes. To verify this hypothesis, a dose-dependent uptake experiment was 
performed in live cells. Figure 98B shows the linear relationship between the 
intracellular concentration of 44-ligand and the extracellular concentration of 44. 
These results indicate that, in the range of concentrations tested, ligand transport is 
not saturated and follows the Fick law for passive diffusion. The accumulation of 44-
ligand reached a plateau by approximately 30 minutes (Figure 98C). On the contrary, 
under the same experimental conditions, copper uptake showed much slower 
kinetics, approaching a steady state at 360 minutes. However, at this time, the copper 
concentration was approximately four-fold higher than the ligand concentration. 
These results suggest that the ligand carries copper across the membrane bilayer by 
virtue of its lipophilicity and favors its accumulation in the intracellular compartment, 
acting as an ionophore for the metal. 
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Figure 98. (A) Cellular concentrations of 42- and 44-ligands were determined by RPLC 
ESI-MS. HT1080 cells were incubated for 6 hours with 5 µM of the indicated 
complexes. (B) Uptake of 44-ligand in HT1080 cells incubated for 2 min with the 
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indicated concentrations of compound 44 (5-200 µM). (C) Uptake kinetics of 44-ligand 
(solid line) and copper (dotted line). HT1080 cells were incubated with compound 44 
(5 µM) for the indicated time periods (0.5-360 min). The inset is an enlargement of 
the first 30 min of uptake. All data are means ± SEM of two independent experiments 
with three replicates each. 
Given the positive correlation between cell copper content and cytotoxic activity of 
36-55 (see Figure 99A and B), we investigated whether inorganic copper (CuCl2) was 
sufficient to produce similar effects. The cytotoxic response to CuCl2 was assessed in 
three human tumor cell lines (HT1080, HeLa, and SW872) and normal fibroblasts (HF) 
and compared to the effects of the most active compound 44. The dose response 
curve showed that CuCl2 was toxic above 200 µM, while compound 44 was active at 
concentrations less than 10 µM . When CuCl2 was used at a toxic concentration, the 
morphological changes induced were identical to those caused by compound 44. 
These alterations were similar to those described for a thioxotriazole copper(II) 
complex that induces paraptosis, a non-apoptotic cell death process.142,155 
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Figure 99. Effects of treatment with 44 and CuCl2 in normal fibroblasts (HF) and tumor 
cell lines (HT1080, HeLa, SW872). (A) Cells were incubated with rising concentrations 
of the complex 44 (1-30µM) or (B) with increasing concentrations of CuCl2 (50-
1000µM) for 48h and viability assessed with the resazurin method. The IC50s obtained 
from the curves are reported. Data are means ± SEM of three independent 
experiments with 6 replicates each. (C) Phase contrast images representative of 
untreated cells or cells incubated for 24 hours with 5µM 44. Cytotoxicity is evident in 
HT1080 and Hela cells while SW872 and HF cultures are spared (original magnification 
100x). 
 
Therefore, copper itself appears to be responsible for the biological alterations 
induced in tumor cell lines, as this correlation is independent of cancer cell type and 
the presence or structure of the ligand. An exception was represented by normal 
human fibroblasts (HF), where high intracellular copper concentration did not 
translate into cytotoxicity, as expected from the curve in Figure 104A. This result 
suggests that HF cells are able to withstand supraphysiological copper concentrations 
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better than cancer cells. Notably, the different sensitivities of the four cell lines to 
compound 44 (HeLa ≈ HT1080 >> SW872 ≈ HF, Figure 99A) and cellular copper 
concentrations (Hela ≈ HT1080 ≈ HF > SW872) were not related to the cellular 
concentration of 44-ligand. In fact, when the four cell types were treated for 6 hours 
with 5 µM compound 44, copper always reached significantly higher cell levels than 
the ligand, with a copper/ligand ratio that varied from 1.6 to 3.7 (Figure 99B). These 
results confirm that ligand and copper establish different transmembrane gradients.  
When equimolar amounts of CuCl2 and DSF were administered to HT1080 and HeLa 
cells (Figure 100A), massive cytoplasmic vacuolization in the absence of apoptotic 
features was observed. These morphological changes coincided with the paraptotic 
morphology141,142 caused by complex 44 or CuCl2 and previously observed with [Cu(8-
hydroxyquinoline)2] and [Cu(clioquinole)2], which promote copper transport into the 
cell (Figure 100). Our findings point to a mechanism of action for copper binding 
agents that can also apply to disulfiram (DSF), a copper-interacting drug described 
extensively as an apoptotic inducer in several in vitro and in vivo cancer models.156,157 
In our models, DSF concentrates copper in the cell (Figure 100B), reproducing the 
morphological and molecular changes observed with other copper complexes, 
indicative of paraptotic cell death (Figure 100).  
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Figure 100. Cytotoxicity of 8-hydroxiquinoline (8-HQ), clioquinol (CQ), histidine (His), 
and disulfiram (DSF) copper complexes. The copper complexes of the indicated 
compounds were obtained as described in the Supplementary Material and Methods 
section. (A and B) Dose responses: HT1080 or HeLa cells were incubated for 48h with 
the indicated concentration of the ligands alone or complexed with copper. Data ± 
SEM are means of two independent experiments with six determination each. The 
morphology of HT1080 and HeLa cells treated for 15 hours with 1.5µM Cu(8-HQ)2, 
12.5µM Cu(CQ)2, or with 30 µM Cu(His)2 is presented. Cytoplasmic vacuolization is 
evident in both HT1080 and HeLa cells treated with Cu(8-HQ)2, and Cu(CQ)2 but not 
with Cu(His)2, (original magnification 100x). (B) HT1080 cells were incubated with the 
CuDSF complex for 6 hours or left untreated. Cellular copper content was determined 
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by means of ICP-AES. Data ± SD are means of two independent experiments with 
three determination each. 
 
For the copper complexes examined in this chapter, as well as for other previously 
described compounds,143,158 the biological effects that we consistently observed are 
the intracellular accumulation of high amounts of copper, the appearance of 
cytoplasmic vacuolization, and the activation of caspase-independent cell death. 
These observations can be reasonably explained if the ligand is considered to be a 
copper ionophore that exacerbates the intrinsic toxicity of the metal by increasing its 
intracellular concentration. If a ligand has autonomous biological activities, as in the 
case of DSF, the two effects might be synergistic, leading to potent cytotoxic behavior. 
While the selectivity of copper complexes to induce cell death in specific cancer cells 
remains to be explained, an understanding of the mechanisms underlying the toxicity 
of copper complexes may lead to more effective anticancer drugs. Because DSF 
associated with copper is currently under clinical investigation as an anticancer agent, 
these findings may be useful for designing an effective therapeutic combination with 
pro-apoptotic drugs.  
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Figure 101. A proposed model for a copper-binding agent mechanism of action. A 
copper complex dissolved in the extracellular environment partially dissociates as a 
consequence of its stability and concentration of other bio-ligands (amino acids and 
serum proteins). According to the diffusion laws, the fraction of undissociated 
complex pass through the plasma membrane, reaching the intracellular space. Here 
the complex completely dissociate because of very high concentration of endogenous 
high affinity copper ligands. The ligand can freely cross back the membrane to start 
another shuttling cycle. The intracellular concentration of copper progressively 
increases and saturates the copper handling ability of the cell until metal overload 
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translates into proteasome inhibition, impairment of correct protein folding, 
consumption of reduced glutathione, and caspase inactivation. The cell is forced to an 
unsolvable oxidative- as well as ER-stress. The apoptotic response is prevented 
because of copper dependent caspase inhibition, while the paraptotic cell death, with 
the typical vacuolization, is triggered as a backup suicide program. 
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     CHAPTER 9 
 
Copper-dependent cytotoxicity of 8-Hydroxyquinoline 
derivatives. 
 
In this chapter we present a study that assesses the structure-activity relationship130 
of a series of 8-HQ derivatives and focuses on the copper-dependent activity of 5-Cl-
7-I-8-HQ (clioquinol, CQ) copper complex (Cu(CQ)). 8-HQs alone caused a dose-
dependent loss of viability of the human tumor HeLa and PC3 cells. The combination 
of 8-HQs with copper increased the ligands effects, with extensive cell death 
occurring in both cell lines. In particular cytotoxic doses of Cu(CQ) promotes 
intracellular copper accumulation and extensive endoplasmic reticulum vacuolization 
that precede a non-apoptotic (paraptotic) cell death. The cytotoxic effect of Cu(CQ) 
was reproduced in normal human endothelial cells (HUVEC) only at concentrations 
double than those effective in tumor cells, pointing to a potential therapeutic window 
for this complex. Finally, the results showed that the paraptotic cell death induced by 
Cu(CQ) while depending on copper accumulation does not require nor involve 
caspases, giving an indication for the current clinical assessment of clioquinol as an 
antineoplastic agent. 
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9.1 Introduction 
Several types of programmed cell death (PCD) have been reported in the literature.159 
Caspase-dependent apoptosis is the most common type of PCD through which normal 
and tumor cells die in an organized manner, both during tissue development or under 
conditions of stress, such as chemotherapeutic treatment.160 From a morphological 
point of view, apoptosis manifests with cell shrinkage, chromatin condensation, and 
the appearance of apoptotic bodies containing nuclear fragments. The apoptotic 
process can be activated either by extracellular ligands through transmembrane death 
receptors (extrinsic pathway) or as a consequence of cellular injury that ultimately 
leads to mitochondrial membrane permeabilization and release of cytochrome C 
(intrinsic pathway). The complex biochemical machinery activated during the cell 
death process usually promotes the activation of caspase-3, which dismantles cellular 
architecture and leads to cell death.161,162 However, caspase-independent apoptosis 
has also been documented.1 Caspase-independent apoptotic cell death usually 
comprises the translocation of endonucleases (ENDOG) and/or apoptosis-inducing 
factor (AIF) from the mitochondria to the nucleus.163,164 The extensive stress on the 
endoplasmic reticulum (ER) caused by the accumulation of unfolded proteins in its 
lumen can trigger the apoptotic pathway. In the presence of this stress, cells activate 
the unfolded protein response (UPR) and inhibit protein synthesis in an effort to 
relieve the ER from excessive protein overload. If the stress persists, the expression of 
the transcription factor CHOP (CCAAT-enhancer-binding protein homologous protein) 
increases, initiating the apoptotic cascade.165,166 
Copper is an essential metal ion involved in several highly conserved biochemical 
processes. Its oxidation state shifts from +2 to +1 upon internalization due to the 
reducing intracellular environment. A mild intracellular excess of copper can normally 
be balanced by the cells through an increased expression of metallothioneins or 
through the activation of specific pumps, such as ATP7A and ATP7B,167,168 whereas 
high copper concentrations cause the activation of the UPR, as described above. For 
this reason, despite its essential role in living cells, copper has been frequently 
employed in the preparation of cytotoxic complexes. In many instances, the choice of 
Cu(II)-based compounds as cytotoxic agents originates from the overproduction of 
reactive oxygen species (ROS) driven by the metal. Alternatively, copper-binding 
agents have been employed for their ability to direct the toxicity of the metal towards 
specific intracellular targets.138 
In cultured cells, the internalization of copper complexes does not usually involve the 
hCTR1 copper-specific transporter but rather occurs primarily via passive 
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diffusion.130,169 For this reason, the chemical features of the ligand appear to be the 
main determinants of the activity of the complex because it may i) modulate its 
permeability through the cell membranes by virtue of its lipophilic character, ii) 
stabilize a specific redox state of the metal, iii) drive the complex to specific cellular 
targets, and iv) exhibit an intrinsic cytotoxic activity when dissociated from the metal. 
8-Hydroxyquinoline (8-HQ) derivatives are planar, N,O-donating ligands that have a 
high affinity for Cu(II). Particular interest has been recently dedicated to 5-Cl-7-I-8-HQ 
(clioquinol, CQ) because CQ was already recognized as an anti-parasitic drug, even 
though its use was discontinued in some countries due to the occurrence of subacute 
myelo-optic neuropathy. In mice, CQ proved to be able to inhibit the accumulation of 
β amyloid (Aβ) in the brain and to mobilize the Aβ from existing deposits,125 which are 
of great relevance for treatments of Alzheimer disease.170,171 The CQ-related 
compound PBT2172 has recently underwent phase II clinical trials as an anti-Alzheimer 
compound.173 Moreover, CQ has entered Phase I clinical trials for the treatment of 
relapsed or refractory hematological malignancy (NCT00963495). 
In previous chapter (chapter 8), we have shown that nitrogen donor ligands behave as 
copper ionophores in cancer cells, thus leading to a toxic accumulation of the metal, 
which eventually triggers paraptotic cell death.130,144The goal of this project is to 
investigate whether non-apoptotic programmed cell death is activated in tumor cell 
lines by the combined treatment of copper and 8-HQ analogs, with a particular focus 
on the copper ionophore CQ.174 
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Figure 102. Ligands used in the study presented in this chapter. 
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9.2 Experimental 
9.2.1. Synthesis 
All reagents and solvents were commercially available. Infrared spectra were 
recorded from 4000 to 700 cm-1 on a Perkin-Elmer FT-IR Nexus spectrometer 
equipped with a Thermo-Nicolet microscope. Elemental analyses (C, H, and N) were 
performed with a Carlo Erba EA 1108 automated analyzer. 
Synthesis of [Cu(L56)2](56). A pale green solution of CuCl2
.2H2O (94 mg, 0.55mmol) 
dissolved in Methanol(5 ml) has been added to a solution of 8-Hydroxyquinoline-5-
sulfonic acid (L56) (250mg, 1.11mmol ) in 10 ml of Methanol/Water (1:1) and then the 
mixture was stirred for 30 min. The solvent was removed under vacuum and a green 
solid precipitated. The solid was filtered and vacuum dried (172 mg, yield 61%). IR 
(cm-1): 454s, 547m, 624m, 706m, 778w, 1024m, 1139s, 1320w, 1369w, 1490m, 
1572w, 3095w. Anal. Calc. for C18H14CuN2O8S2 (513.99): C, 42.06; H, 2.75; N, 5.45. 
Found: C, 43.96; H, 3.42; N, 11.40%.  
Synthesis of [Cu(L57)2](57). A pale green solution of CuCl2
.2H2O (61 mg, 0.35mmol) 
dissolved in Methanol(5 ml) has been added to a pale yellow solution of 8-Hydroxy-7-
iodo-5-quinoline sulfonic acid (L57) (250mg, 0.71mmol ) in 30 ml of Methanol/Water 
(8:2) and the mixture was stirred for 30 min. The solvent was then removed under 
vacuum and a green solid precipitated. The solid was filtered and vacuum dried (193 
mg, yield 72%). IR (cm-1): 591s, 728m, 816m, 1035s, 1167s, 1380m, 1484m, 1556w, 
1616w, 3079w, 3523w. Anal. Calc. for C18H12CuI2N2O8S2 (765.78): C, 28.23; H, 1.58; N, 
3.66. Found: C, 43.96; H, 3.42; N, 11.40%.  
Synthesis of [Cu(L58)2](58). A pale green solution of CuCl2
.2H2O (147 mg, 0.86mmol) 
dissolved in Methanol(5 ml) has been added to a yellow solution of 8-
Hydroxyquinoline (L58) (250mg, 1.72mmol ) in 20 ml of Methanol and suddenly a 
brown solid precipitated. After 30 min of stirring the solid was filtered and vacuum 
dried (233 mg, yield 77%). IR (cm-1): 504m, 635w, 739s, 821s, 1106s, 1265m, 1315s, 
1375s, 1495s, 1578m, 3057w. Anal. Calc. for C18H14CuN2O2 (353.86): C, 61.10; H, 3.99; 
N, 7.92. Found: C, 43.96; H, 3.42; N, 11.40%.  
Synthesis of [Cu(L59)2](59). A pale green solution of CuCl2
.2H2O (119 mg, 0.69mmol) 
dissolved in Methanol(5 ml) has been added to a yellow solution of 5-Chloro-8-
quiloninol (L59) (250mg, 1.39mmol ) in 20 ml of Methanol and suddenly a brown solid 
precipitated. After 30 min of stirring the solid was filtered and vacuum dried (196 mg, 
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yield 66%). The compound was recrystallized by stratifying diethyl ether over an 
acetone solution of the complex, yielding colorless crystals.. IR (cm-1): 504m, 635w, 
739s, 821s, 1106s, 1265m, 1315s, 1375s, 1495s, 1578m, 3057w. Anal. Calc. for 
C18H12CuCl2N2O2 (422.75): C, 51.14; H, 2.86; N, 6.63. Found: C, 43.96; H, 3.42; N, 
11.40%. 
 
Synthesis of [Cu(L60)2](60). A pale green solution of CuCl2
.2H2O (123 mg, 0.72mmol) 
dissolved in Methanol(5 ml) has been added to a pale pink solution of 5,7-Dimethyl-8-
quiloninol (L60) (250mg, 1.44mmol ) in 20 ml of Methanol and suddenly a green solid 
precipitated. After 30 min of stirring the solid was filtered and vacuum dried (221 mg, 
yield 75%). The compound was recrystallized by stratifying diethyl ether over an 
acetone solution of the complex, yielding colorless crystals.. IR (cm-1): 443m, 663s, 
745m, 789s, 997w, 1134m, 1167m, 1353s, 1435m, 1506m, 1572w, 2915w.. Anal. Calc. 
for C22H22CuN2O2 (409.97): C, 64.45; H, 5.41; N, 6.83. Found: C, 43.96; H, 3.42; N, 
11.40%. 
Synthesis of [Cu(L61)2](61). A pale green solution of CuCl2
.2H2O (100 mg, 0.58mmol) 
dissolved in Methanol(5 ml) has been added to a solution of 5,7-Dichlor-8-quiloninol 
(L61) (250mg, 1.16mmol ) in 10 ml of Acetone and suddenly a dark green solid 
precipitated. After 30 min of stirring the solid was filtered and vacuum dried (132 mg, 
yield 46%). The compound was recrystallized by stratifying diethyl ether over an 
acetone solution of the complex, yielding colorless crystals.. IR (cm-1): 482m, 657m, 
750s, 980m, 1112m, 1254w, 1369s, 1435s, 1479m, 1539m, 1764w, 3736w. Anal. Calc. 
for C18H10CuCl4N2O2 (491.64): C, 43.97; H, 2.05; N, 5.70. Found: C, 43.96; H, 3.42; N, 
11.40%. 
Synthesis of [Cu(L62)2](62). A pale green solution of CuCl2
.2H2O (70 mg, 0.41mmol) 
dissolved in Methanol(5 ml) has been added to a solution of Clioquinol  (L62)(250mg, 
1.16mmol ) in 10 ml of Acetone and suddenly a dark green solid precipitated. After 30 
min of stirring the solid was filtered and vacuum dried (207 mg, yield 75%). IR (cm-1): 
487m, 586m, 657s, 750s, 975m, 1112m, 1375s, 1435s, 1539m, 1753w. Anal. Calc. for 
C18H10CuCl2I2N2O2 (674.55): C, 32.05; H, 1.49; N, 4.15. Found: C, 43.96; H, 3.42; N, 
11.40%. 
Synthesis of [Cu(L63)2](63). A pale green solution of CuCl2
.2H2O (53 mg, 0.31mmol) 
dissolved in Methanol(5 ml) has been added to a solution of 5,7-Diiodo-8-
hydroxyquinoline (L63) (250mg, 0.62mmol ) in 20 ml of Acetone/Chloroform (1:1) and 
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suddenly a green solid precipitated. After 30 min of stirring the solid was filtered and 
vacuum dried (238 mg, yield 90%). The compound was recrystallized by stratifying 
diethyl ether over an acetone solution of the complex, yielding colorless crystals.. IR 
(cm-1): 482w, 657m, 750s, 980m, 1112m, 1249w, 1364s, 1435s, 1545s, 1753w. Anal. 
Calc. for C18H10CuI4N2O2 (857.45): C, 25.21; H, 1.18; N, 3.27. Found: C, 43.96; H, 3.42; 
N, 11.40%. 
9.2.2. X-ray crystallography 
Single crystal data were collected with a Bruker Smart APEXII area detector 
diffractometers (Mo Kα; λ = 0.71073 Å). Cell parameters were refined from the 
observed setting angles and detector positions of selected strong reflections. 
Intensities were integrated from several series of exposure frames that covered the 
sphere of reciprocal space.48 A multiscan absorption correction was applied to the 
data using the program SADABS.104 The structures were solved by direct methods 
(SIR2004) and refined with full-matrix least-squares (SHELXL-97),50 using the Wingx51 
software package. Graphical material was prepared with the Mercury 3.052 programs. 
Crystallographic data are reported in Appendix xii. 
 
9.2.3. Stability constants determination 
The thermodynamic stability of Cu(II) complexes with the L58 and L56 ligands was 
studied in DMSO:water 1:1 (w/w) (T = 25 °C, I = 0.1 M (KCl)) by potentiometric 
titrations, using an apparatus already described in the literature 175. Freshly boiled, N2-
saturated doubly distilled water and N2-fluxed DMSO (heated at 180 °C) were used for 
the preparation of the DMSO:water mixtures. The Cu(II) stock solution (CCu = ca. 0.016 
M) was prepared by weight from CuCl2
.2H2O, and its titre was determined by 
complexometric titrations with standard EDTA solutions using pyrocatechol violet as 
the indicator. HCl aqueous solutions (ca. 0.2 M) and KOH solutions (ca. 0.2 M in 
DMSO:water 1:1 (w/w)) were prepared by diluting concentrated Merck Titrisol 
ampoules with the proper amounts of CO2-free water and DMSO, and standardized 
with the usual procedure of this laboratory.175 Solutions of the ligands L58 and L56 (ca. 
0.1 M) were prepared by weight in DMSO:water 1:1 (w/w) using the pure ligands and 
adding a stoichiometric amount of HCl (aqueous 10 N solution). The suspensions were 
stirred overnight to attain complete ligand dissolution, and the solutions filtered 
through a 0.45 μm nylon filter. Their titre (ligand content and excess of acid) was 
checked by potentiometric titration with standard KOH solutions. These solutions 
195 
 
were used within 4-5 days. The titrations were carried out at T = 25.0 ± 0.1 °C and I = 
0.1 M (KCl) under a stream of N2, using 50 ml samples. Prior to its use, the reference 
compartment of the Hamilton combined glass electrode (P/N 238000) was filled with 
a 0.1 M KCl solution in DMSO:water 1:1 (w/w), and left to equilibrate overnight. The 
electrode was calibrated in terms of [H+] by titrating HCl solutions with standard KOH 
solutions and the calculated pKw value resulted to be 15.25(5).  
The protonation constants of the ligands were determined by alkalimetric titration of 
three samples (6.1-9.1 × 10-3 M for L58, 3.3-3.8 × 10-3 M for L56) in the pH range 2-11. 
The complex formation constants of the Cu2+/L58 or L56 systems were determined by 
alcalimetric titrations of three samples (Cu2+/L58 = 1 : 1.0-1.2, CCu = 7.0-7.9 × 10
-4 M; 
Cu2+/L56 = 1 : 2.0-2.2, CCu = 1.5-1.6 × 10
-3 M ) in the pH range 2-9. The L58/ Cu2+ has 
been limited to ca. 1.2 and pH 4.5 because of the poor solubility of the 58 complexes 
in the solvent mixture. 
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9.3. Results and Discussion 
9.3.1.   Solid state structures 
The Cu(II) complexes can be prepared by mixing CuCl2⋅2H2O and the corresponding 
ligands in the 1:1 or 1:2 molar ratio. Complexes of formula [Cu(L)(H2O)2] are obtained 
with the L56 and L57 ligands, whereas the remaining ligands give rise to complexes of 
[Cu(L)2] general formula (Figure 103). Given the different lipophilic properties of the 
ligands, different solvents were employed to prepare solutions of the ligands, whereas 
CuCl2⋅2H2O was dissolved in methanol. The [Cu(L)(H2O)2] or [Cu(L)2] complexes readily 
precipitated from the reaction mixtures as brown or green powders. These 
compounds are usually insoluble in aqueous media, in common organic solvents and 
are poorly soluble in DMSO. For this reason, the biological tests were performed by 
mixing CuCl2⋅2H2O and the corresponding ligands directly into the cell culture media at 
a 1:1 molar ratio. The final concentration of the complex for the biological tests was in 
the 1-30 µM range such that it did not precipitate in the medium. On the basis of our 
determined stability constants for L58 and L56 (see below) in this range of 
concentrations, we expect that 40-50 % of the total Cu(II) forms [Cu(L)], while the 
remaining 50 %-60 % are present as [Cu(L)2] and “free” Cu
2+ ions (25-30 % each).  
L58 and its derivatives are characterized by the presence of a N,O-binding system that 
is suitable to interact strongly with Cu(II) ions. The presence of the –SO3
- group leads 
to the formation of complexes in which the metal:ligand ratio is 1:1 due to the 
involvement of the sulfonate moiety in metal coordination. When R and R’ are 
halogen or alkyl substituents, the metal:ligand ratio becomes 1:2, and the ligands are 
arranged in a trans geometry, with the nitrogen and oxygen atoms on the opposite 
side with respect to the metal center. The molecular structures of 58 and 62176 were 
previously reported, whereas the 60 is reported in Figure 103B. 
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Figure 103. A. The molecular structures of Cu(II) complexes with L58 derivatives. B. 
ORTEP diagram of the X-ray molecular structure of 60, symmetry code ’ = -x; 1-y, -z. 
 
The complex crystallizes in the P-1 space group. The unit cell contains three  complex 
molecules, and the Cu(1) atom lies on an inversion center. The metal coordination is 
square planar with the Cu-N bond distances that are significantly longer than the Cu-O 
ones. The arrangement of the two L60 surrounding each metal gives rise to a trans 
geometry. The three molecular entities comprising the unit cell may be described as a 
trimer according to the presence of very weak interactions between the metal and 
the oxygen atoms of superimposed molecules.  
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Figure 104. Above, molecular structures of 60. The Cu(1) atom lies on an inversion 
center, symmetry code ’ = -x; 1-y; -z. Selected bond distances are reported in Ǻ. C 
(grey), H (white), N (blue), O (red), Cu (brown). Below, crystal packing of 60 projected 
along the a crystallographic axis. 
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9.3.2.   Stability constants determination.  
The stability constants of 56 and 58 were determined by potentiometry in a 1:1 
DMSO:water (w/w) solution. The Cu(II) complexes with these ligands were remarkably 
stable, with Log β1 and Log β2 values on the order of 11.5 and 22.5 for both 58 and 56 
(Table 10). Previous studies reported the stability of these ligands in water, although 
most studies were performed in water/organic mixtures such as alcohol177 or 
water/dioxane mixtures178 to address solubility problems. These studies reported 
formation constants that fall in the range Log β1 11-14 and Log β2 22-25. In this study, 
we used a DMSO:water mixture as an attempt to increase the solubility of the various 
species in order to determine the stability constants in homogeneous conditions. 
Unfortunately, the poor solubility of the remaining ligands (or their complexes) in this 
mixture made it difficult to measure the stability constants for the other complexes. 
Our values fall within the range determined in different solvents, showing that the 
presence of DMSO does not significantly affect the stability of the complexes. 
Moreover, the similarity of the values of Log β for 56 and 58 suggests that any 
interaction between the [Cu(L)] species and a ligand molecule via the sulfonate group 
(as found in the solid state) is negligible in solution. The influence exerted by the 
substituents in the 5 and 7 positions on the hydroxyquinoline moiety is also expected 
to have minimal steric influence on the geometry of the Cu(II) complexes and 
therefore on their stability due to the positioning of these groups at the exterior of 
the coordination site. 
Interestingly, the [Cu(L)2] compounds can precipitate out as solids when using the 1:1 
molar ratio (except those with the L56 and L57 ligands that form complexes with Cu:L 
1:1 stoichiometry). This behavior can be accounted for by their Log β values: in fact, 
the stability constants of the coordination of Cu(II) with the first ligand (giving [Cu(L)], 
Log β1) and the second ligand ([Cu(L)2], Log K2 = Log β2 - Log β1) are approximately the 
same. As a result, the amount of [Cu(L)2] in solution for a HL:Cu(II) ratio of 1 is quite 
high (ca. 20 % total copper for both ligands), likely leading to the precipitation of this 
neutral complex from the solution. This finding is in agreement with the poor 
solubility of the [Cu(L)2] complex with L58 (ca. 10
-6 M), which precipitates out of 
solution at a HL:Cu(II) ratio greater than 1.2, even at pH ca. 4.5 and CCu ca. 10
-4 M.  
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Table 10. Logarithms of proton dissociation and of complex formation constants of the 
[Cu(L)] and [Cu(L)2] complexes for the ligands L58 and L56 in DMSO:water 1:1 (w/w) (T 
= 25.0 ± 0.1 °C and I = 0.1 M (KCl). The pKa values refer to the ligands in the H2L form. 
Charges are omitted for simplicity. 
 
Ligand pKa1, pKa2 Log β1, Log β2 
L58 3.99(1), 10.53(1) 11.26(4), 22.31(3) 
L56 3.14(4), 9.26(2) 11.72(9), 22.76(7) 
 
For both ligands, the first proton dissociation occurs with a pKa of 3.1-4 and is 
associated to the release of the proton from the protonated quinolinic nitrogen atom. 
The second dissociation, occurring with pKa values of 9.2-10.5, is associated to the 
release of protons from the hydroxyl group. Due to its low basicity, the sulfonate 
group results always deprotonated in the pH ranges where the measurements have 
been performed (2-11). On the basis of these protonation constants, it results that the 
predominant forms of the ligands at pH 7.4 are the neutral form HL for L58 and the 
negative charged HL- for L56. These protonation constants are quite similar to those 
reported for alcoholi solutions of the two ligands, at a 0.1 M ionic strength and T = 25 
°C (L58: 4.97, 9.65; L56: 3.90, 8.37)179 . Both for our experimental values and for the 
literature ones, the presence of sulfonate group in position 5 produces a decrease in 
the pKa2 value. 
Since the stability constant values are the same for 58 as well as for the sulfonate-
containing 56, it can be expected that the interaction between the sulfonate group 
and Cu(II) of a [CuL] unit present in the solid state is actually absent in solution. 
Furthermore these similar values suggest that the formation constants for the ligands 
in the series we are presenting in this work might fall in the same order of magnitude, 
being the donor atoms set the same, with similar molecular geometries. As a result, 
these values show that the stability of these hydroxoquinolinic ligands is remarkably 
high (Log β1 ca. 22) even in the presence of a large excess of a competing, soft 
monodentate ligand such as DMSO, and that the values determined in this medium 
(DMSO:water 1:1 (w/w)) compare very well with those reported for the same systems 
in both aqueous and water/organic solvent mixtures.180,181  
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Figure 105. Expected concentrations of the indicated species, calculated in accordance 
with the reported Log β1 and Log β2, at the concentration of 1 µM in the absence of 
other competitors for copper binding 
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Figure 106. Distribution diagrams of the system Cu2+/L56. Above, Cu2+/L56 = 1/1, CCu = 
1 × 10-3 M. Below, Cu2+/L56 = 1/2, CCu = 1 × 10
-3 M. 
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Figure 107. Distribution diagrams of the system Cu2+/L58. Above, Cu2+/L58= 1/1, CCu = 
1 × 10-3 M. Below, Cu2+/L58 = 1/2, CCu = 1 × 10
-3 M. 
 
 
 
9.3.3 Citotoxicity 
The cytotoxic potential of the ligands has been evaluated in two human tumor cell 
lines derived from cervical carcinoma, HeLa, and prostatic adenocarcinoma, PC3. As 
shown in Figure 108, all ligands present cytotoxic activity except for L56 and L57, 
which are almost ineffective on both cell lines up to the maximal concentration 
employed (30 µM). For six out of the eight L58 derivatives, adding an equimolar 
amount of CuCl2 dramatically increases the effect of the ligands in both HeLa and PC3 
cells, decreasing the IC50 values of the active ligands in both cell models. The addition 
of copper shifts the range of ligands IC50 from 13.5-25.2 µM to 1.9-12.8 µM and from 
8.6-25.7 µM to 1.3-16.2 µM, in HeLa and PC3, respectively (Figure 108). 
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Figure 108. Dose-response curves for ligands and copper complexes in HeLa and PC3 
cells. HeLa and PC3 cells were incubated for 48 h with different concentrations of 
ligands (upper panels) or copper complexes (lower panels). Cell viability after 
treatment was assessed using the resazurin method. The data presented are the 
means ± SEM of three independent experiments, each performed in triplicate. Error 
bars are visible when larger than the symbols.  
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Figure 109. Schematic depiction of the molecular structures of the copper complexesa 
together with the IC50 (µM) valuesb in HeLa and PC3 human tumor cell lines. 
Complex Structure 
Ligand 
LogP 
IC50
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58 
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3.50 8.9 9.0 
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63 
 
3.75 12.8 16.2 
a Only the CuL fragment is depicted. b The cytotoxic activity is measured for mixtures 
composed of CuCl2 and hydroxyquinoline derivatives in a 1:1 molar ratio.  
Interestingly, a non-linear correlation between the lipophilic character of the ligand, 
which is modulated by the peripheral functional groups, and the cytotoxic activity of 
the corresponding copper complex was found. When the ligands are ranked by 
increasing lipophilic character, i.e., with increasing LogP values, the activities of the 
corresponding complexes describe a bell-shaped curve (Figure 110). According to this 
relationship, the highest cytotoxic activity is expected to be exhibited by ligands with 
intermediate LogP values, namely between 1.5 and 3. 
Figure 110. Correlation between cytotoxic activity of copper complexes and ligand 
LogP. The activities of the copper complexes, calculated as the inverse of IC50 in HeLa 
and PC3 cells, were matched with corresponding ligand LogP values. The curves were 
extrapolated with the GraphPad Prism software.  
Although the complex 62 is significantly less active than 58 in both cell lines, we 
decided to further investigate its biological behavior, given the known and 
documented use of clioquinol as a drug182 and the recent attention paid to its 
anticancer potential in vitro and in vivo.174,183 It has been reported that the cytotoxicity 
induced by clioquinol is maximally increased by the presence of copper and is 
associated with caspase activation. To assess whether the metal and/or caspases are 
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required for the Cu(CQ) cytotoxic effect, HeLa and PC3 cells were incubated with 
increasing doses of Cu(CQ) in the presence of a high affine extracellular copper 
chelator, ammonium tetrathiomolybdate (TM). The addition of TM dramatically 
reduces the cytotoxic effect of the complex: the IC50 of 62 moves from 9 µM and 8.9 
µM to 24.5 µM and 21.5 µM in HeLa and PC3, respectively, and the dose-response 
profile of the complex in the presence of TM becomes similar to that of the L62 ligand 
alone. Interestingly, higher doses of TM have a moderately toxic effect on HeLa cells, 
as shown by the dose-response curve of 62 in the presence of 40 µM TM. To directly 
assess the effect of 62 on cellular copper homeostasis, the intracellular content of the 
metal has been measured by means of ICP-AES in cells treated for different times with 
14 µM 62. A marked time-dependent accumulation of copper can be observed in both 
cell models (Figure 111B), with the maximal effect being evident after 6 h, when 
copper content is 70- and 50-fold increased in HeLa and PC3 cells, respectively, with 
respect to control (untreated cells). As expected, the simultaneous incubation of the 
cells with 62 and 20 µM TM lowers the intracellular copper content to values 
comparable to those of untreated cells (Figure 111), thus confirming the ionophoric 
properties of clioquinol. 
 
Figure 111. Characterization of 62-dependent cytotoxicity. HeLa and PC3 cells were 
treated for 48 h with different concentrations of L62 or 62, either in the absence or 
presence of 20 µM TM or 50 µM z-VAD. Cell viability was assayed using the resazurin 
method. The data presented are the means ± SEM of three independent experiments, 
each performed in quadruplicate. Error bars are visible when larger than the symbols.  
 
These results confirm the ionophoric nature of L58 derivatives for copper, and 
highlights the ligand hydrophobicity as a determinant of the activity of the complex.  
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CHAPTER 10 
Synthesis of Copper(II)complexes with functionalized 
quinoline derivatives. Study of the citotoxic activity on 
cancer human cells. 
 
 
In this chapter we report a series of ligand that derives by the 8-HQ described in the previous 
chapter.. Sixteen ligands were synthesized by addition of a substituted aromatic side arm with 
potential coordinating ability to 8-hydroxyquinoline and 5,7-dichloro-8-hydroxyquinoline, to 
investigate how different chelating abilities could affect cytotoxic activity. The ligands were 
tested on the human tumor cell line HeLa (cervical carcinoma), alone and in presence of 
equimolar quantities of CuCl2. The molecular structures of some Cu(II) complexes were 
ascertained by means of single crystal X-ray diffraction.  
Acoording to biological tests, some of the ligands have showed considerable cytotoxic activity. 
In agreement with previous studies (Chapter 8 and 9), a different behavior between ligands 
and Cu(II) complexes emerged. In fact,  cuprocomplexes exhibited always significantly higher 
activities with respective to the ligands. Some ligands are fairly cytotoxic, but the simultaneous 
administration of CuCl2 always increases  their antitumor efficacy. 
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10.1 Introduction 
The biological properties of 8-hydroxyquinoline (8-HQ), L58, and of its derivatives was 
studied and a great amount of data can be found in literature. 8-HQ and its 
alogenated derivatives have long been known for their antimicrobial and fungicide 
action; nowadays they are commonly used as constituents of antiseptics, 
antimicrobials and fungicides184. In particular oxine-copper Cu(8-HQ)2 (58) complex is 
extensively used as fungicide thanks to its low toxicity (4700 mg/kg for rats and 9000 
mg/kg for mice and a reference suggested dose of 0.05 mg/kg per day)124. 
 
Figure 112. Schematic structure of 8-hydroxyquinoline L58. 
 
The most known and discussed alogenated derivative of 8-hydroxyquinoline is 
clioquinol (5-chloro-7-iodo-8-hydroxyquinoline, abbreviated (CQ, L62), which has 
been used since the first half of the twentieth century as an antibiotic for the 
treatment of diarrhea and skin infections. In the 1970’s it was claimed to be the cause 
of an epidemic spread of subacute myelo-optic neuropathy (SMON) in Japan and 
therefore banned in many countries. The link between CQ and SMON was never 
confirmed, and the pathology was linked to a deficiency in vitamin B12174. Lately L62 
has drawn attention for its anti-Alzheimer ability and as a potential antitumoral 
agent185.  
 
Figure 113. Schematic structure of clioquinol. 
 
8HQs are excellent metal chelators; for instance logβ1 and logβ2 for the complex 58 
are respectively 12.0 and 22.9184 and the pKa for the deprotonation of the phenolic 
group is 9.54 for L58 and 8.07 for L62, low enough to allow deprotonation by 
coordination184,185. Thus, these compounds can exhibit a wide range of biological 
functions related to metal transportation. It has been shown that L58 and L62 act as 
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Zn(II) and Cu(II) ionophore, increasing the uptake of the metals into the cytosol; they 
can raise the concentration of Cu inside the cell of 135% for L58 and of 55% for L62186. 
This property has been shown in literature to make quinoline derivatives suitable for 
anti-Alzheimer drugs187,188, HIV-Integrase inhibition189, anticancer therapy190, metal 
intoxication therapy191,192. 
Cytotoxic activity of 8-HQ derivatives has been studied extensively, either alone or 
complexed with copper and zinc. The majority of the studies on 8-HQ and its 
alogenated derivatives are related to their copper complexes on the other hand, for 
more diversely substituted quinolines, fewer studies take into account the role of 
copper. The most studied complexes are those of 58 and 62. The copper complexes 
transfer through the cellular membrane can occur in two ways: by active transport, 
which involves the pump hCtr1, or by passive transport. For an efficient passive 
crossing, the characteristics of the molecule are of primary importance; the small 
dimensions and no net charge are favorable, but above all a suitable lipophilicity is 
required. As a matter a fact, a too hydrophilic compounds would not be able to cross 
the membrane, whilst too lipophilic molecules would get stuck inside the membrane. 
Thus, lipophilicity can sometimes clearly correlate to cytotoxic activity.  
Once inside the cytosol, it is likely that the Cu(II) complex is reduced to Cu(I), due to 
the intra-cellular reducing environment, rich in thiols, leading to a loss of affinity for 
the ligands and possible substitution39. Cu(I) complex becomes less stabile with hard 
donors like nitrogen and oxygen, while more stable with soft donors like competing 
cystein thiols.  
The mechanism of action of copper complexes 8-HQ derivatives has been widely 
discussed, and it appears to be strongly dependent on proteasome inhibition (in 
cooperation to some extent with oxidative stress caused by formation of ROS) that 
would successively trigger a programmed cell death (PCD) pathway. While much 
debate still remains on the type of PCD occurring, it seems that, once the complex is 
inside the cytosol, proteasome could be its main target. 
It has been shown that whilst treatment with L58 alone on Jurkat cells (T cell 
leukemia) would result in no proteasome inhibition, treatment with CuCl2 alone at the 
same concentration brought to 30% of inhibition of proteasome. Administering the 
complex 58 gives instead full inhibition of proteasome already at 10 μM. The 
presence of the copper atom is necessary for activity, but this one is tremendously 
increased by adding the right ligand. Moreover, treatment with L58 alone proved to 
be successful in case of pre-administration of CuCl2 to the cells. This means that in 
presence of copper, the ligand could form in situ the antiproliferative complex. 
Finding a ligand with sufficient activity could bring to a double action: sequestration 
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of copper atoms fundamental for angiogenesis processes and, at the meantime, 
forming a proteasome inhibiting species. Another hint of the importance of copper 
chelation over cytotoxicity is the large increase in activity between a clioquinole and 
their respective Zn(II) and Cu(II) complexes193, shown in Table 11.  
 
Table 11. IC50 (µM) for tested compounds and relative Cu(II) complexes on different 
cell lines.  
Compound Panc-1 HL60 DHL-4 
L58 5.89 12.90 2.71 
L58+ Cu 2.07 8.60 2.27 
L58+ Zn 0.76 7.51 0.69 
 
 
Figure 114 shows a schematic representation of the hypothesized mechanism of 
action for quinolinic ionophores such as clioquinol. 
 
 
Figure 114. Schematic representation of the mechanism of action of copper 
ionophores compared to non chelating ligands186. 
 
In addition, 58 complex was shown to induce DNA damages through formation of ROS 
in leukemic cell line HL60124. This hypothesis was supported by measuring the 
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intracellular ROS level and by observing that antioxidants like vitamin C and E 
significantly decrease both ROS generation and DNA damage. 
As a continuation of thi study presented in chapter 9, we decided to investigate, 
through a structure/activity relationship study, how the addition of an aromatic side 
arm with potential coordinating ability to 8-hydroxyquinoline moieties could affect 
anticancer activity. Moreover, we attemped to determine the effects on cytotoxicity 
brought by a different mobility of the peripheral arm and by changes in ligand 
lipophilicity. 
Mobility was modulated by introducing between the two aromatic residues a vinylic 
or an ethylenic linker, while lipophilicity was varied using two quinolinic precursors 
with different lipophilicity, namely 8-hydroxyquinoline and 5,7-dichloro-8-
hydroxyquinoline. A series of 16 diversely substituted ligands was therefore obtained 
(shown below in Figure 115); the 16 ligands can be divided in two series of eight 
ligands each, that differ for the type of linker used. Of the eight ligands in each class, 
six are derivatives of 8-hydroxyquinoline and two are derivatives of 5,7-dichloro-8-
hydroxyquinoline.  
The ligands were biologically tested for antitumoral activity in different 
concentrations in presence of equimolar quantities of CuCl2 on the human tumor cell 
line HeLa (cervical carcinoma). A correlation was searched for between the exhibited 
cytotoxicities and structural features, in order to determine common traits leading to 
better antitumor activities. 
Finally, the molecular structures given by a few ligands in presence of CuCl2 were 
analyzed by means of X-ray crystallography. 
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Figure 115. Synthesized ligands. 
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10.2  Experimental 
 
10.2.1. Synthesis 
 
All reagents were commercially available, except for 2-metoxyaldehyde, which was 
prepared as reported elsewhere194. The ligand synthesis were slightly modified from 
procedures reported in literature195,196. The 1H-NMR spectra were registered on 300 
and 400 MHz Bruker Avance spectrometers using standard pulse sequences. Chemical 
shifts were reported in parts per million (ppm) and referred to residual solvent 
protons. Infrared spectra were registered between 4000 and 400 cm-1 on a Perkin-
Elmer Nexus FTIR  with KBr windows. Elemental analysis (C, H and N) were performed 
on a Carlo Erba EA 1108 automated analyzer. 
 Synthesis of 2-(2-hydroxystyryl)quinolin-8-ol (L64).Under nitrogen, 2-methylquinolin-
8-ol (1.70 g, 10.70 mmol) and 2-hydroxybenzaldehyde (1.30 ml, 12.42 mmol) were 
mixed in acetic anhydride (15 ml), and the mixture was heated at 95°C for 72 hours 
with stirring. After cooling, water (50 ml) was added and stirred for two hours; the 
mixture was then neutralized using NaOH (10% in water). The product was extracted 
with dichloromethane (50 ml) and the organic phase was separated from the aqueous 
one, washed with water (3x30 ml) and Brine (2x30 ml), dried with anhydrous Na2SO4 
and filtered. The solvent was removed under vacuum and a red powder (1.23 g, 33%) 
was precipitated with hexane, filtered and vacuum dried. For the deacetylation, the 
red powder (1.00 g, 3.00 mmol) was added to a solution of sodium methoxide (0.49 g, 
9.00 mmol) in methanol (70 ml) and the mixture was stirred for two hours. The 
mixture was neutralized with HCl (35% in water), the solvent was removed under 
vacuum and then dichloromethane was added (20 ml). The organic phase was then 
washed with water (3x30 ml), dried with anhydrous Na2SO4, filtered and vacuum 
dried. The product was recrystallized by dichloromethane/hexane, yielding a pale 
yellow solid (0.71 g, 90%). Total yield = 30%. IR (cm-1): 3436m, 3386m, 1634m, 1588m, 
1555s, 1509s, 1451s, 1392w, 1326m, 1313s, 1255s, 1238s, 1196s, 1155s, 1092s, 
971m, 871m, 833s, 754s, 629m, 562m, 495w, 450w. 1H NMR (300 MHz, Acetone) δ 
8.89 (bs, 2H, (2OH)), 8.32 (d, J = 8.6 Hz, 1H), 8.26 (d, J = 16.4 Hz, 1H, (CH=)), 7.85 (d, J = 
8.6 Hz, 1H), 7.74 (dd, J1 = 7.7 Hz, J2 = 1.5 Hz, 1H), 7.59 (d, J = 16.4 Hz, 1H, (CH=)), 7.43 
(m, 2H), 7.24 (td, J1 = 7.0 Hz, J2 = 1.0 Hz, 1H), 7.15 (dd, J1 = 6.9 Hz, J2 = 1.9 Hz, 1H), 7.04 
– 6.91 (m, 2H)  
Synthesis of 2-(2-(pyridin-2-yl)vinyl)quinolin-8-ol (L65). The procedure is analogous to 
that reported for L64. Under nitrogen, 2-methylquinolin-8-ol (1.59 g, 10.00 mmol) and 
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picolinaldehyde (0.95 ml, 10.00 mmol) were mixed in acetic anhydride (15 ml), and 
the mixture was heated at 90°C for 72 hours with stirring, yielding, in the first step, a 
dark glue (0.61 g, 2.22 mmol, 21%) and this crude was added, in the second step, to a 
solution of sodium methoxide (0.36 g, 6.66 mmol) in methanol (40 ml). The product 
was a dark oil (0.43 g, 79%) obtained pure without recrystallization. Total yield = 17%. 
IR (cm-1): 3303w, 3065w, 3040w, 2990w, 1580s, 1555s, 1501s, 1451s, 1426s, 1380m, 
1309m, 1280m, 1234s, 1184s, 1138s, 1084w, 967m, 829m, 762m, 733s, 612w, 441m. 
1H NMR (300 MHz, CDCl3) δ 8.67 (d, J = 3.7 Hz, 1H), 8.09 (d, J = 8.5 Hz, 1H), 7.80 (d, 5.3 
Hz, 2H, CH(Ph)), 7.70 (td, J1 = 13.0 Hz, J2 = 5.4 Hz, 1H), 7.62 (d, J = 8.5 Hz, 1H), 7.49 (d, J 
= 7.6 Hz, 1H, CH(Ph)), 7.41 (t, J = 7.9 Hz, 1H, CH(Ph)), 7.33 – 7.25 (m, 1H, CH(Ph)), 7.20 
(dd, J1 = 14.1 Hz, J2 = 5.0 Hz, 2H, CH(Ph)). 
Synthesis of 2-(2-(methylthio)styryl)quinolin-8-ol (L66). The procedure is analogous to 
that reported for L64. Under nitrogen, 2-methylquinolin-8-ol (0.52 g, 3.28 mmol) and 
2-(methylthio)benzaldehyde (0.42 ml, 3.28 mmol) were mixed in acetic anhydride (15 
ml), and the mixture was heated at 130°C for 72 hours with stirring, yielding, in the 
first step, a brown oil that was further purified through silica column chromatography 
(hexane/ethyl acetate 7/3) (0.25 g, 0.76 mmol, 23%) and this crude was added, in the 
second step, to a solution of sodium methoxide (0.12 g, 2.27 mmol) in methanol (40 
ml). The product was a grey powder (0.20 g, 88%) obtained pure without 
recrystallization. Total yield = 20%. IR (cm-1): 3432m, 3053w, 1626s, 1593s, 1555m, 
1501m, 1438s, 1380s, 1326s, 1271m, 1238m, 1159m, 1100s, 954m, 833m, 746s, 
616w, 462w. 1H NMR (400 MHz, CDCl3) δ 8.19 (d, J = 16.1 Hz, 1H, (CH=)), 8.14 (d, J = 
8.6 Hz, 1H), 7.77 – 7.69 (m, 2H, CH(Ph)), 7.43 (t, J = 7.9 Hz, 1H, CH(Ph)), 7.40 – 7.23 (m, 
5H, CH(Ph)), 7.20 (d, J = 7.5 Hz, 1H, CH(Ph)), 2.54 (s, J = 8.8 Hz, 3H, (SCH3)). 
Synthesis of 2-(2-methoxystyryl)quinolin-8-ol (L67). The procedure is analogous to that 
reported for L64. Under nitrogen, 2-methylquinolin-8-ol (1.17 g, 7.34 mmol) and 2-
metoxybenzaldehyde (1.00 g, 7.34 mmol) were mixed in acetic anhydride (15 ml), and 
the mixture was heated at 130°C for 72 hours with stirring, yielding a red glue that 
was recrystallized in dichloromethane/hexane and left in the freezer for 12 hours. A 
light brown precipitate is obtained (0.87 g, 2.75 mmol, 37%) and this crude was 
added, in the second step, to a solution of sodium methoxide (0.45 g, 8.50 mmol) in 
methanol (40 ml). The product was recrystallized in dichloromethane/hexane yielding 
a yellow powder (0.70 g, 93%). Total yield = 34%. IR (cm-1): 3357w, 3044w, 3003w, 
2944w, 2827w, 1622w, 1597s, 1563s, 1513s, 1463s, 1434s, 1392m, 1371m, 1317s, 
1238s, 1192s, 1109s, 1079s, 1021s, 954s, 867w, 829s, 787m, 742s, 712s, 612s, 446s. 
1H NMR (400 MHz, CDCl3) δ 8.11 (s, 1H) 8.08 (d, J=10.2 Hz, 1H, (CH=)), 7.71 (t, J = 8.6 
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Hz, 2H), 7.46 – 7.38 (m, 2H, CH(Ph)), 7.38 – 7.27 (m, 2H, CH(Ph)), 7.20 (t, J = 7.5 Hz, 
1H), 7.05 (t, J = 7.5 Hz, 1H), 6.97 (d, J = 8.2 Hz, 1H), 3.96 (s, 3H, (OCH3)). 
Synthesis of 2-(2-(quinolin-2-yl)vinyl)quinolin-8-ol (L68). The procedure is analogous to 
that reported for L64. Under nitrogen, 2-methylquinolin-8-ol (0.50 g, 3.14 mmol) and 
2-quinolincarboxaldehyde (0.50 g, 3.14 mmol) were mixed in acetic anhydride (15 ml), 
and the mixture was heated at 90°C for 72 hours with stirring, yielding a brown solid 
that was recrystallized in dichloromethane/hexane to obtain a yellow glue (0.45 g, 
1.51 mmol, 48%) and this crude was added, in the second step, to a solution of 
sodium methoxide (0.21 g, 3.93 mmol) in methanol (40 ml). The product was 
recrystallized in dichloromethane/hexane. The yellow solution obtained was dried 
under vacuum yielding a yellow solid (0.28 g, 70%). Total yield = 34%. IR (cm-1): 
3349w, 3048w, 1705w, 1593s, 1555m, 1505s, 1463s, 1422s, 1388w, 1346m, 1317m, 
1221m, 1184m, 1142m, 996m, 913w, 879w, 833s, 754m, 621w, 546w, 450m. 1H NMR 
(400 MHz, CDCl3) δ 8.18 (d, J = 8.6 Hz, 1H, CH(Ph)), 8.15 (d, J = 8.5 Hz, 2H, CH(Ph)) 7.99 
(d, J = 16.3 Hz, 1H, (CH=)), 7.87 (d, J = 16.3 Hz, 1H, (CH=)), 7.84 - 7.78 (m, 2H, CH(Ph)), 
7.75 (t, J = 8.5 Hz, 2H, CH(Ph)), 7.54 (t, J = 7.4 Hz, 1H, CH(Ph)), 7.44 (t, J = 7.9 Hz, 1H, 
CH(Ph)), 7.32 (d, J = 8.1 Hz, 1H, CH(Ph)), 7.21 (d, J = 7.5 Hz, 1H). 
Synthesis of 1,2-bis(2-quinolinyl-8-ol)ethene (L69). The procedure is analogous to that 
reported for L64. Under nitrogen, 2-methylquinolin-8-ol (0.55 g, 3.46 mmol) and 8-
hydroxy-2-quinolincarboxaldehyde (0.60 g, 3.46 mmol) were mixed in acetic 
anhydride (15 ml), and the mixture was heated at 90°C for 72 hours with stirring, 
yielding a light brown glue recrystallized in hot methanol to obtain a yellow powder 
(0.82 g, 2.12 mmol, 61%) and this crude was added, in the second step, to a solution 
of sodium methoxide (0.33 g, 6.18 mmol) in methanol (40 ml). The product was a pale 
yellow powder (0.51 g, 79%) obtained pure without recrystallization. Total yield = 
48%. IR (cm-1): 3340m, 3036w, 2919w, 2852w, 1588m, 1559m, 1505s, 1463s, 1434m, 
1352 s, 1313s, 1230m, 1180m, 1150m, 1088 m, 979m, 883w, 833s, 746s, 704w, 579w, 
546w, 437m. 1H NMR (300 MHz, CDCl3) δ 8.19 (d, J = 8.6 Hz, 2H), 7.93 (s, 2H, (CH=)), 
7.77 (d, J = 8.6 Hz, 2H), 7.45 (t, J = 8.0 Hz, 2H), 7.34 (dd, J1 = 8.2 Hz, J2 = 1.1 Hz, 2H), 
7.21 (dd, J1 = 7.5 Hz, J2 = 1.2 Hz, 2H). 
Synthesis of 5,7-dichloro-2-(2-hydroxystyryl)quinolin-8-ol (L70).The procedure is 
analogous to that reported for L64. Under nitrogen, 5,7-dichloro-2-methylquinolin-8-
ol (1.01 g, 4.43 mmol) and 2-hydroxybenzaldehyde (0.92 ml, 4.43 mmol) were mixed 
in acetic anhydride (15 ml), and the mixture was heated at 90°C for 72 hours with 
stirring, yielding a dark glue recrystallized in dichloromethane/hexane obtaining a 
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light brown powder (0.61 g, 1.50 mmol, 34%) and this crude was added, in the second 
step, to a solution of sodium methoxide (0.24 g, 4.49 mmol) in methanol (40 ml). The 
product was a red powder (0.50 g, 98%) obtained pure without recrystallization. Total 
yield = 33%. IR (cm-1): 3441m, 3345m, 3065w, 1580s, 1551s, 1492s, 1438s, 1384s, 
1338m, 1305s, 1213s, 1184s, 1138s, 1088m, 1004m, 963s, 938m, 850m, 817m, 737s, 
721s, 596w, 571w. 1H NMR (300 MHz, MeOD) δ 8.38 (d, J = 8.9 Hz, 1H, (B)), 8.15 (d, J = 
16.5 Hz, 1H, (CH=)), 7.82 (d, J = 8.9 Hz, 1H), 7.63 (d, J = 7.0 Hz, 1H), 7.47 (d + s, J = 8.2 
Hz, 2H, (CH= + H)), 7.15 (t, J = 7.7 Hz, 1H), 6.86 (t + d, J = 7.3 Hz, 2H). 
Synthesis of 5,7-dichloro-2-(2-(pyridin-2-yl)vinyl)quinolin-8-ol (L71). The procedure is 
analogous to that reported for L64. Under nitrogen, 5,7-dichloro-2-methylquinolin-8-
ol (1.50 g, 6.57 mmol) and picolinaldehyde (0.60 ml, 6.57 mmol) were mixed in acetic 
anhydride (15 ml), and the mixture was heated at 90°C for 72 hours with stirring, 
yielding a dark red glue that was recrystallized in dichloromethane/hexane to obtain a 
black powder (1.07 g, 2.97 mmol, 45%) and this crude was added, in the second step, 
to a solution of sodium methoxide (0.41 g, 8.91 mmol) in methanol (40 ml). The 
product was recrystallized in dichloromethane/hexane yielding a brown powder (0.79 
g, 84%). Total yield = 38%. IR (cm-1): 3382m, 1626w, 1584m, 1555m, 1522m, 1430s, 
1346s, 1146s, 1113s, 988w, 954m, 871w, 812m, 767m, 737m, 637m, 608m, 550w, 
508w. 1H NMR (300 MHz, MeOD) δ 8.55 (d, J = 4.8 Hz, 1H), 8.38 (d, J = 8.8 Hz, 1H), 
7.90 – 7.79 (m, 4H, CH(Ph)), 7.75 (d, J = 7.9 Hz, 1H, CH(Ph)), 7.48 (s, 1H), 7.35 – 7.27 
(m, 1H). 
Synthesis of 2-(2-hydroxyphenylethyl)quinolin-8-ol (L72). After two H2 cycles to rinse 
the Parr vessel with hydrogen, the mixture of L64 (0.50 g, 1.90 mmol) and 10% Pd/C 
(5% in weight of the substrate) in EtOH (50 ml) was vigorously stirred at room 
temperature under 2 atm of hydrogen for 12 hours. The reaction mixture was filtered 
and the filtrate was concentrated to provide a white precipitate, which was filtered 
and washed with hexane. A white powder was obtained (0.250 g, 51%). Final yield = 
15%. IR (cm-1): 3203s, 2936w, 2911w, 2886w, 1605m, 1563s, 1484s, 1426s, 1363m, 
1271s, 1242s, 1205m, 1079m, 1059m, 933w, 838m, 800m, 762s, 725w, 554w, 483w. 
1H NMR (400 MHz, Acetone) δ 8.71 (bs, 1H, (OH)), 8.40 (bs, 1H, (OH)), 8.21 (d, J = 8.5 
Hz, 1H), 7.45 (d, J = 8.5 Hz, 1H), 7.34 (m, 2H), 7.16 (dd, J1 = 7.4 Hz, J2 = 1.3 Hz, 1H), 7.11 
(dd, J1 = 7.3 Hz, J2 = 1.3 Hz, 1H), 7.03 (td, J1 = 7.8 Hz, J2 = 1.6 Hz, 1H), 6.87 (d, J = 7.9 Hz, 
1H), 6.75 (t, J = 7.4 Hz, 1H), 3.33 (m, 2H, (CH2)), 3.22 (m, 2H, (CH2)). 
Synthesis of 2-(2-(pyridin-2-yl)ethyl)quinolin-8-ol (L73). After two H2 cycles to rinse the 
Parr vessel with hydrogen, the mixture of L65 (0.72 g, 2.89 mmol) and 10% Pd/C (5% 
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in weight of the substrate) in EtOH (50 ml) was vigorously stirred at room 
temperature under 2 atm of hydrogen for 72 hours. The reaction mixture was filtered 
and the filtrate was concentrated to provide a brown oil (0.64 g, 88%). Final yield = 
15%. IR (cm-1): 3375m 3044w 2925w 1592s 1571s 1503s 1474s 1427s 1325 m 1244m 
1202w 1155w 1083w 994w 828 m 748m 599w. 1H NMR (300 MHz, CDCl3) δ 8.68 (d, J 
= 4.8 Hz, 1H), 8.09 (d, J = 8.4 Hz, 1H), 7.75 (td, J1 = 7.6 Hz, J2 = 6.3 Hz, 1H), 7.45 – 7.21 
(m, 6H, CH(Ph)), 3.60 – 3.43 (m, 4H, (2CH2)).
 
Synthesis of 2-(2-(methylthio)phenylethyl)quinolin-8-ol (L74). After two H2 cycles to 
rinse the Parr vessel with hydrogen, the mixture of L66 (0.20 g, 0.67 mmol) and 10% 
Pd/C (5% in weight of the substrate) in EtOH (50 ml) was vigorously stirred at room 
temperature under 2.5 atm of hydrogen for 72 hours. The reaction mixture was 
filtered, the filtrate was concentrated and recrystallized in warm diethyl ether using 
an ultrasound emitter, to provide a yellow solution, which was evaporated, obtaining 
a yellow oil (0.15 g, 77%). Final yield = 16%. IR (cm-1): 3378w, 3053w, 2915w, 2848w, 
1597m, 1576m, 1505s, 1467s, 1434m, 1371m, 1326w, 1234s, 1205m, 1088m, 1042w, 
967w, 833m, 746s, 600w, 466w. 1H NMR (400 MHz, CDCl3) δ 8.08 (d, J = 8.4 Hz, 1H), 
7.42 (t, J = 7.9 Hz, 1H, CH(Ph)), 7.33 (t, J = 8.9 Hz, 2H, CH(Ph)), 7.25 (m, 2H, CH(Ph)), 
7.19 (d, J = 7.5 Hz, 2H, CH(Ph)), 7.13 – 7.07 (m, 1H, CH(Ph)), 3.39 – 3.32 (m, 2H, (CH2)), 
3.32 – 3.26 (m, 2H, (CH2)), 2.53 (s, 3H, (SCH3)).
 
Synthesis of 2-(2-methoxyphenylethyl)quinolin-8-ol (L75). After two H2 cycles to rinse 
the Parr vessel with hydrogen, the mixture of L67 (0.20 g, 0.72 mmol) and 10% Pd/C 
(5% in weight of the substrate) in EtOH (50 ml) was vigorously stirred at room 
temperature under 0.8 atm of hydrogen for one hour. The reaction mixture was 
filtered and the filtrate was concentrated to provide a brown powder (0.14 g, 70%). 
Final yield = 24%. IR (cm-1): 3353m, 3011w, 2948w, 2932w, 2831w, 1605m, 1572m, 
1513s, 1497s, 1484s, 1371m, 1317m, 1238s, 1155m, 1104s, 1025s, 967w, 829s, 750s, 
725m, 621m, 466w. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 8.4 Hz, 1H), 7.46 – 7.38 
(m, 1H, CH(Ph)), 7.33 – 7.29 (m, 2H, CH(Ph)), 7.23 (td, J1 = 7.5 Hz, J2 = 1.4 Hz, 1H, 
CH(Ph)), 7.18 (td, J1 = 7.5 Hz, J2 = 1.4 Hz, 2H, CH(Ph)), 6.92 - 6.85 (m, 2H, CH(Ph)), 3.85 
(s, 3H, (OCH3)), 3.32 (m, 2H, (CH2)), 3.20 (m, 2H, (CH2)).
 
Synthesis of 2-(2-(quinolin-2-yl)ethyl)quinolin-8-ol (L76). After two H2 cycles to rinse 
the Parr vessel with hydrogen, the mixture of L68 (0.26 g, 0.86 mmol) and 10% Pd/C 
(5% in weight of the substrate) in EtOH (50 ml) was vigorously stirred at room 
temperature under 0.8 atm of hydrogen for one hour. The reaction mixture was 
filtered and the filtrate was concentrated to provide a brown powder (0.15 g, 56%). 
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Final yield = 19%. IR (cm-1): 3384w, 3049w, 2921w, 1597m, 1563m, 1508s, 1469m, 
1427m, 1376m, 1325m, 1240m, 1193w, 1134w, 1083w, 833m, 743m, 667w, 612w, 
472w. 1H NMR (400 MHz, MeOD) δ 8.25 (d, J = 8.5 Hz, 1H, CH(Ph)), 8.13 (d, J = 8.4 Hz, 
1H, CH(Ph)), 8.02 (d, J = 8.5 Hz, 1H, CH(Ph)), 7.89 (d, J = 8.1 Hz, 1H, CH(Ph)), 7.75 (ddd, 
J1 = 8.4 Hz, J2 = 7.0 Hz, J3 = 1.4 Hz, 1H, CH(Ph)), 7.56 (t, J = 7.5 Hz, 1H, CH(Ph)), 7.50 (d, 
J = 8.5 Hz, 1H, CH(Ph)), 7.43 – 7.29 (m, 3H, CH(Ph)), 7.09 (dd, J1 = 7.4 Hz, J2 = 1.3 Hz, 
1H, (A)), 3.56 (m, 2H, (CH2)), 3.51 (m, 2H, (CH2)).
 
Synthesis of 1,2-bis(2-quinolinyl-8-ol)ethane (L77). After two H2 cycles to rinse the Parr 
vessel with hydrogen, the mixture of L69 (0.38 g, 1.20 mmol) and 10% Pd/C (5% in 
weight of the substrate) in EtOH (50 ml) was vigorously stirred at room temperature 
under 0.8 atm of hydrogen for one hour. The reaction mixture was filtered and the 
filtrate was concentrated to provide a light brown solid, which was recrystallized in 
hot chloroform/diethyl ether and left in freezer for 12 hours, yielding a dark yellow 
powder filtered and washed with diethyl ether (0.19 g, 49%). Final yield = 24%. IR (cm-
1): 3449w, 3048w, 2932w, 2865w, 1593m, 1563s, 1505s, 1451s, 1392m, 1367m, 
1330s, 1271s, 1242s, 1134m, 1088s, 1054m, 829s, 754s, 725s, 541m. 1H NMR (300 
MHz, CDCl3) δ 8.06 (d, J = 8.4 Hz, 2H), 7.44 – 7.21 (m, 6H, CH(Ph)), 7.14 (d, J = 7.4 Hz, 
2H), 3.59 (s, 4H, (2CH2)).
 
Synthesis of 5,7-dichloro-2-(2-hydroxyphenylethyl)quinolin-8-ol (L78).To a solution of 
L70 (0.10 g, 0.30 mmol) in EtOH (8 ml) hydrate hydrazine (2 ml) was added at 70°C. 
The mixture was heated under reflux at 80°C for 20 hours. The solvent was then 
evaporated, the product was extracted with dichloromethane (40 ml) and washed 
with H2O (2x20 ml), dried with anhydrous Na2SO4 and filtered. The solvent was 
evaporated under vacuum and a brown solid was obtained, which was recrystallized 
in dichloromethane/hexane. The brown precipitate was filtered and dried (0.03 g, 
25%). Final yield = 9%. 1H NMR (400 MHz, Acetone) δ 8.39 (d, J = 8.6 Hz, 1H), 7.60 (m, 
2H), 7.13 (d, J = 7.4 Hz, 1H), 7.02 (t, J = 7.2 Hz, 1H), 6.88 (d, J = 7.9 Hz, 1H), 6.74 (t, J = 
7.4 Hz, 1H), 3.37 (m, 2H, (CH2)), 3.21 (m, 2H, (CH2)). 
Synthesis of 5,7-dichloro-2-(2-(pyridin-2-yl)ethyl)quinolin-8-ol (L79).The procedure is 
analogous to that reported for L78. The mixture of L71 (0.65 g, 2.05 mmol) with 
hydrate hydrazine (13 ml) in EtOH (30 ml) was heated under reflux for 20 hours, 
yielding a dark yellow solid (0.42 g, 65%), obtained pure without recrystallization. 
Final yield = 25%. IR (cm-1): 3332w, 3044w, 3011w, 2923w, 2652w, 1584s, 1563s, 
1534m, 1488m, 1434s, 1392m, 1346s, 1234m, 1188, 1146w, 1100m, 1004w, 942m, 
858m, 817m, 771m, 733m, 616w, 554m. 1H NMR (300 MHz, CDCl3) δ 8.55 (d, J = 3.7 
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Hz, 1H), 8.32 (d, J = 8.6 Hz, 1H), 7.58 (td, J1 = 7.7 Hz, J2 = 1.6 Hz, 1H), 7.48 (s, 1H), 7.39 
(d, J = 8.3 Hz, 1H), 7.19 – 7.07 (m, 2H), 3.47 (m, 2H, (CH2)), 3.35 (m, 2H, (CH2)). 
 
10.2.2.  X-rays structural determination 
A summary of data collection and structure refinement for [Cu(L64)]2, [Cu(L67)]2, L72 
and [Cu(L73)]2 is repoted in Appendix xiii. Single crystal data were collected with a 
Bruker Smart APEXII area detector diffractometers, Mo Kα: λ = 0.71073 Å. The unit 
cell parameters were obtained using 60 ω-frames of 0.5° width and scanned from 
three different zone of reciprocal lattice. The intensity data were integrated from 
several series of exposures frames (0.3° width) covering the sphere of reciprocal 
space48. An absorption correction was applied using the program SADABS104. The 
structures were solved by direct methods (SIR2004) and refined on F^2 with full-
matrix least squares (SHELXL-9750), using the Wingx software package51. The hydrogen 
atoms were placed at their calculated positions, and the non-hydrogen atoms of 
[Cu(L64)]2, [Cu(L67)]2 and L72 were refined anisotropically. Due to the poor data set 
of [Cu(L75)]2, the atoms in this model where refined with isotropic thermal 
parameters. Graphical material was prepared with  Mercury 3.052 programs. 
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10.3. Results and Discussion 
10.3.1.   Ligand synthesis 
The synthetic route (Figure 116) comprises three steps: the first two steps lead to the 
synthesis of the styrylquinolinic compounds L64-L71 and the third step leads to their 
reduction to arylethylenquinolinic species L72-L79.  
The first is a condensation in acetic anhydride, depicted by others as a Perkin-like 
condensation56,57, between the nucleophilic carbanion of 2-methyl-8-hydroxyquinoline, 
which is stabilized by resonance, and an appropriate aldehyde. This reaction occurs 
together with protection of the nucleophilic hydroxyl group of 8-hydroxyquinoline by 
means of nucleophilic acyl substitution with acetic anhydride, which yields the acetylated 
intermediate and an acetate ion. Without this protection, the hydroxyl group could act as 
nucleophile for the aldehydic carbonyl, competing with the formation of the 
styrylquinoline intermediate and generating unwanted sideproducts.  
The reaction mechanism has not been further investigated. 
 
 
Figure 116. Synthetic scheme. 
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The yields of this step are modest and range from 25% for compound L65 (Ar = pyridine, X 
= H) to 61% for compound L69 (Ar = 8-HQ, X = H). 
The second step is the deacetylation of the intermediate in basic environment by means 
of NaOCH3  or NaOH
195. The highly nucleophilic methoxide anion reacts with the 8-acetylic 
carbonyl, providing methylacetate and the quinolin-8-olate anion, which is subsequently 
neutralized to obtain the styrylquinolinic product (compounds L64-L71). Yields of this step 
are high and range from 70% for product L68 (Ar = quinoline, X = H) to 98% for product 
L70 (Ar = phenol, X = H). Final yields, accounting for both steps, vary between 17% for 
compound L70 (Ar = pyridine, X = H) and 48% for compound L69 (Ar = 8-HQ, X = H).  
An alternative synthetic path194 could rely on a first separate protection of the 8-hydroxyl 
group by methylation with CH3I, followed by deprotonation of the 2-methyl group 
through a non-nucleophilic base like LDA (lithium diisopropylamide), to give the quinolinic 
carbanion. This could successively react with the desired aldehyde affording the 
methylated styrylquinoline intermediate. At last, the deprotection in acid environment of 
the phenolic group would provide the final product. 
 
 
Figure 117. Alternative synthetic path. 
 
The higher number of steps that this procedure requires and the fact that the final 
demethylation could result in a more complex reaction than the efficient deacetylation 
made us choose to follow the first, more affordable, synthetic route. Other more complex 
synthesis pathways have also been proposed197. 
The double bond hydrogenation was achieved in two different ways due to anomalous 
behavior of the 5,7-dicholoro-8-hydroxyquinoline derivatives, which were more inert than 
the other ligands towards Pd-catalyzed hydrogenation. For ligands L64 - L69 we 
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proceeded through catalyzed hydrogenation with H2(g) and Pd/C (10% in weight) in 
ethanol59. Different H2 pressures and times were used, because of dissimilar reactivity of 
the compounds, ranging from 0.8 atm/1h to 2.5 atm/72h. 
Ligands L70 and L71 were resistant to catalytic hydrogenation and were then reduced 
with hydrate hydrazine, which acted both as the reductant and as the solvent198.  
Since the cytotoxic assays on human tumor cell lines comprise the administration of CuCl2 
and of ligands directly into the cell growth medium, the final synthesis of copper 
complexes was not deeply investigated. The mixing of equimolar quantities of the ligands 
and of CuCl2 in methanol would result in the instantaneous formation of a dark 
precipitate, insoluble in any common laboratory solvent, with a wide range of polarity. 
Copper complexes crystals suitable for X-ray analysis were obtained only for compounds 
L64, L67 and L73 by in-gel crystallization. This method consists in the stratification of 
ligand MeOH solutions over agar gels of CuCl2.  
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10.3.2.   Molecular Structures 
Four crystal structures were obtained: 
• two complexes of olefinic ligands - [Cu(L64)2] and [Cu(L67)2], 
• one hydrogenated ligand (L72), 
• one complex with an hydrogenated ligand - [Cu(L73)2]. 
 
 
The complex [Cu(L64)2] - (L64 = 2-(2-hydroxystyryl)quinolin-8-ol) crystallizes in the P21/c 
space group (monoclinic crystal system). The asymmetric unit is a complex with 
stoichiometry M:L 1:2, in which a copper atom surrounded by two N,O chelate ligands. 
The 8-hydroxyl group is deprotonated upon metal coordination, whereas the 2-hydroxyl 
group of the phenolic side arm is not deprotonated and does not participate into the 
metal coordination; the doubly positive charge brought by the copper ion is then 
neutralized by the two quinolinic moieties, yielding a neutral complex. Cu(II) shows a 
slightly distorted square planar geometry. The ligand adopts a trans geometry with 
respect to the double bond system and the lateral phenolic arm cannot therefore 
cooperate into the metal coordination. This group takes part into an extensive hydrogen 
bond network. As a matter of fact, the complex exchanges two significative hydrogen 
bonds with the phenolic arm, one towards the phenolic side arm (d(O–O) = 2.80 Å) and 
one towards the quinolinic hydroxy group (d(O–O) = 2.68 Å) of two different ligand 
molecules.  
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Figure 118. Crystal structure of [Cu(L64)2]. 
 
Table 12. Selected bond lengths (Å) and angles (°) for [Cu(L73)2], [Cu(L64)2] and 
[Cu(L67)2]. 
[Cu(L73)2]  [Cu(L67)2]  
Cu-O(1) 1.88(2) Cu-O(1) 1.91(3) 
Cu-N(1) 2.12(2) Cu-N(12) 2.06(4) 
O(1)-Cu-N(1’) 95.2(8) N(1)-Cu-O(1) 83.9(1) 
O(1)-Cu-N(1) 84.8 (8) O(1)-Cu-N(1’) 101.2(1) 
[Cu(L64)2]    
Cu-O(11) 1.89(1)   
Cu-N(11) 2.06(4)   
Cu-O(12) 1.91(1)   
Cu-N(12) 2.06(2)   
N(11)-Cu-O(11) 84.05(6)   
O(11)-Cu-N(12) 98.83 (6)   
N(12)-Cu-O(12) 83.69(6)   
O(12)-Cu-N(11) 99.11(7)   
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The complex [Cu(L67)2] - (L67 = 2-(2-methoxystyryl)quinolin-8-ol) crystallizes in the C2/c 
space group (monoclinic crystal system). In this structure the asymmetric unit comprises 
only one ligand molecule. The metal complex of stoichiometry M:L 1:2 is generated by 
symmetry (C2 rotation axes). The structure is very similar to that of complex [Cu(L64)2], 
but the metal has more pronounced, though distorted, tetrahedral coordination 
geometry. The coordinating atoms are two nitrogens and two oxygen atoms of two 
different quinolinic moieties. The 8-hydroxyl groups are deprotonated giving rise a 
neutral complex. Due to the methylation of the peripheral phenolic function, this group 
does not exchange hydrogen bonds with surrounding molecules. 
 
 
 
Figure 119. Crystal structure of complex [Cu(L67)2]; symmetry operation ’= - x, y, - z + 1/2. 
 
 
The hydrogenated ligand L72 - (L72 = 2-(2-hydroxyphenylethyl)quinolin-8-ol) crystallizes 
in the P21/n space group (monoclinic crystal system). The asymmetric unit comprises one 
ligand molecule. The phenolic side arm is oriented toward the quinolinic N,O coordinating 
system and the second hydroxyl group is turned inwards, as would be the case in 
presence of a metal ion. This conformation is stabilized by the formation of two hydrogen 
bonds, an intramolecular one, between the phenolic arm and the pyridinic nitrogen (d(O–
N) = 2.76 Å) and an intermolecular one, between the quinolinic phenol and the lateral 
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phenolic arm (d(O–O) = 2.72 Å). The four ligand molecules in the unit cell are thus held in 
pair by four hydrogen bonds and are correlated by an inversion centre. This ligand 
conformation would be then favorable to three-term O,N,O chelation on Cu(II), possibly 
forming a doubly deprotonated M:L 1:1 neutral complex. 
 
 
 
 
 
Figure 120. Crystal structure of ligand L72 and its coupling through hydrogen bonds; 
symmetry operation ’= - x, - y, - z. 
 
The complex [Cu(L73)2] - (L 73 = 2-(2-(pyridin-2-yl)ethyl)quinolin-8-ol) crystallizes in the 
P21/c space group (monoclinic crystal system). The asymmetric unit contains only one 
ligand molecule that forms the M:L 1:2 complex by symmetry (inversion centre coincident 
with the copper atom position). Copper is again coordinated by two different quinolinic 
N,O systems and it is a regular square planar geometry (sum of coordination angles of 
360°). The complex is neutral due to the two deprotonated 8-hydroxyl groups. The 
pyridinic side arm is not involved into the metal coordination and is held backwards, even 
though it is not conformationally blocked as in the first two structures. The nitrogen atom 
of this pyridine residue forms a strong hydrogen bond with a solvent water molecule 
(d(O–N) = 2.68 Å) that sets up a 2D hydrogen bond network of water molecules  forming a 
zig-zag strand. The flexibility of this peripheral group together with the energy gained 
from the hydrogen bond network might explain the exclusion of the pyridine ring from 
metal chelation. 
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Figure 121.  Above: crystal structure of complex [Cu(L73)2]; symmetry operation ’= - x, - y, 
- z+1.Under: supramolecular packing and water strand-like channel in complex [Cu(L73)2]. 
 
 
From the crystal structures it appears that these ligand systems tend to use only the N,O 
donor set, irrespective of the presence of additional donor groups. The resulting 
stoichiometry is therefore usually M:L 1:2 in analogy to that reported for [Cu(CQ)2], Figure 
122.  
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Figure 122 Crystal structure of 5-chloro-7-iodo-8-hydroxyquinoline. 
 
The trans (Z) isomerism of the olefinic ligands L64-L71 rules out any possible involvement 
of the peripheric group into the metal coordination. This is in agreement with the 
structures of [Cu(L64)2] and [Cu(L67)2]. In fact a tridentate chelation would require a 
configuration rearrangement leading to the cis (E) isomer through rotation around a 
double bond, which is energetically demanding. Ligands L64-L71 were prepared in acetic 
anhydride and the (E) isomer is preferentially formed, due to the less steric hindrance 
that these species suffer rather than the (Z) isomers. The formation of the (E) isomer was 
proved by 1H-NMR coupling constants of the synthesized ligands. Figure 132 shows the 
aromatic signals of the 1H-NMR spectra of ligand L64; two doublets that integrate for one 
proton each have a coupling constant of 16.4 Hz, a typical value for signals of vinylic 
protons with trans isomerism (E). 
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Figure 123. Expansion of the aromatic pattern for 1H-NMR spectra of ligand L64. 
 Isomer over the E one can also be appreciated by inspecting the crystal structure of the 
[Cu(L77)] shown in Figure 125. 
 
 
Figure 124.: Crystal structure of compound 2,7’-ethylenebis(8-hydroxyquinoline). 
 
In order to investigate how a higher stability of the cuprocomplexes could influence 
cytotoxic activity, we were interested in synthesizing new ligands able to chelate copper 
atoms with both quinolinic N,O system and a diversely substituted side arm (compounds 
L72-L79) and to compare their cytotoxic activity with the activity of analogue ligands not 
able to sustain  a 3/4-term chelation (compounds L64-L71) see Figure 118.  
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Figure 125. Crystal structure of complex [Cu(L77)] reported by others. 
 
 
The only structure in which both ligand parts intervene into the metal coordination is the 
one with the symmetric L77 ligand, Figure 125. In this structure both systems coordinate 
the metal with the identical N,O chelate moiety giving rise to a neutral complex. In the 
other hand, less symmetric ligand such as those reported in Figure 126, may be able to 
coordinate on a tridentate fashon. They can in fact be deprotonated on both phenol 
groups and giving rise to more stable neutral complexes.  
 
 
 
Figure 126. Ligands with two deprotonable phenolic moieties.  
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10.3.3.   Cytotoxicity  
As a continuation of the previous studies (Chapter 9) we then decided to investigate more 
in details how variations of coordination properties and of lipophilicity of a ligand series 
can affect cytotoxicity. The 8-hydroxyquinolinic moiety was then functionalized with a 
moderately lipophilic side arm with a potential coordinating ability. The 16 ligands 
previously described differ from each other for three main aspects: 
• type and position of the third/fourth coordination atom, 
• rigidity of the coordination structure, 
• lipophilicity of the ligand. 
Structural rigidity was modulated by varying the type of linker placed between the 
aromatic moieties, using a double bond for ligands L64-L71 (vinylic linker) and a single 
bond for ligands L72-L79 (ethylenic linker).  
Variations of lipophilicity were obtained in the first place by different substitution of the 
aromatic ring of the side arm and, in the second place, by using two different starting 
quinolines, 8-hydroxyquinoline (ligands L64-L69 and L72-L77) and 5,7-dichloro-8-
hydroxyquinoline (ligands L70, L71, L78 and L79), which is more lipophilic thanks to the 
two chlorine atoms. An estimation of lipophilicity was achieved by calculating the 
octanol/water partition coefficient (logPow) through the freeware software ALOGPS 2.1 
(available on http://www.vcclab.org/lab/alogps/). Figure 127 shows a summary of the 
logPow of the synthesized ligands and of the IC50 for their complexes.  
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Figure 127. Calculated LogP of synthesized ligands and cytotoxicity of their corresponding 
Cu complexes. 
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Cytotoxicity of the ligands and of their copper complexes in stoichiometry 1:1 was 
evaluated on human tumoral cells, namely HeLa cell line (cervical carcinoma). Biological 
tests were performed both on the free ligand and on the metal complexes for comparison 
purposes and to better evaluate the role of the metal. 
Dose/response diagrams for the compounds are shown in Figures 128 and 129. 
 
 
 
Figure 128. Dose/response diagrams for six ligands and respective Cu(II) complexes. 
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Figure 129. Dose/response diagrams for the other ligands and Cu(II) complexes. 
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Cells were incubated for 48 hours in presence of different concentration of the tested 
compounds and their viability was then measured by fluorimetry using the resazurin 
method. The antitumoral activity of the cuprocomplexes was evaluated by in-situ 
complexation of the 1:1 complex, from equimolar solutions of the ligands and of CuCl2. 
This was done mainly because copper complexes showed poor solubility (complete 
insolubility for complex of L66 and L74) in DMSO and complete insolubility in water, the 
usual media used for biological tests. 
Complexes of ligands L66 and L74 were not tested due to their complete insolubility in 
water and DMSO. 
In agreement with previously reported observations, a neat increase of cytotoxicity was 
observed when CuCl2 was co-administered with the ligands. IC50 values for the ligands 
were not calculated because the model used for interpolation of experimental points of 
the dose/response did not fit the data well enough, as can be seen for ligand L67. 
Nevertheless it can be noted that cytotoxicity of the complexes is always greater than 
that of the ligands. 
In agreement with results obtained for previously tested quinolines, some ligands prove 
fairly cytotoxic, above all ligands L65, L67 and L75.  
Almost all copper complexes show good antitumoral activities, except from complexes of 
ligands L69 and L72; most active ones are complexes with ligands L70, L71, L75, L76, L77, 
L78 e L79. Best activities was observed  with complexes of L77 (IC50 = 1.2 µM) and L79 
(IC50 = 1.7 µM), which are more cytotoxic than 8-hydroxyquinoline (IC50 = 1.9 µM). 
Complex of L76 is also very active and has an IC50 = 1.9 µM, equal to that of 8-HQ. 
Complexes of L70, L71, L75 and L78 show slightly less activity, ranging from IC50 = 2.1 µM 
to IC50 = 2.5 µM. 
Apart from introduction of the metal atom, also the hydrogenation of the double bond 
has generally led an increase of antitumoral activity. In particular, L69 and L77 showed 
the highest increase of activity after hydrogenation of the vinylic linker. Two exceptions 
to the higher activity brought by hydrogenation are though represented by complex pairs 
[Cu(L65)]/[Cu(L73)] and [Cu(L64)]/[Cu(L72)]; in the first case activity did not raise after 
reduction of the double bond, but kept almost unvaried; in the second case there was a 
drastic lowering of the activity, in fact the IC50 shifted from 7.1 µM to almost 21 µM. 
Even though the series of ligands derived from 5,7-dichloro-8-hydroxyquinoline (L70, L71, 
L78 and L79) is too small to allow any significant hypothesis, complexes of ligands L70 and 
L71 are the most active of the whole vinylic series (IC50 = 2.5 µM for both complexes). 
Their cytotoxicity slightly increases with hydrogenation of the double bond to give ligands 
L78 and L79 (IC50 = 2.1 and 1.7 µM, respectively). 
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No neat correlation was found between activity and lipophilicity, maybe due to the 
narrow range of lipophilicity exhibited by the ligands and the different residual charges 
that complexes can present.  
Even though the quinolinic moiety is invariate in the ligand structures, the presence of 
very different peripheral groups (pyridinic, phenolic, anisolic, quinolinic and 8-
hydroxyquinolinic) may introduce several other activity modulators, apart from 
lipophilicity.  
Ligand L75 has lower coordinating ability than the other ligand, for its 2-methoxide 
substituent. Nevertheless its complex shows great cytotoxicity, comparable to that of 
above said complexes and even its vinylic analogue Cu(67) has a fair activity (IC50 = 5.2 
µM). Apparently, coordination with a supplemental side arm can be important but is not 
enough to cause higher activity, and other not yet well defined factors could play 
important roles. A few of these could be the residual net charge and the stoichiometry of 
the formed complexes. 
Comparing the obtained activities with those of the starting quinolines, it can be seen 
that, even though every complex with 8-HQ based ligand shows good activity, only 
complexes of L75, L76 and L77 have activities comparable with that of [Cu(8-HQ)]. A neat 
increase of activity was seen when comparing L70, L71, L78 and L79 with 5,7-dichloro-8-
hydroxyquinoline, whose cuprocomplex has an IC50 of 5.3 µM on HeLa cells. The analogue 
complexes [Cu(L70)], [Cu(L71)], [Cu(L78)] e [Cu(L79)] show an activity two to three fold 
greater than the corresponding 5,7-dichloro-8-hydroxyquinoline.  
In conclusion no neat correlation between lipophilicity and cytotoxicity has been found, 
perhaps because the logPow range exhibited by ligands is too narrow. 
On the contrary, an evident increase in activity was found for almost all hydrogenated 
ligands.  
It was concluded that some other not yet examined factors, like residual net charge and 
stoichiometry of the complexes formed in the cellular medium, might play fundamental 
roles in cytotoxic activity, maybe acting together in a cooperative way.  
In order to design new complexes with increased anticancer action, it will be required to 
bring systematic structural modifications to the ligands that have been shown so far as 
the most actives, namely [Cu(L76)], [Cu(L77)], [Cu(L78)] e [Cu(L79)]. 
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